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Abstract 
The synthesis and characterisation of novel multidentate N-heterocyclic carbene (NHC) 
ligand precursors built on calixarene, DOTA, and DTPA scaffolds is reported in this 
thesis. Several synthetic procedures to these imidazolium salts were attempted, and it 
was generally found that the best approach was to react a bromomethylated or 
chloromethylated reagent with an N-substituted imidazole, forming the imidazolium salt 
cleanly and in high yields.  
Neutral tetrakis(methylimidazole) calix[4]arene (2.4) and cationic 
tetrakis(methylimidazolium) calix[4]arene (2.5) were prepared and their solid state and 
solution behaviour was examined. It was found that compound 2.4 forms a zwitterion at 
elevated temperatures, which was seen in both solution and in the solid state. The anion 
binding properties of compound 2.5 were probed through 
1
H NMR titration 
experiments, combined with X-ray crystallography. It was found that compound 2.5 
exhibits a large range of hydrogen bonding interactions with anions, interacting via 
acidic protons on both the upper and lower rim of the calixarene.  
Propanol-tethered methyl-imidazolium mesityl-calix[4]arene (3.4) and acetate-
tethered methyl-imidazolium mesityl calix[4]arene (4.2) were prepared and their 
structures examined through anion binding experiments and X-ray crystallography. It 
was found that the propanol tethers of compound 3.4 form the primary interaction with 
anions, of the type [(O-H)
+....
X
-
], over any other acidic protons in the compound. 
Different routes to form metal-NHC complexes using these imidazolium salts were 
explored. However, as these compounds contained several acidic protons, traditional 
routes to form metal-NHC complexes were unsuccessful, resulting in either the 
formation of a complicated mixture of products, or decomposition of the ligand.  
It was found that an alternative novel electrochemical method of metal-NHC 
formation, developed in the Willans group, could be used to prepare metal-NHC 
complexes from compounds that incorporated several acidic protons. The 
electrochemical method was used to prepare tetrakis-p-(copper-N-heterocyclic 
carbene)mesityl calixarene (4.6), which was used as a ligand transfer agent to form 
tetrakis-p-(palladium-N-heterocyclic carbene) mesityl calix[4]arene (4.7). The activity 
of the palladium complex was probed in the Suzuki-Miyaura cross-coupling reaction, 
and was found to be active for the coupling of aryl bromides and phenylboronic acid. 
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An inverse correlation between activity and the concentration of the pre-catalyst (4.7) 
was observed, suggesting that the calix[4]arene does not offer any protection against 
aggregation of palladium to form palladium(0)-nanoclusters.  
NHC-ligand precursor bis[2-imidazolium(3-tert-butylacetate)ethyl]amino benzyl 
(6.5)  was prepared, which was inspired by the structure of DTPA. Using compound 
6.5, two bis-imidazolium amine salts were prepared that incorporated different potential 
donor groups (6.6 and 6.11). The electrochemical procedure was used to prepare a 
chelating copper(I)-NHC complex (6.16) from compound 6.5.  
NHC-ligand precursors were also prepared that were appended to a DOTA 
scaffold (compounds 7.15 and 7.16). The electrochemical approach was explored with 
compound 7.15, resulting in the formation of a mixed valence copper complex, where a 
copper(II) ion is coordinated inside the macrocycle, in addition to the formation a of  
copper(I)-NHC. Compound 7.16 was coordinated to gadolinium (7.17) and the potential 
of this complex as a contrast agent was examined by measuring the relaxivity. It was 
found that complex 7.17 has a relaxivity of (r1) = 5.70 mM
-1
 s
-1
 (0.5 T, 23.8 ± 0.5 °C), 
which is larger than the commercially available Gd-DOTA contrast agent Dotarem® (r1 
= 3.3 mM
-1
 s
-1
 (1.5 T, 37 °C)).  
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1 Introduction  
1.1 Introduction  
This thesis focuses on the synthesis, characterisation, and evaluation of novel 
multidentate N-heterocyclic carbene (NHC) ligand precursors and their coordination to 
metal centres. NHC ligand precursors have been designed that are appended to 
calixarene cores, as well as those that were inspired by the ligands DTPA and DOTA, 
which are used in contrast agents for magnetic resonance imaging. This chapter will 
introduce NHCs and present a review of their chemistry.  
1.2 An Introduction to Carbenes  
A carbene is a divalent carbon centre possessing six valence electrons and no charge.
1
 
The carbene centre itself can adopt one of two geometries, linear or bent. The linear 
geometry implies an sp-hybridised carbene centre, where the two non-bonding electrons 
occupy two degenerate p-orbitals (px and py) (Figure 1.1 A). The unpaired electrons are 
spin aligned following Hund‟s rule, where the electron configuration that gives the 
highest multiplicity has the lowest energy, giving linear carbenes triplet multiplicity. If 
the molecule is bent, this degeneracy is broken and the carbon centre adopts an sp
2
- 
hybridised form.
2
 The py orbital remains almost unchanged and is known as pπ, and the 
px orbital is stabilised and acquires some s-type orbital character so is referred to as σ. 
The ground state of a bent carbene therefore has four possible electronic configurations, 
being either singlet (Figure 1.1 B, C, D), or triplet (Figure 1.1 E) in nature.  In a singlet 
carbene the σ- or pπ-orbital contains an electron pair (Figure 1.1 B, C), leaving the other 
orbital empty. The lowest energy configuration for a singlet carbene is displayed in 
Figure 1.1 B, where the stabilised σ-orbital contains the electron pair. In a triplet 
carbene, both the σ- and pπ-orbital contain a single unpaired electron with parallel spins 
(Figure 1.1 E). An excited state singlet carbene can also be envisaged, where a single 
electron is promoted from the σ-orbital to the pπ-orbital. Hence both the σ-orbital and 
pπ-orbital contain a single unpaired electron with opposing spins (Figure 1.1, D).  
 The linear geometry is an extreme case, with most carbenes having bent 
geometry. The electronic configuration, hence multiplicity of the carbene centre, is 
therefore strongly dependent upon the energy gap between the σ- and pπ-orbitals. A 
large energy gap favours the formation of a singlet carbene, where both electrons 
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occupy the stabilised σ-orbital. Conversely, a small energy gap favours the formation of 
a triplet carbene, where both the σ and pπ-orbitals contain one unpaired electron. 
 
Figure 1.1  Possible electronic configurations of carbenes.
2
  
The multiplicity of a bent carbene is strongly dependent upon the nature of the two α-
substiuents, with inductive and mesomeric effects influencing the relative energies of 
the σ and pπ-orbitals. Electron withdrawing groups favour the singlet state by stabilising 
the filled non-bonding σ-orbital, which increases the σ-pπ gap (Figure 1.2, A).
3
 π-
Donating groups also favour the singlet state by destabilising the pπ-orbital, which again 
increases the σ-pπ gap.
4
 The triplet carbene state (Figure 1.2, B) is favoured for π-
withdrawing groups, where the pπ-orbital is stabilised so lowered in energy. σ-Donating  
groups also favour the triplet state by destabilising the σ-orbital, which decreases the σ-
pπ gap (Figure 1.2, B).
5
 
 
Figure 1.2  Orbital diagram showing the influence of the α-substituents on the multiplicity of the carbene 
centre.
1
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If electronic factors are negligible, then steric factors can influence the ground-state spin 
multiplicity of a carbene centre. The addition of large substituents forces the carbene to 
adopt a more linear geometry, which inherently favours the triplet ground-state.
1, 6
  
1.3 An Introduction to N-Heterocyclic carbenes (NHCs) 
N-heterocyclic carbenes (NHCs) are a type of diaminocarbene. They are typically five 
membered rings that incorporate two nitrogen atoms (Figure 1.3). The NHC ring can be 
fully saturated (imidazolidin-2-ylidenes, Figure 1.3, B) or contain an amount of  
unsaturation (imidazolin-2-ylidenes, Figure 1.3, A).
7
 The carbenic carbon positioned 
between the two nitrogen atoms is referred to as the C2 carbon, and will be referenced 
as such throughout this thesis.  
 
Figure 1.3  N-Heterocyclic carbenes 
NHCs possess bent geometry, imposed by their cyclic nature, where the carbene centre 
is sp
2
-hybridised and the singlet state dominates. Singlet multiplicity is achieved as a 
result of the constraints imposed by the geometry and nature of the α-nitrogen atoms. 
The α-nitrogen atoms are electron withdrawing which stabilises the non-bonding lone 
pair. In addition, they donate their lone pairs into the empty p-orbital which destabilises 
the empty orbital (Figure 1.4). This π-donor and σ-attractor relationship preserves the 
electroneutrality of the carbenic centre and ensures that the singlet state dominates.
1
 
 
Figure 1.4  π-Donation from the α-nitrogen atoms into the pπ orbital, stabilising the NHC. 
Consequently, NHCs act as Lewis base donors to metal ions, forming Fischer-type 
carbene complexes. The carbene donates an electron pair from the σ-orbital to the metal, 
and simultaneously accepts π-back donation from the metal d-orbitals into the empty pπ- 
orbital (Figure 1.5). However, the extent of π-back donation in metal-NHC complexes is 
usually considered to be small,
8
 as the π-donating α-nitrogen atoms ensure that NHCs 
have no requirement for backbonding (Figure 1.4).
5
 Therefore, unlike Fischer carbenes, 
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NHCs can be viewed as purely σ-donors. It should be noted here that the extent of π-
back donation in metal-NHC complexes is an area that is still in dispute, with some 
research suggesting the extent of π-interaction in electron rich metal NHC-complexes is 
significant, forming 20-30 % of the overall orbital interaction.
9, 10
   
 
Figure 1.5  Metal bonding in Fischer type carbene complexes.
5
 
As NHCs are strong σ-donors they are often compared to tertiary phosphine ligands. 
Indeed, a lot of early work in NHC chemistry involved replacing phosphine ligands in 
established transition metal complexes with NHCs and comparing the properties of the 
complexes. For example, a second generation Grubbs catalyst was prepared in which 
one of the tertiary phosphine ligands was replaced by an NHC group (Figure 1.6).
11
 
This was shown to have improved catalytic activity over the Grubbs first generation 
catalyst in olefin metathesis reactions.  
 
Figure 1.6  Second generation Grubbs catalyst.
11
  
NHCs are now considered to be much more than just phosphine mimics, offering 
several advantages over phosphine ligands such as tighter binding, greater thermal 
stability, increased basicity, and easier synthesis.
12, 13
 Furthermore, in contrast to aryl 
phosphines, NHCs have no requirement for backbonding, making them more suited to 
bind to a wider range of elements across the whole periodic table, including early 
transition metals and lanthanides ions.
14-16
 It is these features that have prompted 
research groups to use NHCs as ligands to coordinate to a wide range of metals, either 
to replace phosphine ligands in established transition metal complexes or to design new 
organometallic species.   
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1.4 The Origins of NHC Chemistry      
In 1969, the first examples of metal-NHC complexes were published independently by 
Wanzlick and Öfele. Wanzlick et al. treated an imidazolium salt with a basic metal 
precursor (Hg(OAc)2) to generate a mercury-NHC complex in situ (Scheme 1.1, A).
17
 
Öfele et al. also used the in situ method with [HCr(CO)5]
-
 as the basic metal precursor 
to form a chromium-NHC complex (Scheme 1.1, B).
18
   
 
Scheme 1.1  Preparation of the first metal-NHC complexes synthesised by deprotonation of an 
imidazolium salt by a basic metal precursor.
17, 18
 
Work in the field continued, and in 1991 the next major breakthrough was reported by 
Arduengo et al., who isolated the first uncoordinated NHC.
19
 1,3-Di-1-
adamantylimidazolium chloride was deprotonated by DMSO / NaH  in THF, which 
resulted in the formation of an NHC that was stable in anoxic conditions (Scheme 1.2). 
This procedure produced a „bottle-able‟ carbene that could be used to prepare metal-
NHC complexes directly from the free carbene, leading to a revival in the area.
20
  
 
Scheme 1.2  Preparation of the first stable crystalline uncoordinated NHC.
19
 
Since then, many different metal-NHC complexes have been prepared and 
characterised, with NHCs now recognised as very versatile ligands. They have tuneable 
steric and electronic properties that can be varied by changing the R-groups on the 
nitrogen atoms (Figure 1.3), or by changing the carbon backbone. They are also 
relatively easy to synthesise, with a range of synthetic methods being reported in the 
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literature.
1, 21-23
 Hence, NHCs are now used widely as ligands in organometallic 
chemistry.  
1.5 Synthesis of NHC ligand precursors  
NHCs are usually formed via the deprotonation of an azolium salt precursor e.g. 
imidazolium, triazolium, benzimidazolium or imidazolinium salts. For this work we are 
interested in the preparation of NHCs from their imidazolium salt precursors. Generally, 
imidazolium salts are prepared following one of two synthetic procedures: a) the 
quaternization of a neutral N-substituted imidazole compound to form the imidazolium 
salt (Scheme 1.3);
24
 or b) a multi-component reaction forming the heterocycle with the 
required substituents in one step, through the condensation of a primary amine with 
glyoxal and paraformaldehyde under acidic conditions (Scheme 1.4).
20
 Notably, this 
second method can only be used to synthesise symmetrical imidazolium salts.  
 
Scheme 1.3  Preparation of imidazolium salt from the N-substituted imidazole.  
 
 
Scheme 1.4  Preparation of imidazolium salt by condensation of two equivalents of a primary amine with 
glyoxal and paraformaldehyde.  
The C2 proton of imidazolium salts, which is on the carbon positioned between the two 
nitrogen atoms, has a characteristic low field resonance in 
1
H NMR spectra. 
Imidazolium salts can be deprotonated at the C2 position to yield an NHC.  
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1.6 Synthesis of metal-NHC complexes  
Most metal-NHC complexes are prepared either through the deprotonation of an 
azolium salt and formation of the metal-NHC complex in situ, or by adding the already 
formed NHC to a metal precursor. The typical methods used for the synthesis of metal-
NHC complexes from imidazolium salts are discussed below.
12, 20
  
1.6.1 Free carbene route  
The free carbene is generated through the deprotonation of the imidazolium salt using a 
strong base (e.g. 
n
BuLi, NaH, KO
t
Bu). The uncoordinated NHC is then added to a metal 
precursor to form the metal-NHC complex (Figure 1.7, A).
25
 This method is used if the 
free NHC is relatively stable, which is often the case for NHCs that have „bulky‟ 
substituents on the nitrogen atoms that offer steric protection about the carbenic carbon, 
e.g. 1,3-di-1-adamantylimidazolium chloride, which was deprotonated by Arduengo et 
al., to form the free carbene, and was shown to coordinate to transition metals.
19
  
1.6.2 The in situ formation of a metal-NHC complex 
The imidazolium salt is deprotonated using a base (e.g. KH, KO
t
Bu, NEt3, K2CO3) in 
the presence of a metal precursor, with the metal-NHC complex being formed in situ 
(Figure 1.7, D). This procedure offers the advantage of not having to isolate the free 
carbene, which can be unstable and difficult to handle.  
1.6.3 Transmetallation from silver  
The imidazolium salt is reacted with a basic silver precursor (such as Ag2O or 
Ag(OAc)), which deprotonates it and forms the silver-NHC complex in situ (Figure 1.7, 
C).
26
 The silver-NHC complex can then be used as a ligand transfer agent to form other 
transition metal-NHC complexes.
23
 This transmetallation route has been used 
extensively for the preparation of a range of transition metal-NHC complexes.
22
  
1.6.4 Direct metallation  
The desired transition metal-NHC complex is formed in situ using a basic metal 
precursor such as Pd(OAc)2, Rh(CO)2(acac), Cu2O (Figure 1.7, B).
27-30
 This route is 
analogous to the silver oxide route, but forms the desired transition metal-NHC complex 
in one step.  
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Figure 1.7  Different synthetic routes for the formation of a palladium(II)-NHC complex (X = Cl, Br, I).
31
 
The methods discussed above have been used extensively for the preparation of metal-
NHC complexes from their azolium salt precursors. However, other methods for NHC 
formation have been reported in the literature. For example, an NHC ligand precursor 
can be functionalised on the C2 carbon with a thermally labile group. This is then 
heated in the presence of a transition metal to form the metal-NHC complex.
32
 This 
method was used by Grubbs et al. for the synthesis of a ruthenium-NHC complex from 
the alcohol azolium, or chloroform azolium adducts.
33
    
 Further examples include a templated approach, where an isocyanide ligand is 
used as the NHC building block. The isocyanide ligand is coordinated to a transition 
metal first, and then the NHC is formed. 
34, 35
 Also Lapperts‟ method, which involves 
the insertion of a metal into the electron rich carbon-carbon double bond of a 
bis(imidazolidin-2-ylidene)-dimer (Figure 1.8).
36, 37
  
 
Figure 1.8  Synthesis of an iron(0)-NHC complex using the Lappert method (R = Me).
38
 
The synthetic procedure that is used for the synthesis of a particular metal-NHC 
complex may be dependent on the nature of the metal and the ligand. For example, the 
transmetallation from silver is not a viable route for the synthesis of early transition 
metal- or lanthanide-NHC complexes. However, a synthetic route is often selected due 
to the preference of the researcher, or availability of starting materials.  
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1.7 Mid- to late-transition metal-NHC complexes  
There are numerous examples of transition metal-NHC complexes in the literature, with 
NHCs being known to coordinate to all the d-block elements. As previously discussed, 
early work in the field concentrated on the replacement of phosphine ligands in 
established mid- to late-transition metal organometallic complexes with NHCs, and 
examining the catalytic potential of these new complexes. NHCs are known to form 
strong bonds to mid- to late-transition metals due to their soft nature, forming 
complexes with higher stability than their phosphine analogues.
39, 40
 Research began 
with simple monodentate ligands, but soon expanded to multidentate and functionalised 
NHCs bearing donor groups such as amino, amido, ether, aryloxy and alkoxy groups.
41
 
There is now a wealth of literature available on mid- to late-transition metal NHC-
complexes and their applications. In this section a few examples will be discussed. 
 Ruthenium(II)-NHC complexes have attracted wide interest due to their 
potential use as catalysts in olefin metathesis.
42
 Grubbs second generation catalysts, in 
which the phosphine ligand has been replaced by an NHC, displayed higher activity and 
stability than the first generation Grubbs catalyst (Figure 1.9).
11, 43, 44
 The observed 
increase in activity was originally thought to be a consequence of the strong trans effect 
of the NHC ligand increasing the rate of phosphine dissociation, hence the rate of 
formation of the catalytically active 14 electron species (Scheme 1.5). However, further 
studies by Grubbs et al., showed that the rate of phosphine dissociation was actually 
slower in these complexes. Instead, it appeared that the greater affinity of the 14 
electron species to bind the alkene substrates was most likely responsible for the 
increase in catalytic activity.
45, 46
 Complex D remains one of the most successful 
ruthenium pre-catalysts for olefin metathesis, and is now commercially available.
47
 
Since then, many different ruthenium-NHC complexes have been synthesised and tested 
as catalysts in olefin metathesis.
48
  
 
Figure 1.9  Grubbs first generation catalyst (A) and Grubbs second generation catalysts (B-D).
11, 43, 44
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Scheme 1.5  Possible mechanism for olefin cross metathesis, where [Ru] = Ru(NHC)Cl2. 
The applications for ruthenium-NHCs extends well beyond olefin metathesis.
42
 They 
have been used to promote reactions such as; polymerisations, olefin isomerisation, 
carbon-carbon bond forming reactions, and hydrogenation reactions.
49-53
 An interesting 
report by Whittlesey et al. described the activation of carbon-fluorine bonds using a 
ruthenium-NHC complex (Figure 1.10).
54
 The catalyst promoted the 
hydrodefluorination of hexafluorobenzene, pentafluorobenzene and pentafluoropyridine 
with alkylsilanes, with a good turnover (turnover number of up to 200), and frequency 
(0.86 h
-1
) (Figure 1.10).      
 
Figure 1.10  Catalytic C-F bond activation using a ruthenium(II)-NHC complex (Ar = IMes, IPr, SIMes, 
SIPr, and R = Et, i-Pr, Ph, EtO).
54
 
Palladium-NHC complexes have also attracted a great deal of attention due to their use 
in carbon-carbon cross-coupling reactions. They have been found to be effective 
catalysts for Heck (M = aryl), Suzuki-Miyaura (M = B(R‟‟)2), Stille (M = SnR‟‟3), 
Negishi (M = ZnBr), Hiyama (M = Si(OR‟‟)3) and Kumada-Tamao-Corriu (M = MgBr) 
coupling reactions, which all differ in the choice of transmetallating agents (R‟-M).55 In 
general, the accepted mechanism follows the route outlined in Figure 1.11, where the 
difficulty of the reaction decreases in order R-Cl > R-Br > R-I. One of the most widely 
studied of these cross-coupling reactions is the Suzuki-Miyaura reaction, due to the low 
toxicity of the starting materials and good tolerance to different functional groups.  
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Figure 1.11 Proposed mechanism for palladium(II) cross-coupling reactions, where X = Cl, Br or I, and 
M = aryl, B(R‟‟)2, SnR‟‟3, ZnBr, Si(OR‟‟)3 or M = MgBr.
55
  
The Suzuki-Miyaura reaction involves the coupling of an aryl or vinyl boronic acid / 
ester with an aryl or vinyl alkyl halide. The reaction is commonly catalysed by either a 
pre-formed palladium(II) complex,
56
 or from the in situ formed catalyst generated from 
the ligand and a palladium precursor.
57
 Elegant catalysts have been designed such as the 
complex in Figure 1.12, which allows for the coupling of sterically hindered aryl 
chlorides and aryl boronic acids to form di- and tri-substituted biaryls. The reaction can 
be performed  at room temperature, and is complete in around one hour.
58
    
 
Figure 1.12  Palladium(II)-NHC catalyst for the Suzuki-Miyaura cross-coupling reaction.
58
 
Nickel-NHC complexes are generally not as efficient as palladium-NHC complexes in 
cross-coupling reactions, and as a result are not as widely used. However, the use of 
nickel catalysts offers the advantage of lower cost, hence the design of efficient nickel 
catalysts is of interest. Chen et al., prepared a mononuclear nickel(II) complex (Figure 
1.13, A) and a binuclear nickel(II) complex (Figure 1.13, B), which were both found to 
be effective catalysts in the Negishi cross-coupling reaction, allowing for the coupling 
of unactivated aryl chlorides with organozinc reagents under mild conditions.
59
 They 
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found the bimetallic complex (B) displayed higher activity than the mononuclear 
complex (A), which they postulate is due to a bimetallic cooperative effect.   
 
Figure 1.13  Nickel(II)-NHC catalysts for the Negishi cross coupling reaction.
59
  
Rhodium-NHC and iridium-NHC complexes have attracted interest as catalysts for 
hydrogenation reactions.  The cationic iridium complex (Figure 1.14, A) was reported to 
catalyse the hydrogenation of alkenes, under mild conditions (room temperature, 1atm 
H2), with excellent enantioselectivity.
60
 The cationic rhodium complex (Figure 1.14, B) 
was reported to catalyse the transfer hydrogenation of ketones and imines, via hydrogen 
transfer from iPrOH / KOH, with a low catalyst loading of 0.001 mol % being adequate 
to completely reduce the substrate.
61
  
 
Figure 1.14  Iridium(I)-NHC and rhodium(III)-NHC for catalytic hydrogenation reactions.
60, 61
 
Recently, gold-NHCs have emerged as interesting new catalysts, predominantly being 
used for the cycloisomerization of polyunsaturated substrates, and the hydration of 
alkynes.
62
 An interesting report by Lin et al., showed that gold(I)-NHC complexes of 
the type [Au(NHC)(Py)]PF6 and [Au(Et2-bimy)Cl] can catalyse the oxidation of benzyl 
alcohol to benzaldehyde, a reaction that gold complexes were previously seen to be 
barely active for.
63
 In addition to showing catalytic potential, gold-NHCs have also 
attracted attention as potential drugs
64, 65
 and luminescent complexes.
66
   
 Although transition metal-NHC chemistry has been somewhat dominated by 
catalysis, other potential applications for mid- to late-transition metal-NHC complexes 
have been reported in the literature. Work by Youngs et al. reported silver-NHCs that 
are water soluble and have antimicrobial properties comparable to silver nitrate.
67
 NHC 
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complexes of silver(I), gold(I), palladium(II) and copper(I) have all been reported to be 
potential anticancer agents, with some displaying cytotoxicity values comparable to cis-
platin.
68
 A recent report by Santini, Dias et al. described the synthesis of amide and 
ester functionalised silver(I)-NHCs that are water soluble (Figure 1.15).
69
 Complex A 
was shown to have cytotoxicity values similar to cis-platin against HCT-15 (colon) and 
A549 (lung) cancer cells, but had three times lower cytotoxity towards non-cancerous 
cells. A limitation for the application of metal-NHCs in biomedicine is likely to be 
complex stability in biomedical environments.  
 
Figure 1.15  Ester and amide functionalised silver(I)-NHC complexes that display anticancer activity.
69
 
1.8 NHC complexes of the early transition metals and f-elements 
In contrast to their phosphine analogues, NHCs have no requirement for backbonding. 
Hence, they are more suited  than phosphines to bind to hard, electropositive metals, 
such as the early transition metals and f-elements.
2
 The first examples of these types of 
complexes had simple monodentate ligands, and were prepared through the substitution 
of weakly coordinating donor molecule(s) by a „free‟ NHC (Scheme 1.6).70 However, 
NHCs are relatively „soft‟ ligands, so in order to synthesise stable metal-NHC 
complexes, functionalised NHC ligands were designed which incorporate an anionic 
tether.
2
 The tether provides a form of covalent attachment between the metal ion and the 
ligand. Therefore, even if the metal-NHC interaction is broken, the NHC ligand will 
remain in close proximity to the metal. NHC ligands with alkoxide and amide tethers 
are most commonly used. 
 
Scheme 1.6  Preparation of an ytterbium-NHC complex by substitution of a THF ligand by the NHC.
70
  
The titanium(IV)-NHC complex (A), which incorporates an alkoxide tether, and the 
ytterbium(III)-NHC complex (B), which incorporates an amide tether, were prepared by 
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Arnold et al., and found to catalyse the polymerisation of lactide to polylactic acid 
(PLA) (Figure 1.16).
71
 The complexes were prepared through the deprotonation of the 
functionalised imidazolium salt with an s-block base, to form the s-block-NHC adduct, 
in which the NHC acts as a donor to the alkali metal. The s-block-NHC adduct was then 
used as a transmetallation agent to prepare the desired complexes, via a salt metathesis 
reaction. In recent years, early transition metal-NHC and f-block-NHC complexes have 
often been prepared through this transmetallation route, rather than through the free 
NHC route.  
 
Figure 1.16  Synthesis of amido and alkoxy functionalised NHC complexes.
71, 72
  
The suggested mechanism for the polymerisation of lactide using these complexes as 
catalysts is displayed in Scheme 1.7.
71
 The lactide monomer coordinates to the metal 
centre, displacing the NHC. The „free‟ NHC then attacks the lactide monomer, ring 
opening the lactide, and initiating polymerisation. Arnold et al. suggest that further 
chain growth occurs by monomer insertion at the metal centre. The anionic tether is 
crucial in this polymerisation reaction as it allows the NHC to be displaced from the 
metal centre but still be held in close proximity. This introduces the idea that an NHC 
could potentially act as a „gatekeeper‟ which opens and closes at the active site, with the 
metal becoming involved in reactions such as atom abstraction and polymerisation. It 
should be noted that free NHCs are also reported as catalysts for this particular reaction, 
hence the metal centre may not be involved in polymersiation.
73
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Scheme 1.7  Suggested mechanism for the polymerisation of lactide catalysed by ytterbium(III) or 
titanium(IV) anionic tethered metal-NHC complexes.
71
 
Other types of anionic tethers have been reported that are not so widely used, such as 
indenyl and fluorenyl tethered NHC complexes (Figure 1.17). These complexes were 
found to be active catalysts for the living polymerisation of isopropene, with the 
fluorenyl substituted ligand (B) displaying the higher activity.
74, 75
  
 
Figure 1.17  Indenyl and fluorenyl functionalised NHC complexes (Ln = Y, Ho, Lu).
75
 
Multidentate NHC ligands have also been employed for the synthesis of stable early 
transition metal-NHC complexes. A pincer type titanium(III) complex was found to be 
active for the polymerisation of ethylene, following methylaluminoxane (MAO) 
activation, with a productivity of 790 kg mol
-1 
h
-1 
being reported (Figure 1.18). 
76
 The 
vanadium(III) complex of the same ligand was also synthesised and was found to be 
more active than the titanium analogue, with an activity of  >1000 kg mol
-1
 h
-1
.  
 
Figure 1.18  Pincer-type metal-NHC complexes that catalyse the polymerisation of ethylene (M = 
vanadium(III) or titanium(III), Ar = 2,6-
i
PrC6H3).
76
 
Examples of actinide-NHC complexes are rare, and consist primarily of uranium-NHC 
complexes.
77-81
 Arnold et al. describe the synthesis of an alkoxide tethered 
uranium(IV)-NHC complex by treatment of the potassium alkoxide adduct with 
UI3(THF)2 (Scheme 1.8).
80
 The outcome of the reaction was found to be dependent on 
the stoichiometry. If 3 equivalents of ligand are used in the reaction, a complex is 
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formed in which an NHC ligand remains uncoordinated. The free carbene can then be 
trapped by other reagents, demonstrating the possibility of complexes to participate in 
the bifunctional activation of small molecules.  
 
Scheme 1.8  Synthesis of alkoxide tethered uranium(IV)-NHC.
80
 
To date, the applications of early transition metal and f-block NHC complexes are 
limited to polymerisation reactions. However, these complexes have potential to be used 
as bifunctional catalysts, and in the activation of small molecules. Another potential 
application of lanthanide-NHCs is in imaging. Gadolinium(III) coordination complexes 
have been used for a long time as imaging agents in magnetic resonance imaging 
(MRI), therefore it is possible that gadolinium-NHC complexes could find application 
in this field. As mentioned previously, the limitation for the application of metal-NHCs 
in biomedicine is likely to be complex stability in biomedical environments.  
1.9 Abnormal NHCs  
This thesis focuses on the synthesis of „normal‟ NHCs, where the NHC coordinates to 
the metal ion through the C2 carbon (Figure 1.19, A). However, it is worth mentioning 
that unusual binding of a NHC to the metal ion can occur, where the NHC is instead 
coordinated to the metal through one of the backbone carbons (C4 / C5) and the C2 
carbon remains protonated (B). These types of complexes are known as abnormal 
NHCs.  
 
Figure 1.19  N-heterocyclic carbenes; (A) normal NHC, (B) abnormal NHC.
12
 
The formation of an abnormal metal-NHC complex is favoured when steric strain is 
reduced at the metal centre.
82
 Also, if the counter ion of the azolium salt is changed 
from a strongly coordinating anion (Br) to a weakly coordinating anion (PF6) the 
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formation of the abnormal carbene becomes increasingly favourable (Br < BF4 < PF6 < 
SbF6).
83, 84
 A simple way to ensure that the abnormal carbene is formed exclusively is to 
introduce a substituent onto the C2 carbon of the azolium salt (e.g. a methyl group), 
forcing the NHC to coordinate to the metal in an abnormal fashion.
85
  
 Abnormal NHCs are not as widely explored as normal NHCs, but research in 
this field is growing. NHCs themselves are considered to be strong σ-donor ligands, but 
abnormal NHCs are known to be even stronger σ-donors, which can introduce some 
interesting properties.
86
 Albrecht et al. synthesised a palladium complex (Figure 1.20) 
which, in the absence of other donor ions, could form an unusually short Pd-Ag 
interaction (2.8701(8) Å), highlighting the high electron density at the palladium 
centre.
87
 Notably, the silver adduct could not be formed when the C2 bound carbene 
complex was synthesised using the same ligand (without the methyl groups on the C2 
positions). The abnormal palladium-NHC complexes was found catalyse the 
hydrogenation of cyclooctene to cyclooctane under mild conditions (room temperature, 
1 atm H2), whereas the normal NHC complex was inactive. This suggests that the 
increased electron density at the metal centre was aiding the activation of the H2 bond.  
 
Figure 1.20  An abnormal palladium(II)-NHC complex which was found to be an effective catalyst 
precursor for the hydrogenation of cyclooctene to cyclooctane.
87
 
In addition to displaying catalytic potential,
88
 there are few other reported applications 
for abnormal metal-NHC complexes. A recent report by Brown et al., describes the 
synthesis of a heteroleptic bis(tridentate) ruthenium(II) complex, that was found to have 
a microsecond excited-state lifetime (Figure 1.21). This is the highest lifetime that has 
been found for a unimolecular ruthenium(II) complex, being four times larger than 
[Ru(II)(terpyridine)2]
2+
.
89
 Brown et al. propose that the long lived excited state lifetime 
is a consequence of the strongly σ-donating abnormal triazole carbene ligand.  
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Figure 1.21  A heteroleptic bis(tridentate) ruthenium(II) complex bearing a terpyridine ligand and a 
tridentate abnormal carbene ligand.
89
 
To the best of our knowledge, the only biomedical study on abnormal metal-NHC 
complexes examined the toxicity of abnormal ruthenium(II)-NHC complexes on 
zebrafish embryos.
90
 The ruthenium(II)-NHC complexes were found to be non-toxic 
(LD50 > 100 mg L
-1
), behaving as antioxidants at low concentrations, and pro-oxidants 
at higher concentrations.
91
 The researchers suggest that these types of complexes may 
find application as antitumoral or neuroprotective drugs.    
1.10 Multidentate and macrocyclic NHCs  
The stability of metal-NHC complexes can be increased by using multidentate ligands. 
Indeed, one of the most stable palladium-NHC complexes reported to date is a bidentate 
pincer-type NHC-complex, which required prolonged heating at 140 °C before 
decomposing to form palladium(0) (Figure 1.22).
92
 The enhanced stability of this 
complex is attributed to the chelate effect, which is generally thought to be an entropic 
effect resulting from the displacement of the non-chelating ligands around the metal 
centre, increasing the disorder within the system. 
 
Figure 1.22  Bidentate palladium(II)-NHC complex where R= Me, Mes, 
t
Bu, or Dipp, and n = 0 or 1.
92
  
An interesting example of a tridentate NHC complex was reported by Meyer et al., and 
was the first example of a thallium(I)-NHC complex (Scheme 1.9).
93
 However, the 
complex was found to be highly temperature sensitive, and was only stable in THF at -
35 °C. Tridentate NHC ligands have also been used to synthesise very stable metal-
NHC complexes, such as an iron(III)-NHC complex (Figure 1.23) .
94
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Scheme 1.9  Synthesis of the first thallium(I)-NHC complex from a tridentate NHC ligand.
93
  
 
 
Figure 1.23  A stable iron(III)-complex bearing a tridentate NHC.
94
 
The formation of macrocyclic metal-NHC complexes can be challenging, however, 
there are now a few examples reported in the literature.
95
 They can be formed through a 
templated approach (Scheme 1.10),
96
 or from the macrocyclic azolium salt (Scheme 
1.11).
97
   
 
Scheme 1.10  Template synthesis of a macrocyclic tetracarbene platinum(II)-NHC complex.
96
 
 
 
Scheme 1.11  Synthesis of a macrocyclic nickel(II)-NHC complex from the bisimidazolium salt.
97
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1.11 Conclusion  
Over the last twenty years, the field of NHC chemistry has expanded. NHCs are no 
longer viewed as simply phosphine mimics and are now seen as versatile ligands with 
unique properties. By far the most widely reported application for NHCs is as ligands 
for the preparation of transition-metal catalysts. However, there are a growing number 
of reports of non-transition metal-NHC complexes, and NHCs are now finding potential 
application in the fields of biomedicine and materials. Although the field of NHC 
chemistry has reached a level of maturity, there is still much that remains to be 
discovered.  
1.12 Project aims  
This project seeks to prepare novel, multidentate, NHC ligand precursors, with a view 
to forming metal-NHC complexes with unique properties that can be exploited in 
catalytic and biomedical applications. Ligand precursors have been designed that are 
appended to calixarene cores, in addition to those that are inspired by the structural 
motifs of DTPA and DOTA. The target ligands all incorporate at least two potential 
NHC coordination sites, with some also incorporating anionic alkoxide binding sites. 
Hence, a combination of both soft (NHC) and hard (anionic tether) donor sites may help 
stabilise complexes that are not possible through a combination of monodentate ligands.
 The calix[4]arene scaffold was selected as it provides a rigid platform that can 
be functionalised with up to four imidazolium groups. This presents the opportunity to 
prepare unique metal-NHC complexes that can incorporate up to four metal centres per 
ligand. These complexes can be monometallic or incorporate more than one type of 
metal (e.g. bimetallic systems). The project will firstly focus on synthesising two 
different types of calix[4]arenes, the cone type calix[4]arene and the 1,3-alternate 
calix[4]arene, that are functionalised with imidazolium groups. The synthetic routes will 
be obtimised where possible in order to produce compounds in high yield and purity. 
The N-substituent on the imidazolium nitrogen will be varied to include ligands that 
also incorporate anionic tethers, to extend the range of metals that the ligands can 
coordinate to. The coordination of these ligands to various metals will be explored, 
including silver, palladium, ruthenium, copper and rhodium, in order to generate 
complexes to examine in catalysis.  
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Ligands have also been designed that are inspired by the structural motifs of the acyclic 
chelating ligand DTPA, and the macrocyclic ligand DOTA, with a view to forming 
metal-NHC complexes with greater stability than traditional metal-NHC complexes. 
This may enable the application of metal-NHCs in biomedicine, an area that has not 
been widely studied. A synthetic route for the formation of these ligands will be 
determined and optimised. The coordination of these ligands to late-transition metals 
will be explored for potential application in catalysis. The ligands will also be 
coordinated to gadolinium(III) and their efficacy as contrasts agent examined through 
NMR experiments. 
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2 Tetrakis(methylimidazole) and tetrakis(methylimidazolium) calix[4]arenes: 
competitive anion binding and deprotonation 
Calixarene is the name given to a group of macrocyclic compounds that consist of 
linked phenol units. The term was originally conceived to describe the shape of the 
tetrakis phenol calixarene that is described in this chapter, but its use has been extended 
to include compounds that incorporate more or fewer phenol units, and those 
incorporating other aromatic groups. Calixarenes can adopt shapes from cones and 
baskets to wheels.
1
 They contain hydrophobic cavities within the structure that are able 
to „fit‟ other molecules, leading to them receiving wide attention in host-guest 
chemistry.
2-4
 The design of these molecules can be varied by functionalising the 
phenolic (lower) and / or non-phenolic (upper) ring,
5
 giving access to a range of 
compounds with interesting and useful properties.
6-8
 Neutral tetrakis(methylimidazole) 
calix[4]arene (2.4) and the novel cationic tetrakis(methylimidazolium) calix[4]arene 
(2.5) have been prepared and their solid-state and solution behaviour examined. It was 
found that compound 2.4 forms a zwitterion at elevated temperatures, which was 
observed both in solution and in the solid-state. Compound 2.5 exhibits a range of 
hydrogen bonding interactions with anions, interacting via acidic protons on both the 
upper and lower rim of the calixarene. The anion binding properties of compound 2.5 
were probed through 
1
H NMR titration experiments combined with X-ray 
crystallography. 
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2.1 Synthesis of tetrakis(methylimidazole) and terakis(methylimidazolium) 
calix[4]arenes (2.4 and 2.5) 
 
Scheme 2.1  Synthesis of tetrakis(methylimidazole) calix[4]arene 2.4 and tetrakis(methylimidazolium) 
calix[4]arene 2.5 (X = Br or PF6). 
The preparation of 4-hydroxy-tert-butyl calix[4]arene (2.1) was carried out via the base 
induced condensation of para-tert-butyl phenol and formaldehyde.
9
 The procedure is 
well established, originally being reported by Zinke and later modified by Gutsche.
9, 10
 
The desired calixarene 2.1 is produced in moderate yields of 40-50 %, and isolated by 
recrystallisation from toluene. The removal of the tert-butyl groups using aluminium 
chloride generates 4-hydroxy calix[4]arene (2.2), a reagent suitable for functionalisation 
on the upper rim.
9, 11, 12
 The bromomethylation of compound 2.2 was performed with 
HBr and paraformaldehyde in glacial acetic acid, isolating 1-bromomethyl-4-hydroxy 
calix[4]arene (2.3) as an off-white solid.
13
 Compounds 2.1 and 2.3 were isolated and 
characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with mass 
spectrometry. The reaction of compound 2.3 with excess imidazole in methanol yields 
tetrakis(methylimidazole) calix[4]arene (2.4).
14
 A base is not required due to the 
amphoteric nature of imidazole, which acts as a base in these types of nucleophilic 
substitution reactions. Although the compound is reported in the literature, we have 
developed a simpler synthetic procedure resulting in a product of similar purity and 
comparable yields.
15
 Compound 2.4 was isolated as a colourless solid and characterised 
by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass spectrometry and elemental 
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analysis. Colourless prism crystals were obtained by heating a saturated chloroform 
solution of compound 2.4 to 60 °C in a sealed vessel, then allowing the solution to cool 
slowly to room temperature. The molecular structure is displayed in Figure 2.1, and is 
the first time that the solid state structure has been reported.    
 The compound crystallised in the monoclinic P crystal system, and the structural 
solution was performed in the space group P21/c. To the best of our knowledge, this is 
the first calix[4]arene structure with methyl imidazole substituents on the upper rim 
(para positions with respect to the hydroxyl groups).  
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Figure 2.1  Molecular structure of compound 2.4•CH3Cl•2H2O illustrating a) cone conformation with a 
molecule of chloroform in the cavity, b) deprotonation of the hydroxyl group (O4) and protonation of the 
imidazole nitrogen (N4), c) hydrogen bonding network within the structure. The majority of the hydrogen 
atoms have been omitted for clarity. Ellipsoids are displayed at 50% probability. 
 
a 
c 
b 
a 
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N(4)-C(35) 1.383(3) N(2)-C(30)-N(1) 112.25(19) 
N(4)-C(34) 1.394(2) C(30)-N(2)-C(31) 104.59(18) 
O(2)-H(2) 0.857(1)   
O(2)-O(3) 2.704(2)   
O(6)-N(6B) 2.269   
Table 2.1  Selected bond distances (Å) and angles (deg) for compound 2.4. 
From the crystal structure it can be seen that compound 2.4 adopts the expected cone 
type conformation, where the imidazole groups project upwards with respect to the 
plane defined by the bridging methylene groups. The compound adopts the cone 
conformation due to the favourable hydrogen bonding network of the hydroxyl groups 
on the lower ring, as displayed in Figure 2.1b. Two of the imidazole groups orientate 
themselves with the carbon between the two nitrogen atoms (C2) protons pointing 
towards the centre of the ring, and two with the C2 protons pointing away, resulting in 
an unsymmetrical structure.       
 Compound 2.4 crystallises as a clathrate complex with a molecule of chloroform 
contained within the cavity. The inclusion of solvent in the solid state structures of 
calixarenes is often observed, with para-tert-butyl calix[4]arene being shown to form 
clathrate complexes with chloroform, toluene, xylene and anisole.
16-18
 Parma et al. 
studied the factors that affect this complexation and found that it was dependent on the 
size of the calixarene, the substituents in the para position, and the conformational 
rigidity of the calixarene molecule.
17, 19, 20
      
 An interesting feature of the structure is that compound 2.4 exists as the mono-
zwitterion in the solid state, with one of the hydroxyl groups deprotonated (O4), and 
one of the imidazole nitrogens protonated (N4). The protonated nitrogen (N4) on the 
imidazole of one calixarene hydrogen bonds with a non-protonated nitrogen (N2) on a 
neighbouring calixarene (Figure 2.1c). The remaining two imidazole groups interact 
with water molecules contained within the structure appearing to cause disorder, with 
the imidazole groups occupying two sites (N6A / B, N8A / B).   
 The formation of the mono-zwitterion was not entirely unexpected. The first 
deprotonation of a hydroxyl group of a calix[4]arene molecule has been shown to be 
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favourable by Grootenhuis et al., with the reasons being twofold.
21
 Firstly, the 
formation of a charged species dramatically increases the favourable electrostatic 
interactions of the calixarene with the solvent molecules. Secondly, from their 
calculations, it was shown that the hydrogen bonding interactions at the lower rim of the 
calixarene can be strengthened upon deprotonation of one of the hydroxyl groups. 
However, the deprotonation of the second, third and fourth hydroxyl group becomes 
progressively more unfavourable due to the repulsive interactions formed between the 
negatively charged oxygen atoms. As a result this mono-zwitterionic structure would be 
a favourable conformation for compound 2.4 to adopt.    
 A 
1
H NMR spectrum of compound 2.4 in DMSO-d6 at room temperature is 
displayed in Figure 2.2. The poor solubility of compound 2.4 in most organic solvents 
(it is only soluble in DMSO at room temperature and chloroform at elevated 
temperatures) made studying the solution-state properties of compound 2.4 a challenge. 
An interesting feature of the 
1
H NMR spectrum is the appearance of the methylene 
proton signals of carbon 6 (Figure 2.2). At room temperature these appear as a broad set 
of doublets at δ = 3.13 ppm and δ = 4.21 ppm. This is attributed to the interconversion 
of the cone conformation that occurs slowly on the NMR timescale at room 
temperature, resulting in the signals broadening and unresolved coupling of the 
methylene protons. The remainder of the spectrum appears as expected, with the 
imidazole CH resonances as singlets at δ = 7.95 ppm (1), δ = 7.72 ppm (2 / 3) and δ = 
7.06 ppm (2 / 3) (the 
1
H NMR spectrum being too broad to show any coupling between 
the inequivalent backbone imidazole protons). The aromatic protons appear as a singlet 
at δ = 6.80 ppm (5), and a further singlet resonance at δ = 4.91 ppm is attributable to the 
CH2 protons which tether the imidazole groups to the calixarene skeleton (4). We did 
not observe any signals for the hydroxyl protons in the 
1
H NMR spectrum in DMSO-d6.  
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Figure 2.2  
1
H NMR (DMSO-d6) spectrum of compound 2.4 at 298 K.  
The 
1
H NMR spectrum of compound 2.4 in DMSO-d6 does not show any evidence for 
the formation of the mono-zwitterion. This would likely exhibit a low field resonance at 
around 9 ppm attributable to the imidazolium C2 proton. However, upon heating the 
DMSO-d6 solution to 382 K, the 
1
H NMR spectrum displays a lowering of symmetry 
and the appearance of a resonance at δ = 9.02 ppm, suggesting that the mono-zwitterion 
is formed at elevated temperatures (Figure 2.3). Upon cooling the
 
NMR sample back to 
room temperature, the 
1
H NMR spectrum remains unchanged rather than converting 
back to the original spectrum (Figure 2.4). This suggests that the mono-zwitterion is 
formed at elevated temperatures and is retained in solution upon cooling. We 
investigated this further by examining the conditions under which the crystals were 
prepared. Compound 2.4 was heated at 60 °C in chloroform for 18 hours in a sealed 
vessel. The solvent was removed in vacuo and the product examined by 
1
H NMR 
spectroscopy in DMSO-d6 at room temperature. Again, a high field resonance was 
observed at δ = 9.15 ppm that was attributed to the imidazolium C2 proton. We propose 
that the mono-zwitterion is formed on heating the molecule in chloroform, and 
crystallises when the solution is cooled.  
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Figure 2.3  VT 
1
H NMR spectra of compound 2.4 in DMSO-d6. 
 
Figure 2.4  
1
H NMR spectrum of compound 2.4 after heating in DMSO-d6 to 382 K, then allowing the 
NMR sample to cool to 302 K. 
A further difference between the 
1
H NMR spectra of compound 2.4 in DMSO-d6 at 
room temperature and at elevated temperatures is the appearance of the methylene 
bridging protons (carbon 6). As discussed previously, the methylene protons appear as a 
broad set of doublets at room temperature at δ = 3.13 ppm and δ = 4.21 ppm, attributed 
to the interconversion of the cone that occurs slowly on the NMR timescale at room 
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temperature. As the temperature is raised this interconversion becomes more rapid and 
therefore the resonances coalesce and appear as a broad singlet at 3.7 ppm (Figure 2.3, 
1
H NMR spectrum recorded at 382 K). Upon closer examination of the spectra at 
elevated temperature, two sharp doublets at δ = 3.21 ppm and δ = 4.38 ppm can also be 
seen on either side of the singlet resonance. We propose that this is owing to restricted 
rotation on one side of the calixarene due to the formation of the mono-zwitterion and 
the resulting hydrogen bonding interactions. The formation of the zwitterion would also 
account for the lowering of symmetry that is observed in the 
1
H NMR spectra at 
elevated temperatures.         
 Compound 2.4 was initially synthesised as a precursor to prepare the novel 
tetrakis(methylimidazolium) calix[4]arenes. The proposed synthetic route was to 
functionalise the uncoordinated nitrogen on the neutral imidazole of compound 2.4 to 
form an imidazolium species (Scheme 2.2). The quaternarisation of a neutral N-
substituted imidazole is a method that is often used to prepare imidazolium salts.
22
 The 
reaction of compound 2.4 with haloalkanes, haloalcohols and haloacetates was 
attempted as dry melts and in solution (THF / DCM). A complicated mixture of 
products was consistently formed which appeared to include imidazolium species, 
supported by the appearance of downfield resonances in the 
1
H NMR spectra at between 
8.5 ppm and 9.5 ppm. However, there were always multiple products and purification of 
the product mixtures proved unsuccessful.  
 
Scheme 2.2  Attempted synthesis of novel tetrakis methylimidazolium calix[4]arene molecules (R = 
alkyl, X = halide). 
For the reaction to produce the desired tetrakis(methylimidazolium) calix[4]arene, all 
four uncoordinated nitrogen atoms on compound 2.4 would need to be alkylated. The 
product mixtures isolated from this set of reactions is likely due to the reaction forming 
the 4-, 3-, 2- and 1- substituted products in varying ratios (Figure 2.5).  The desired 4-
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tethered product (A) could not be isolated from the reaction mixture, which was most 
likely due to the similar properties that these molecules are expected to possess. There 
was also the possibility of the phenolic oxygens on the lower rim of compound 2.4 
reacting with the alkylating agent to form the corresponding ester or ether. This would 
further complicate the product mixtures isolated from the reaction.   
 
Figure 2.5  Suggested products from the reaction of compound 2.4 with haloalkanes, haloalcohols and 
haloacetate (R= alkyl group and X = halide).  
The approach to the synthesis of the target imidazolium salts was therefore altered. 1-
Bromomethyl-4-hydroxy calix[4]arene (2.3) was reacted with the already N-substituted 
imidazole to produce compound 2.5 directly (Scheme 2.1), rather than proceeding via 
compound 2.4. The simplest imidazole, 1-methyl imidazole, was used as a starting point 
to test the synthetic method. 1-Methyl imidazole was added to a DCM solution of 
compound 2.3 and a white precipitate formed immediately. The mixture was stirred at 
room temperature, under a nitrogen atmosphere, for 12 hours. The white solid was 
isolated by filtration, and purified by washing further with DCM and was dried in 
vacuo. Compound 2.5 Br was characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy combined with mass spectrometry. The bromide anions were exchanged 
for hexafluorophosphate using ammonium hexafluorophosphate in water to afford the 
hexafluorophosphate salt of 2.5 as a white solid. Compound 2.5 PF6 was characterised 
by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass spectrometry and elemental 
analysis.           
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 The 
1
H NMR spectrum of compound 2.5 PF6 in MeCN-d3 is displayed in Figure 
2.6, with the relevant peaks assigned in Table 2.2. At room temperature, the 
1
H NMR 
spectrum appears as expected, with the resonance for the imidazolium C2 proton 
appearing at 8.47 ppm, which is a downfield shift compared to the neutral imidazole 
compound 2.5 at δ = 7.99 ppm.  However, the signals for the methylene bridging 
protons (carbon 6) were not observed. This was the case for both the bromide and the 
hexafluorophosphate salts in DMSO-d6, MeCN-d3 and MeOH-d4. On cooling the 
MeCN-d3 sample to 248 K, a pair of doublets appeared in the 
1
H NMR spectrum at δ = 
4.17 ppm and δ = 3.50 ppm, that were assigned as the methylene protons from carbon 6 
(Figure 2.6). This is in contrast to the neutral imidazole compound 2.4, where the 
signals from the methylene protons are observed as a broad set of doublets at room 
temperature. This suggests that the interconversion of the cone is faster in compound 
2.5 than in compound 2.4 in the solvents studied, or alternatively another exchange 
process is occurring within the molecule. For example, the methylene protons could be 
exchanging with the acidic imidazolium protons in compound 2.5. 
 
Figure 2.6  
1
H NMR spectra (MeCN-d3) of compound 2.5 PF6 at 300 K and 248 K. 
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Chemical shift (δ ppm) 1H Assignment 
8.47 (s, 4H) 1 
7.32 (s, 4H) 2 / 3 
7.26 (s, 4H) 2 / 3 
7.15 (s, 8H) 5 
5.03 (s, 8H) 4 
4.17 (d, 2H, 
2
JHH = 13.8 Hz) 6  
3.78 (s, 12H) 7 
3.50 (d, 2H, 
2
JHH = 13.8 Hz) 6 
Table 2.2  
1
H NMR assignment for compound 2.5 PF6 at 248 K. 
Crystals were obtained by slow diffusion of diethyl ether into a methanol solution of 
compound 2.5 Br (Figure 2.7). To the best of our knowledge, this is the first structure of 
a cationic calix[4]arene (bearing hydroxyl groups) in the absence of a metal. Once 
more, the structure shows the expected cone conformation, with the imidazolium groups 
projecting upwards with reference to the plane defined by the bridging methylene 
groups. Unlike compound 2.4, the molecule is symmetrical, with the imidazolium 
groups pointing in the same direction on either side of the molecule (Figure 2.7a). The 
hydroxyl groups on the bottom of the ring interact with a bromide anion (Br3), 
illustrating that it is not just the imidazolium groups that interact with the anions (Figure 
2.7b). The remaining bromide anions interact with the relatively acidic imidazolium 
protons within the structure. The calixarenes are arranged “back to back” with each aryl 
ring involved in π-π bonding with the neighbouring calixarene molecules (Figure 2.7c 
and d).  
 
 
 
 
 
 
 
 
Chapter 2. Tetrakis(methylimidazole) and tetrakis(methylimidazolium) calix[4]arenes: 
competitive anion binding and deprotonation  
  
37 
 
 
Figure 2.7  Molecular structure of 2.5 Br illustrating a) the molecular structure of 2.5 Br, b) OH···anion 
interactions, c) π-π interactions between neighbouring aromatic rings, d) packing of the molecule 
displaying the 2D layers. The hydrogen atoms and methanol molecules have been omitted for clarity. 
Ellipsoids are displayed at 50% probability. 
b 
d 
a 
c 
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N(4)-C(17) 1.362(10) N(3)-C(18)-N(4) 109.1(6) 
N(4)-C(18) 1.344(10) N(3)-C(15)-C(13) 110.5(5) 
N(3)-C(18) 1.327(9) O(1)-C(7)-C(2) 120.9(5) 
O(1)-C(7) 1.389(6)   
Table 2.3  Selected bond distances (Å) and angles (deg) for compound 2.5. 
The packing diagram for compound 2.5 Br shows that the calixarene units are arranged 
in 2D layers, with the OH groups pointing inwards and the imidazolium groups pointing 
towards each other (Figure 2.8). The bromide anions that are interacting with the 
backbone C4 protons sit between the layers, with large pores between these bridging 
bromide ions. The distance between closest bridging bromide ions is 10.8 Å, and 
between OH-coordinating bromide ions is 9.8 Å. Disordered methanol molecules 
occupy the channels. The structure shows that several hydrogen bonding interactions 
with guest anions exist in this calixarene due to the range of acidic protons on both the 
upper and the lower rims. As the channels in the structure of compound 2.5 Br are 
relatively large, and are lined by imidazolium moieties, the material offers distinct 
possibilities for use in both catalysis and gas storage.
23, 24
 
  
Figure 2.8  X-ray crystal packing diagrams of compound 2.5 Br displaying 2D channels in the structure  
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2.2 Anion binding studies of tetrakis(methylimidazolium) calix[4]arene (2.5) 
Anions play important roles in biological systems, medicine and the environment. 
Consequently, the design of anion binding and anion sensing systems is extremely 
topical.
25-29
 Anion sensors usually rely on the presence of non-covalent interactions 
between the host and guest to allow for host-guest recognition. The range of interactions 
includes electrostatic interactions, hydrogen bonding interactions, dispersion 
interactions, coordination to a metal ion, or a combination of these non covalent 
interactions. Imidazolium units offer the potential of being effective anion receptors due 
to the strong hydrogen bonding interactions they are able to form with anions of the 
type [(C-H)
+
····X
-
].          
 A key challenge in anion recognition is the design of anion sensors that are 
selective. One way to achieve selectivity is the pre-organisation of the host molecule to 
„fit‟ a guest based upon its size and charge distribution. Tripodal imidazolium, 
pyridinium and cryptand based systems, in addition to calixarenes, are examples of such 
pre-organised cavities.
30-32
 With pre-organisation, even weak anion binding sites can act 
as effective anion receptors.
31, 33
 In addition, many systems are highly dependent upon 
the location of the anion binding sites and can give an interesting response to anion 
binding. For example, an induced conformational change may bring about a 
photophysical, colourimetric or an electrochemical response.
34-39
   
 Calixarenes are versatile frameworks that can act as hosts for cations, anions and 
neutral molecules, depending upon their functionalisation. Calix[4]arenes can exist in 
four possible conformations; cone, partial cone, 1,2-alternate and 1,3-alternate. Each of 
these offers different advantages in terms of anion binding, with cone type structures 
acting as rigid scaffolds, whereas 1,2-alternate and 1,3-alternate calix[4]arenes have 
more flexible configurations. Studies on imidazolium calixarenes have shown that both 
cavity size and pre-organisation are important, with bis(imidazolium) calix[4]arenes 
showing selectivity for carboxylates, while tetrakis(imidazolium) calix[4]arenes are 
selective for dicarboxylates.
40, 41
Allosteric enhancement has also been shown to play a 
part in binding affinity.
42
         
 The anion binding properties of tetrakis(methylimidazolium) calix[4]arene (2.5) 
were probed by 
1
H NMR spectroscopic titration with various tetrabutylammonium salts. 
As a precipitate formed during the titration experiments in MeCN-d3, the spectroscopic 
data was obtained in DMSO-d6. Compound 2.5 PF6 was dissolved in 0.8 ml of DMSO-
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d6.  The anions as their tetrabutylammonium salts were made up to 1 mL in DMSO-d6, 
and were approximately 10 times the concentration of the host (Table 2.4). 20 µL 
aliquots of the guest were added to the NMR tube and the spectra recorded after each 
addition. Upon addition of chloride, bromide and nitrate anions, there is a downfield 
shift of the C2 proton of the imidazolium, clearly indicating (C-H)
+
····X
-
 interactions. 
The downfield shift is most significant with chloride and least significant with nitrate, 
which reflects decreasing basicity, though size selectivity cannot be ruled out (Figure 
2.9). 
Guest as their 
Bu4N
+
X
- 
salts   
Mass of 2.5 PF6 
(g) 
Moles of 2.5 PF6  Mass of Guest 
(g) 
Moles of Guest 
Br
- 0.0201  1.45×10-5
 
0.0637  1.98×10-4 
Cl
- 0.025  1.81×10-5 0.0630  2.27×10-4 
CH3COO
- 
0.025  1.81×10-5 0.0635  2.11×10-4 
H2PO4
- 
0.023  1.66×10-5 0.0629  1.85×10-4 
NO3
- 
0.025  1.81×10-5 0.0630  2.07×10-4 
Table 2.4  Moles of host (2.5 PF6) and guest (Bu4NX, X = Cl, Br, CH3COO, PO4, NO3) used in the 
1
H 
NMR titration experiments.   
The equivalents of guest that had been added were calculated by taking the ratio of host: 
guest concentration after each 20 µL addition, hence taking into account the change in 
volume. The equivalents of guest were plotted against the chemical shift of the C2 
proton and the results are displayed in Figure 2.9. Figure 2.9 illustrates that as the 
tetrabutylammonium chloride and bromide salts were titrated into the DMSO-d6 
solution of 2.5 PF6, there is a significant change in the chemical shift up to the point 
where four equivalents of the anion has been added. The largest change in the chemical 
shift of the C2 proton occurs between 0-1 equivalents of guest. Above four equivalents, 
the graph begins to level off, with the chemical shift only changing slightly between 
four and six equivalents. During the addition of the tetrabutylammonium nitrate salt, 
there is less of a change in the chemical shift, with only a slight increase observed up to 
the point where 2 equivalents of the nitrate anion has been added, then the graph begins 
to level off.  
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Figure 2.9  
1
H NMR spectroscopic titration data for binding of Cl
-
, Br
-
 and NO3
-
 by compound 2.5 PF6 in 
DMSO-d6. 
The stoichiometry of the chloride and bromide binding was examined by the Job‟s 
method. The plot maximum falls at 0.5, suggesting 1:1 binding for both chloride and 
bromide (Figure 2.10). The binding of nitrate was also probed by the Job‟s method but 
showed no correlation, suggesting that binding was less selective for nitrate than for 
chloride and bromide anions. The data obtained from these experiments was used to 
calculate the anion binding constants. Using HypNMR, fits were obtained manually for 
anion binding constants based upon a 1:1 stoichiometry (Table 2.5).  
 
Figure 2.10  Job plot in DMSO-d6 for the interaction of compound 2.5 PF6 with Bu4NBr and Bu4NCl. 
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Anion logβ11 Δδ at 1 
equivalent 
Cl
-
 1.45 0.201 
Br
-
 1.40 0.110 
NO3
-
 1.06 0.026 
Table 2.5  Anion binding constants of 2.5 PF6 with tetrabutylammonium salts.  
The calculated binding constants show, as expected, that chloride has the highest 
stability constant for 1:1 binding, and nitrate the lowest. Automatic refinement was not 
possible, likely due to the broad range of CH hydrogen bonding interactions involving 
not just the acidic NCHN units but also the backbone imidazolium protons and the 
lower rim hydroxyl groups. Evidence for this is in the 
1
H NMR spectra, where a 
chemical shift change occurs for the backbone imidazolium protons as well as for the 
C2 proton. In compound 2.5 PF6, the backbone resonances appear as a singlet at δ = 
7.65 ppm and, upon addition of anions, split into two singlets, with one moving further 
downfield (Figure 2.11). The downfield shift is most pronounced for chloride and least 
for nitrate. Further evidence of a broad range of anion interactions is seen in the crystal 
structure discussed previously (Figure 2.7). The bromide anions form several different 
hydrogen bonding interactions with the acidic protons on both the upper and lower rims 
of the calix[4]arene. 
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Figure 2.11  
1
H NMR (DMSO-d6) spectroscopic titration data for compound 2.5 PF6 on addition of 
Bu4NBr. 
The anion binding of compound 2.5 PF6 was also probed with tetrabutylammonium 
acetate and tetrabutylammonium dihydrogen phosphate, both of which show unusual 
behaviour. A downfield shift of the C2 proton resonance is observed up to the addition 
of one equivalent of guest. Following this, there is a slight upfield shift of the C2 proton 
resonance to about 1.5 equivalents of guest, before the resonance continues to move 
downfield upon further addition of guest (Figure 2.12). As acetate and phosphate are 
basic anions, they also have the potential to deprotonate acidic protons and, as discussed 
previously, compound 2.5 has a broad range of acidic protons. It appears that the first 
equivalent of these guests interacts with the imidazolium C2 protons at the upper rim, 
resulting in the downfield shift of the proton resonance for these protons. Following this 
the anions interact with a different part of the calixarene, with a change in molecular 
shape being the likely cause of the slight upfield chemical shift of the C2 protons. It is 
probable that the second equivalent of these basic anions are interacting with the acidic 
lower rim, causing (partial) deprotonation of one of the hydroxyl groups, which will 
result in a slight change in the shape of the calixarene. The anions then continue to 
interact with the C2 protons of the upper rim. This behaviour would lead to the unusual 
appearance of the titration curves.  
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Figure 2.12  
1
H NMR spectroscopic titration data for binding of acetate (top) and dihydrogen phosphate 
(bottom) by compound 2.5 PF6 in DMSO-d6. 
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2.3 Conclusion  
In conclusion, a synthetic procedure has been developed for the synthesis of neutral 
tetrakis(methylimidazole) calix[4]arene (2.4) and the novel cationic 
tetrakis(methylimidazolium) calix[4]arene (2.5). The properties of these compounds in 
solution and the solid state have been thoroughly investigated.    
 It was found that the neutral compound 2.4 can exist as the mono-zwitterion, 
both in solution and the solid state. The zwitterion has the potential to bind cations on 
the lower rim through electrostatic interactions e.g. alkali metals, or in the cavity 
engaging in cation-π interactions. The compound could also bind anions on the non-
phenolic upper rim through hydrogen bonding to the acidic protons of the imidazole. 
The solubility of compound 2.4 is the limiting factor in studying these applications. The 
project could be extended by looking into the synthesis of soluble imidazole 
calixarenes, with the potential to act as hosts for salts. The solubility would most likely 
be improved by adding a functional group to the phenolic oxygen of the lower rim.
 The novel cationic tetrakis(methylimidazolium) calix[4]arene 2.5 has also been 
prepared and fully characterised. Compound 2.5 shows increased solubility compared to 
the neutral tetrakis(methylimidazole) calixarene 2.4, allowing the binding properties of 
this molecule to be studied. The studies on compound 2.5 have shown that it contains a 
plethora of acidic CH groups which take part in hydrogen bonding interactions with 
anions, observable both in solution and in the solid-state. The location of the interaction 
site with basic anions appears to be selective depending upon the concentration of 
anions relative to calixarene. This offers the possibility of sensing, or communication 
between the different binding regions, which is dependent upon anion concentration. 
2.4 Future work  
The tetrakis(methylimidazolium) calix[4]arene has been prepared using the simplest N- 
substituted imidazole (1-methyl imidazole) as a precursor. This has allowed the 
development of a synthetic procedure, and the opportunity to study the properties of this 
molecule in comparison to the neutral tetrakis(methylimidazole) calix[4]arene. As the 
molecule has been shown to display interesting interactions with anions, the project has 
the potential to be developed further. The N-substituent on the imidazole could easily be 
changed from methyl to another more complex substituent such as propanol, acetate, 
aromatic, or even a biologically relevant group e.g. peptide. It would be expected that 
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the desired product could be synthesised following the same synthetic procedure.  This 
may introduce further anion binding possibilities or even fluorescent properties to the 
molecule, depending on the substituent that was selected.     
 The introduction of the imidazolium functionality to the tetrakis calix[4]arene 
molecule also offers the potential to prepare metal-NHC complexes of this ligand. This 
has not been investigated to date as it is anticipated that the hydroxyl groups on the 
lower rim would make the formation of the desired carbene complex problematic. 
However, if the hydroxyl groups were protected, the formation of the metal-NHC 
complex should be possible and would be an interesting extension to this work.  
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3 Propanol tethered methylimidazolium mesityl calix[4]arene: Ligand synthesis 
and metal complexation 
As discussed in chapter two, calixarene is a name given to a group of macrocyclic 
molecules that consist of four or more linked aromatic units. Calix[4]arenes can adopt 
four possible conformations; cone, partial cone, 1,2-alternate and 1,3-alternate, with the 
conformation of the calixarene being dependent on the rotation about the CH2-aromatic 
bond. The previous chapter focused on calix[4]arenes that adopt the cone-type 
conformation, which is favoured due to the hydrogen bonding network formed between 
the hydroxyl groups on the lower rim. In this chapter we are concerned with the 
synthesis of the 1,3-alternate calix[4]arene, where two of the functional groups project 
upwards, and two project downwards, in reference to the plane defined by the bridging 
methylene groups. In this scenario, the conformation of the molecule is no longer 
restricted by the hydrogen bonding of the hydroxyl groups, since mesityl moieties 
replace the phenol groups. The steric bulk of the mesityl groups forces the molecule to 
adopt the 1,3-alternate conformation.        
 Propanol tethered methylimidazolium mesityl calix[4]arene (3.4) has been 
prepared and examined through 
1
H NMR spectroscopy and X-ray crystallography. 
Compound 3.4 was used as an NHC ligand precursor to prepare metal-NHC complexes 
through a range of experimental techniques.  A silver-NHC complex of the ligand was 
prepared following the well-documented Ag2O route.
1-3
 A copper(I)-NHC complex was 
prepared using Cu2O, following a similar procedure to the Ag2O reaction.
4
 The use of 
the silver-NHC and copper-NHC complexes as transmetallation agents to form 
palladium-NHC complexes was explored.
5-7
 The palladium-NHC complex is expected 
to find application in catalysis e.g. cross-coupling reactions.
8
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3.1 Synthesis of propanol tethered methylimidazolium mesityl calix[4]arene 
(compound 3.4)  
 
Scheme 3.1  Proposed synthetic routes for the preparation of propanol tethered methylimidazolium 
mesityl calix[4]arene 3.4 (X = Br, Cl, I or PF6). 
The preparation of mesityl calix[4]arene (3.1) was carried out via the SnCl4 catalysed 
cyclisation of α-chloroisodurene.9 The product was isolated in moderate yields of 40-50 
% and purified by extraction into DCM from water. The molecule is locked in the 1, 3- 
alternate conformation, and can be used as a platform to support functional groups such 
as organometallic anion binding groups, or anion receptor groups.
10, 11
   
 The bromomethylation of compound 3.1 was performed using HBr and 
paraformaldehyde in glacial acetic acid, isolating the bromo-methylated mesityl 
calix[4]arene (3.2), a reagent that is suitable for functionalisation by nucleophiles.
12
 The 
reaction of 3.2 with excess imidazole in methanol affords methylimidazole mesityl 
calix[4]arene (3.3).
13
 As previously discussed, a base is not required in these types of 
nucleophilic substitution reactions as imidazole itself acts as a base. Compound 3.3 was 
isolated as a cream coloured solid and characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy combined with mass spectrometry. The compound is reported in the 
literature, however, we report a simplified synthetic procedure that results in a product 
of similar purity and comparable yield.
14
 Compound 3.3 was initially prepared as a 
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precursor to synthesise the novel propanol tethered methylimidazolium mesityl 
calix[4]arene (3.4). The synthetic route attempted was the quaternization of the neutral 
imidazole compound (3.3) as described in Chapter 2 (Chapter 2, Scheme 2.2). 
Compound 3.3 was reacted with four equivalents of bromopropanol as a dry melt. The 
mixture was heated at 60 °C for 24 hours, under a nitrogen atmosphere. A yellow oil 
formed which, when washed with acetone, became a white solid. Low field resonances 
were observed in the 
1
H NMR spectrum between δ = 8.5 ppm and δ = 9.5 ppm, 
suggesting that the reaction was forming imidazolium species. However, there were 
multiple products formed, and the purification of the product mixture proved 
unsuccessful. We propose that the reaction was forming the 4-, 3-, 2-, and 1-substituted 
products in varying ratios (Chapter 2, Figure 2.5), and as these molecules are likely to 
have very similar properties they were not easily separable from each other. The 
reaction was repeated using iodopropanol, as iodide is a better leaving group than 
bromide, but the same result was observed. Increasing the reaction time or increasing 
the reaction temperature did not force the reaction to completion, and multiple 
imidazolium species were always observed.       
 Due to the mixture of products formed in the above reactions, the approach to 
the synthesis of compound 3.4 was altered. Bromo-methylated mesityl calix[4]arene 
(3.2) was reacted with 1-propanol imidazole, rather than proceeding through compound 
3.3. 1-Propanol imidazole was added to a DCM solution of compound 3.2 and the 
solution was stirred at room temperature, under a nitrogen atmosphere, for 12 hours. 
During this time, a white solid precipitated from solution. The solvent was decanted 
from the solid and the compound was purified by washing with DCM, and was dried in 
vacuo. Compound 3.4 Br was characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy combined with mass spectrometry. The bromide counter ions were 
exchanged for hexafluorophosphate using ammonium hexafluorophosphate in water to 
afford the hexafluorophosphate salt of 3.4 as a white solid. Compound 3.4 PF6 was 
characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass spectrometry and 
elemental analysis.          
 The 
1
H NMR spectrum of compound 3.4 Br in DMSO-d6 is displayed in Figure 
3.1, with the relevant peaks assigned in Table 3.1. The 
1
H NMR spectrum appears as 
expected, with a characteristic resonance for the imidazolium C2 proton downfield at δ 
= 8.93 ppm.  The hydroxyl group protons are seen in the 
1
H NMR spectrum as a triplet 
at δ = 4.70 ppm, coupling to the neighbouring methylene protons. Notably, the methyl 
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groups of the mesityl moieties appear as two separate resonances at δ = 1.12 ppm and δ 
= 2.34 ppm, with those that are shielded by the aromatic flux shifted upfield by 1.22 
ppm.            
 The 
1
H NMR spectrum of compound 3.4 PF6 (DMSO-d6) is consistent with the 
1
H NMR data reported for compound 3.4 Br (DMSO-d6). A slight change in chemical 
shift is observed for the C2 proton, which is shifted upfield by 0.1 ppm, to δ = 8.83 
ppm. This is expected due to the change from a coordinating anion (Br) to a non-
coordinating anion (PF6). Notably, the resonance for the hydroxyl protons no longer 
appears as a sharp triplet, but is observed as a broad singlet resonance at δ = 4.69 ppm.  
 
 
Figure 3.1  
1
H NMR spectrum (DMSO-d6) of compound 3.4 Br at 298 K (top). Expansion of the region δ 
= 1.9 ppm to δ = 4.7 ppm (bottom). 
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Chemical shift (δ ppm) 1H Assignment 
8.93 (s, 4H) 1 
7.83 (s, 4H) 2 / 3 
7.46 (s, 4H) 2 / 3 
5.53 (s, 8H) 4 
4.70 (t, 4H, 
3
JHH = 4.9 Hz) OH 
4.24 (t, 8H, 
3
JHH = 6.9 Hz) 5 
4.02 (s, 8H) 6 
3.38 (q, 8H, 
3
JHH = 5.3 Hz) 7 
2.34 (s, 24H) 8 
1.92 (quintet, 8H, 
3
JHH = 6.3 Hz)  
) 
9 
1.12 (s,12H) 10 
Table 3.1  
1
H NMR assignments for compound 3.4 Br.  
Colourless needle crystals of compounds 3.4 3Cl.PF6 and 3.4 4Br were obtained by 
slow evaporation of saturated acetonitrile solutions of 3.4 PF6 with four equivalents of  
NBu4
+
 X
- 
salts (where X = Cl or Br). These were structurally characterised using single 
crystal X-ray diffraction analysis and the molecular structures are displayed in Figure 
3.2. Both compounds crystallised in the triclinic crystal system and structural solutions 
were obtained in the space group P-1. Interestingly, although four equivalents of the 
NBu4
+
 X
- 
salts were added to both crystallisations, the chloride anion only replaced 
three of the PF6 anions, whereas the bromide anion replaced all four. Several crystals 
were removed from the 3.4 PF6 and NBu4
+
 Cl
-
 solution, and analysed by single crystal 
X-ray diffraction, and they all showed the same structure with the 3:1 anion ratio. 
 Both 3.4 3Cl.PF6 and 3.4 4Br show the expected 1,3-alternate conformation of 
the calixarene core, with two imidazolium groups projecting upwards, and two 
projecting downwards (Figure 3.2). The molecules are locked in this conformation due 
to the steric effects of the mesityl groups. However, the tethered imidazoles can freely 
rotate within that constraint and orientate themselves with different geometries.
11
 Steed 
et al. reported a comparable crystal structure of an imidazolium calixarene that has the 
1,3-alternate calixarene framework, with methyl groups as the substituents on the 
imidazolium nitrogen atoms.
11
 They describe how the molecule can exist in two 
different conformations, either in-out or out-out conformers, depending on whether the 
imidazolium C2 proton is orientated towards the calixarene axis or away. It is reported 
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that the in-in conformation is never observed, which they propose is due to steric 
constraints. In both our structures we observe the out-out conformation, with all four 
imidazolium groups orientated away from the calixarene core.   
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Figure 3.2  Molecular structure of (a) 3.4 3Cl.PF6, and (b) 3.4 4Br . Hydrogen atoms and solvent 
molecules are omitted for clarity. Ellipsoids are displayed at 50% probability.  
 
O(3)-C(38) 1.430(8) N(6)-C(33)-N(5)  108.6(4) 
C(38)-C(37) 1.510(6) C(33)-N(6)-C(35) 108.7(3) 
N(6)-C(33) 1.334(5) C(33)-N(5)-C(34) 108.2(3) 
C(35)-C(34) 1.356(6)   
N(5)-C(31) 1.486(4)   
Table 3.2  Selected bond distances (Å) and angles (deg) for compound 3.4 3Cl.PF6 (Figure 3.2a). 
 
O(2)-C(48) 1.427(5) N(4)-C(43)-N(3) 109.1(3) 
C(48)-C(47) 1.529(5) C(43)-N(4)-C(45) 108.2(3) 
N(4)-C(43) 1.335(4) C(43)-N(3)-C(44) 108.1(3) 
C(45)-C(44) 1.354(5)   
N(3)-C(41) 1.489(4)   
Table 3.3  Selected bond distances (Å) and angles (deg) for compound 3.4 4Br (Figure 3.2b). 
Imidazolium groups have the potential of being effective anion binders due to the 
hydrogen bonding interactions they form with anions of the type [(C-H)
+
····X
-
]. Steed et 
a 
b 
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al. report that the imidazolium calixarene molecule, discussed previously, binds to 
anions within the structure through a broad range of hydrogen bonding interactions. 
Interactions exist not only through the imidazolium NCHN protons, but also through the 
backbone protons on the imidazolium groups and through the methyl groups.
11
 We also 
observed similar behaviour with the tetrakis(methylimidazolium) calix[4]arene (2.5) 
reported in Chapter 2 (Figure 2.7). The solid state structure of compound 2.5 displays a 
broad range of hydrogen bonding interactions with anions through acidic protons on 
both the upper and lower rim of the calixarene molecule.
15
 An interesting feature of 
compound 3.4 is that the molecule interacts with anions primarily through hydrogen 
bonding with the hydroxyl groups on the propanol substituents, forming interactions of 
the type [(O-H)
+
····X
-
], rather than through the acidic imidazolium protons, or other 
acidic protons contained within the structure.      
 Upon closer examination of the X-ray crystal structure of compound 3.4 
3Cl.PF6, it can be seen that the hydroxyl groups interact with two of the chloride anions 
(Cl2 / Cl3), with the length of the [(O-H)
+
····Cl
-
] bonds being 3.113-3.168 Å (O····Cl 
distance), which is typical for this type of interaction (Figure 3.3).
16
 The remaining 
chloride anion (Cl1) interacts with two enclathrated water molecules, and does not form 
any interaction with the calixarene atoms. There is no evidence that any of the other 
acidic protons of compound 3.4 3Cl.PF6 interact with the anions.    
  The molecule packs as a 1D ladder, propagated through a three 
coordinate hydrogen bond from the hydroxyl groups to Cl3 (Figure 3.4). Cl2 forms a 
single terminal hydrogen bond with one hydroxyl group (O3-H3), and does not 
influence the hydrogen bonding network.  
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Figure 3.3  X-ray crystal structure displaying the hydrogen bonding interactions observed in the solid 
state structure of 3.4 3Cl.PF6. Symmetry operations for symmetry generated atoms i: -x, 1-y, 1-z; ii: x, y-
1, z; iii: x, 1+y, z; iv: -x, 1-y, 1-z. Solvent atoms and anions not involved in hydrogen bonding to the 
calixarene (Cl1 and PF6) have been omitted for clarity. Ellipsoids are displayed at 50% probability.  
 
Figure 3.4  X-ray crystal packing diagram of compound  3.4 3Cl.PF6 displaying the 1D hydrogen 
bonding ladder. Solvent atoms and anions not involved in the hydrogen bonding network (Cl1, Cl2 and 
PF6) have been omitted for clarity.  
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The X-ray crystal structure of compound 3.4 4Br shows similar bonding patterns to 
compound 3.4 3Cl.PF6, with the primary interactions to the bromide anions being 
through the hydroxyl groups on the propanol substituents (Figure 3.5). In this structure 
the hydroxyl groups interact with three bromide anions (Br3 / Br2 / Br4A), with the 
hydrogen bond lengths of [(O-H)
+
····Br
-
] being 3.166-3.341 Å (O····Br distance), which 
is typical for this type of bond.
16
 This is slightly longer than the [(O-H)
+
····Cl
-
] bonds in 
3.4 3Cl.PF6, which would be expected due to the relative basicity of the anions and 
size.  Br1 does not appear to form any close interactions with the calixarene.  
 Upon closer examination of the crystal structure of 3.4 4Br it can be seen that, in 
this case, an acidic imidazolium proton (H63) does form an interaction with one of the 
bromide anions (Br4B). The occupancy of Br4 is disordered over two positions (Br4A / 
B), interacting with either the hydroxyl proton (H4) or the imidazolium proton (H63) 
(Figure 3.5). The two parts have SOFs of 85 % (Br4A) and 15 % (Br4B) respectively. 
Therefore, it is predominantly in position Br4A, where it interacts with the hydroxyl 
proton (H4). Again, this highlights the preferred binding of 3.4 to anions through the 
hydroxyl protons over the other acidic protons present in the compound. There is no 
further evidence of the other acidic protons in compound 3.4 4Br interacting with the 
bromide anions.         
 The molecule packs as a 1D chain, propagated through a two coordinate 
hydrogen bond from the hydroxyl groups to Br3 (Figure 3.6). The hydrogen bonds from 
the hydroxyl groups to Br2 and Br4 are terminal, and do not influence the hydrogen 
bonding network.  
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Figure 3.5  X-ray crystal structure of compound 3.4 4Br displaying the hydrogen bonding interactions 
observed in the solid state structure. Symmetry operations for symmetry generated atoms i: -x, 2-y, 1-z. 
Solvent atoms and anions not involved in hydrogen bonding to the calixarene (Br1) have been omitted for 
clarity. Ellipsoids are displayed at 50% probability. 
 
Figure 3.6  X-ray crystal packing diagram of compound 3.4 4Br displaying the 1D hydrogen bonding 
chain. Solvent atoms and anions not involved in the hydrogen bonding network (Br1, Br2 and Br4) have 
been omitted for clarity. 
Both crystal structures of compound 3.4 reveal that it is not the acidic imidazolium 
protons (C2 protons) that form the primary interactions with the anions in the solid 
state, but it is the hydroxyl groups of the propanol substituents. In order to investigate if 
this behaviour is also evident in solution, the anion binding properties of 3.4 PF6 were 
probed. The changes in the 
1
H NMR spectra of compound 3.4 PF6 were monitored as 
aliquots of tetrabutylammonium bromide were added, exchanging the non-coordinating 
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PF6 anion for the coordinating bromide anion. Compound 3.4 PF6 (0.01 g, 6.02×10
-6
 
moles) was dissolved in 0.5 ml of MeCN-d3. Tetrabutylammonium bromide (0.0234 g, 
7.25×10
-5
 moles) was dissolved in 1 mL of MeCN-d3, approximately 10 times the 
concentration of the host. 10 µL aliquots of the guest (tetrabutylammonium bromide 
solution) were added to the NMR tube and the spectra recorded following each addition. 
The equivalents of guest that had been added were calculated, taking the ratio of host: 
guest concentration after each 10 µL addition. The equivalents of guest added was then 
plotted against the chemical shift of the C2 proton, and against the chemical shift of the 
hydroxyl proton. The results are displayed in Figures 3.7 and 3.8 respectively. The 
graphs are plotted up to the point where just over two equivalents of guest had been 
added, as at this point the compound precipitated from solution   
 Figure 3.7 shows the change in the chemical shift of the C2 proton as the 
tetrabutylammonium bromide solution was added. Initially the signal shifts downfield, 
from δ = 8.14 ppm when no guest is present, to δ = 8.37 ppm when one equivalent of 
guest has been added. After this point, there is an upfield shift in the C2 proton 
resonance, up to the addition of 1.3 equivalents of guest (δ = 8.30 ppm). The signal then 
moves downfield again until the product precipitated from solution, with the final 
recorded shift for the C2 proton being δ = 8.41 ppm. Unsurprisingly, there is also a 
significant change observed in the chemical shift of the hydroxyl group protons as the 
tetrabutylammonium bromide solution was added (Figure 3.8).  The change in the 
chemical shift for the hydroxyl protons mirrors the change in the chemical shift 
observed for the C2 protons, with the signal moving downfield from δ = 2.86 ppm to δ 
= 3.20 ppm between 0-1 equivalents of guest. Following this there is an upfield change 
in chemical shift until 1.3 equivalents of the guest has been added (δ = 3.17 ppm). Then 
the signal moves downfield again to δ = 3.30 ppm, at the point before the product 
precipitated from solution.        
 These observations infer that the first equivalent of guest binds to both the C2 
and the hydroxyl group protons, resulting in a downfield shift of the proton resonances 
for both groups. Following this there is an upfield change in the chemical shift of both 
these signals, which is most likely due to the anions interacting with a different part of 
the calixarene molecule. Other acidic protons that are likely to take part in the hydrogen 
bonding are those of the imidazolium backbone. This interaction presumably results in a 
slight conformational change of the calixarene molecule, accounting for the upfield 
chemical shifts observed in the 
1
H NMR spectra for the C2 and hydroxyl protons 
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between 1–1.3 equivalents of guest. Following this the anions continue to interact with 
the C2 protons and the hydroxyl group protons. The overall change in the chemical shift 
is more significant for the hydroxyl group protons (0.44 ppm), than for the C2 
imidazolium protons (0.27 ppm), which supports observations made in the solid state 
that it is the hydroxyl group protons that form the primary interaction to the anions. 
However, the 
1
H NMR data does suggest that when the molecule is in solution, and able 
to rotate freely, other acidic protons of 3.4 interact with the anions.   
 Figure 3.9 shows the change in the chemical shift of one of the imidazolium 
backbone protons (Figure 3.1, H2 / H3) as tetrabutylammonium bromide solution was 
added. Interestingly, the observed change in the chemical shift for the imidazolium 
backbone protons follows the opposite trend of that observed for the C2 and hydroxyl 
group protons. Initially the signal shifts upfield, from δ = 7.11 ppm when no guest is 
present to δ = 7.06 ppm when one equivalent of guest has been added. Following this, 
there is a downfield change in the chemical shift until the point where 1.3 equivalents of 
guest has been added (δ = 7.09 ppm). The signal then shifts upfield again to δ = 7.07 
ppm, at the point before the product precipitated from solution. The overall change in 
the chemical shift of the imidazolium backbone protons is less significant than for the 
C2 and hydroxyl protons (0.05 ppm). However, the data supports the theory that the 
upfield change in the chemical shifts of the C2 and hydroxyl protons observed between 
1-1.3 equivalents of guest was due to the anions interacting with the acidic imidazolium 
backbone protons, as there is a simultaneous downfield shift in the imidazolium 
backbone protons chemical shift at this point.  
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Figure 3.7  
1
H NMR spectroscopic titration data for the shift in the C2 imidazolium protons of compound 
3.4 PF6 upon addition of tetrabutylammonium bromide (MeCN-d3). 
 
 
 
Figure 3.8  
1
H NMR spectroscopic titration data for the shift in the hydroxyl protons of compound 3.4 
PF6 upon addition of tetrabutylammonium bromide (MeCN-d3).  
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Figure 3.9  
1
H NMR spectroscopic titration data for the shift in one of the backbone imidazolium protons 
(Figure 3.1, H2 / H3) of compound 3.4 PF6 upon addition of tetrabutylammonium bromide (MeCN-d3). 
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3.2 Formation of metal-NHC complexes using NHC-ligand precursor 3.4 Br 
NHC-substituted calixarenes is an area that remains relatively unexplored, with only a 
few reported examples in the literature.
17-21
 Compound 3.4 offers the potential of 
forming a unique metal-NHC complex as, to the best of our knowledge, all NHC 
substituted calixarenes reported to date are functionalised with only one or two NHC 
groups, forming monodentate or bidentate metal-NHC complexes.
17-21
 Compound 3.4 is 
functionalised with four imidazolium groups and, as a result, has the potential to form 
four metal-NHC bonds, forming a bidentate or monodentate metal-NHC complex that 
can incorporate two or four metal centres respectively. The propanol substituents in 
compound 3.4 offer the potential of forming an anionic interaction to the metal centre 
which, if formed, can be expected to increase the stability of the metal-NHC complex.
22
 
The use of compound 3.4 as an NHC-ligand precursor was investigated through its 
reaction with basic metal precursors (Ag2O, Cu2O, Pd(OAc)2), to form the metal-NHC 
complexes in situ. The products from these reactions were analysed using 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with mass spectrometry.   
 Silver-NHCs are of particular interest as they are easily synthesised, and it is 
well established that they can be used as carbene transfer agents, which can allow the 
formation of a wide range of transition metal-NHC complexes.
1, 2, 5
 In addition, silver-
NHCs are known to have exploitable properties themselves, and have found application 
as antimicrobial agents and as anticancer agents.
23, 24
 There are two methods that are 
routinely used to prepare silver-NHCs; a) the deprotonation of an imidazolium 
precursor (using a strong base such as BuLi or KO
t
Bu) to form the free carbene, 
followed by addition of a silver salt (e.g. AgBF4),
25
 b) the reaction of an imidazolium 
salt with a basic silver reagent, such as Ag2O, which deprotonates the imidazolium salt 
and forms the silver-NHC in situ.
1, 3
 The use of a basic silver reagent is often preferred 
as it avoids the need to isolate the free carbene intermediate, which is often extremely 
unstable, and circumvents the need for strict inert conditions. It also negates the need for 
a strong base which can react with other acidic protons in the ligand and cause 
undesirable side reactions.         
 Compound 3.4 Br was reacted with two equivalents of silver oxide in anhydrous 
methanol at room temperature, in the dark, under a nitrogen atmosphere, for 1.5 hours 
(Scheme 3.2). The reaction was stopped once the solution appeared light brown, 
indicating the consumption of Ag2O and the formation of AgBr.  3Å molecular sieves 
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were added to absorb the water formed in the reaction, as it has been reported that the 
addition of molecular sieves decreases the reaction time, as well as improving the purity 
of the product.
1, 26, 27
 The mixture was filtered through celite and the solvent removed in 
vacuo to yield a white solid that was analysed by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy combined with mass spectrometry. The formation of a silver-NHC was 
indicated by the absence of the low field resonance in the 
1
H NMR spectrum (DMSO-
d6) at δ = 8.93 ppm, indicating the removal of the C2 imidazolium proton (Figure 3.10). 
However, no low field resonance was seen in the 
13
C{
1
H} NMR spectrum for the C2 
carbon bound to silver, usually observed at around 180 ppm. Also, the mass 
spectrometry data was very weak and inconclusive. Despite repeated attempts, a crystal 
structure could not be obtained, which would have assisted in the analysis. Colourless 
crystals were grown from methanol / diethyl ether, but they decomposed as soon as they 
were removed from solution and exposed to the air. This is likely due to the loss of 
solvent from the crystal lattice.   
 
Scheme 3.2  Proposed product from the reaction of compound 3.4 Br with Ag2O. 
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Figure 3.10  
1
H NMR spectra (DMSO-d6) displaying 3.4 Br (bottom) and the product formed in the 
reaction between 3.4 Br and Ag2O in methanol (top).  
It has been observed within our group that some silver-NHC complexes synthesised in 
methanol tend to be unstable, becoming brown over time and depositing a dark brown 
solid. These compounds were found to contain a large excess of silver bromide, which 
could have been incorporated into the structure through a halide bridging system.
28
 
When the reaction was performed in DCM or DCM / methanol (7:1), the silver-NHCs 
formed were found to be more stable and appeared not to contain any excess AgBr.
23
 
This was attributed to the low solubility of silver salts in DCM, resulting in the silver 
bromide formed precipitating from solution.      
 The reaction of compound 3.4 Br with Ag2O was therefore investigated in a 
range of solvents to see if this increased the stability of the silver-NHC complex, 
enabling more characterisation data to be obtained. Using the same reaction conditions 
in anhydrous DCM at room temperature, or with heating (30 °C), no reaction occurred, 
and only starting material was isolated from the reaction. This was thought to be due to 
the poor solubility of compound 3.4 Br in DCM. A mixture of DCM / methanol (2:1) 
was therefore used, with enough methanol added to solubilise the compound. The 
reaction produced the same result as when using only methanol in the reaction, with the 
1
H NMR spectrum indicating the presence of a silver-NHC complex by the absence of 
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the low field resonance attributed to the C2 proton (Figure 3.10).
13
C{
1
H} NMR 
spectroscopy and mass spectrometry provided no further evidence for the formation of 
the desired silver-NHC complex. The reaction was also attempted in THF / methanol 
(1:1) and worked up in the same way as previously, but this time yielded a yellow film. 
The 
1
H NMR spectrum obtained was the same as that from the previous methanol 
reaction, though in this case the 
13
C{
1
H} NMR spectrum displayed evidence for the C2 
carbon coordinating to silver, with a resonance observed at δ = 182.4 ppm. Again the 
mass spectrometry data did not provide further insight into the structure of the silver-
NHC complex. Crystallisations were attempted in a range of solvents / solvent mixtures, 
but no crystals were obtained that were suitable for single crystal X-ray diffraction 
analysis.           
 Due to the nature of compound 3.4, there are numerous possibilities for the 
structure of the silver-NHC complex. Firstly, there is the potential to form either the 
neutral monodentate NHC complex 4Ag(NHC)Br, or the cationic bidentate silver-NHC 
complex 2[Ag(NHC)2]
+
2Br
-
, incorporating four or two silver centres respectively. The 
formation of the neutral complex, 4Ag(NHC)Br, would be expected due to the 
coordinating nature of the bromide anion. Conversely, if the reaction was performed 
with compound 3.4 PF6 and Ag2O, the charged 2[Ag(NHC)2]
+
2PF6
- 
complex would be 
the expected product due to the non-coordinating nature of the PF6 anion.
28
  
 Another consideration is that the propanol substituents of compound 3.4 are 
likely to be deprotonated under the basic reaction conditions, leading to a mixed binding 
complex, with the alkoxy groups forming an anionic interaction to the silver metal 
centre in addition to the silver-NHC bond. The hydroxyl groups were shown to have the 
most acidic protons in compound 3.4 in the solution studies. Their relative acidity also 
suggests that they would be deprotonated during the reaction, with the pKa of a primary 
alcohol being around 16 compared to the C2 imidazolium proton pKa that is in the 
region of 20-25. Arnold et al. reported an alcohol functionalised imidazolium that, when 
reacted with Ag2O, lead to deprotonation of both the C2 proton and hydroxyl group, in 
this case generating the halide free alkoxy bound silver-NHC complex (Figure 3.11).
29
 
Notably, this is a tertiary alcohol not a primary alcohol, with tertiary alcohols having a 
higher pKa of around 19.  
Chapter 3. Propanol tethered methylimidazolium mesityl calix[4]arene: Ligand 
synthesis and metal complexation  
 
68 
 
 
Figure 3.11  Reported product from the reaction of an alcohol functionalised imidazolium with Ag2O.
29
 
If the alkoxy groups in compound 3.4 do interact with silver, either a discrete complex 
(as in Figure 3.11) or a polymeric complex may form. The tendency of silver to form 
silver-silver and / or silver-halide interactions could also aid the formation of a 
polymeric species.
30
 The analysis obtained of the silver-NHC complexes does not 
provide any confirmation as to whether the alkoxy tethers are interacting with the silver 
centres. In the 
1
H NMR spectrum of the product formed from the reaction of Ag2O and 
compound 3.4 Br (Figure 3.10), the hydroxyl protons are no longer present (they were 
observed as a triplet resonance at δ = 4.70 ppm in compound 3.4 Br). This could be an 
indication that the hydroxyl groups have remained deprotonated during the reaction and 
formed an interaction with silver, but this evidence is not conclusive.   
 Although we were unable to fully characterise the silver-NHC complex formed, 
we are confident that the reaction of 3.4 Br with Ag2O generated a silver-NHC of some 
description. This was confirmed by the 
1
H NMR spectra which, under all the different 
reaction conditions investigated, had no evidence of the resonance attributed to the C2 
proton. The use of this silver-NHC complex as a ligand transfer agent was therefore 
explored. Silver-NHCs are often used as intermediate species for the formation of other 
transition metal-NHC complexes, and it is not always necessary to isolate the silver 
intermediate.
31
 We were interested to see if we could use this silver-NHC complex in 
this way.           
 The product formed in the reaction of 3.4 Br with Ag2O (in methanol) was 
reacted with PdCl2(MeCN)2 in anhydrous DCM at room temperature, in the dark, for 12 
hours (Scheme 3.3).
2, 32
 The reaction was filtered and the solvent removed from the 
filtrate in vacuo to yield a yellow oil, which was analysed by 
1
H NMR and 
13
C{
1
H} 
NMR spectroscopy (in both CDCl3 and MeCN-d3) combined with mass spectrometry. 
The 
1
H NMR spectrum was indicative of a reaction occurring, as the starting material 
was not present, though the identity of the product was not clear. There was no C2 
imidazolium proton resonance in the 
1
H NMR spectrum (MeCN-d3), but there was also 
no evidence of the C2 carbon coordinating to palladium in the 
13
C NMR spectrum 
(MeCN-d3), which appears in the region of δ = 140 ppm to 170 ppm. The mass 
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spectrometry data indicated that palladium species were present due to the observed 
splitting patterns. However, these signals could not be attributed to a desirable product. 
Crystallisations were attempted (MeCN / diethyl ether), but unfortunately no crystals 
were suitable for analysis by single crystal X-ray diffraction.  
 
Scheme 3.3  Proposed product from the attempted carbene transfer reaction from silver(I) (reaction of 
compound 3.4 Br with Ag2O) to palladium(II) (X = Cl, Br).  
As the transmetallation reaction was inconclusive, compound 3.4 Br was reacted with 
Pd(OAc)2 to try and form the palladium species directly (Scheme 3.4). Reaction 
conditions reported by Dinares et al. were used,  where a bidentate palladium-NHC 
supported by a calixarene scaffold was synthesised.
33
 Compound 3.4 Br was reacted 
with Pd(OAc)2 in anhydrous dioxane at 50 °C for 1 hour, then at reflux (110 °C) for 12 
hours, under a nitrogen atmosphere. The solution became black, indicative of 
palladium(II) being reduced to form palladium(0). The solvent was removed in vacuo 
and the resulting solid dissolved in DCM and filtered through celite. The solvent was 
removed from the filtrate in vacuo and the yellow solid was analysed by 
1
H NMR 
spectroscopy (CDCl3) combined with mass spectrometry, but there was no evidence that 
the palladium product had formed. The reaction was also attempted under milder 
conditions in anhydrous acetonitrile (80 °C), in the presence of a base (K2CO3). Again, 
the reaction appeared to form palladium(0) and no desired product was isolated from the 
reaction solution. It appeared that Pd(OAc)2 was being reduced in the reaction rather 
than forming the palladium-NHC complex. This is likely due to the hydroxyl tether of 
3.4, which itself can be oxidised to an aldehyde as the palladium(II) is reduced to 
palladium(0).  
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Scheme 3.4  Reaction of compound 3.4 Br with Pd(OAc)2 in dioxane or MeCN. 
The reaction of 3.4 Br with Cu2O was explored, with the route being analogous to the 
Ag2O route (Scheme 3.5).
4, 34, 35
 Compound 3.4 Br was reacted with six equivalents of 
Cu2O, in anhydrous acetonitrile at reflux (80 °C), for 120 hours, under a nitrogen 
atmosphere. 3Å molecular sieves were added to remove the water formed in the 
reaction. The solvent was removed in vacuo and the resultant red solid dissolved in 
anhydrous acetone. The solution was filtered and the solvent removed in vacuo, to yield 
a pale yellow solid, which was analysed by 
1
H NMR spectroscopy ((CD3)2CO) 
combined with mass spectrometry. The product had very limited solubility and was not 
soluble in chloroform, THF, DCM or acetonitrile. The 
1
H NMR spectrum ((CD3)2CO) 
shows the formation of new products, however, there is still a small resonance at δ = 
8.65 ppm in the imidazolium C2 proton region (Figure 3.12). The 
1
H NMR spectrum 
was also complicated, suggesting the formation of more than one species. Mass 
spectrometry data confirmed the formation of multiple copper(I) containing species, 
namely the 1-, 2-, 3- and 4-copper-NHC complexes (Figure 3.13, A, B, C and D) with 
m/z; 1678.1 [D+Na]
+
; 1593.2 [C+H]
+
; 1449.3 [B-Br]
+
; 1385.4 [A-Br]
+
. This explains 
the presence of the C2 imidazolium proton peak in the 
1
H NMR spectrum, as all four 
imidazolium groups on 3.4 Br have not formed the copper carbene in all cases, and a 
product mixture was generated. In an attempt to form the 4-copper-NHC complex 
selectively the reaction was repeated, increasing the reaction time (168 hours), and 
increasing the volume of acetonitrile used. However, a product mixture was always 
observed. Due to the poor solubility of the copper(I)-NHC complexes, combined with 
their air sensitivity, the reaction mixture could not be purified.  
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Scheme 3.5  Reaction of compound 3.4 Br with Cu2O.  
 
Figure 3.12  
1
H NMR spectrum ((CD3)2CO) displaying the products formed in the reaction between 
compound 3.4 Br and Cu2O. 
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Figure 3.13  Proposed products from the reaction between compound 3.4 Br and Cu2O.  
A reaction was performed with these copper-NHC products (Figure 3.13, A, B, C and 
D) to see if the copper-NHC could be used as a ligand transfer agent to form other 
transition metal-NHCs, with the aim of forming more stable / soluble metal complexes 
that could be purified. It has been reported that copper(I)-NHCs can be used as ligand 
transfer agents in the same ways as silver-NHCs. Cazin et al. reported that copper(I)-
NHCs could be used as ligand transfer agents to form gold(I)- and palladium(II)-NHC 
complexes.
6
 Albrecht et al. reported copper(I)-NHCs as ligand transfer agents to form a 
ruthenium(II)-NHC complex.
36
       
 The product mixture formed from the reaction of 3.4 Br with Cu2O was reacted 
with PdCl2(MeCN)2 in acetone, at room temperature, for 12 hours (Scheme 3.6). A 
precipitate formed almost immediately, indicating the formation of CuBr. The solvent 
was removed in vacuo and the red solid was dissolved in acetonitrile and filtered. The 
1
H NMR spectrum (MeCN-d3) was complicated, but showed the formation of new 
products. As expected, small resonances were observed in the region for the 
imidazolium C2 proton, at δ = 8.41 ppm and δ = 8.31 ppm. The 13C{1H} NMR 
spectrum (MeCN-d3) displayed high field resonances at δ = 153.86 ppm and δ = 197.85 
ppm, attributed to the C2 carbon bound to the palladium centre in two different 
geometries, Pd(NHC)(MeCN)X2 and Pd(NHC)2X2. The mass spectrometry data 
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strongly suggests that a polymeric species had been formed, with the peaks all being 
separated by a mass of 75. The peaks were, however, unable to be assigned to a desired 
product. Single crystals suitable for analysis by single crystal X-ray diffraction were 
obtained from MeCN / diethyl ether. However, they were found to be a polymeric 
copper(I) chloride acetonitrile complex. It should be noted that the mass of this did not 
match any of the mass spectrometry data. Although we were unable to characterise the 
products formed in this reaction, obtaining a CuCl structure strongly suggests that 
palladium had displaced the copper in the complex, and a transfer had occurred. This 
supports the potential of the copper(I)-NHC being used as a ligand transfer agent to 
form other transition metal-NHC complexes of compound 3.4.  
 
Scheme 3.6  Carbene transfer reaction from copper(I) (reaction of compound 3.4 Br with Cu2O) to 
palladium(II) (X = Cl, Br). 
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3.3 Conclusion  
In conclusion, a synthetic procedure has been developed for the synthesis of the novel 
propanol tethered methyl-imidazolium mesityl calix[4]arene (3.4), and the compound 
has been fully characterised. The properties of the compound in the solid state and in 
solution have been examined. The studies on compound 3.4 have shown that the 
hydroxyl groups on the propanol tether form the primary hydrogen bonding interaction 
with anions, of the type [(O-H)
+
····X
-
], over any other acidic protons in the molecule. 
This was observed in the solid state and in solution studies.    
 The use of compound 3.4 as an NHC ligand precursor to form metal-NHC 
complexes was explored. Compound 3.4 was reacted with basic metal precursors, in an 
attempt to form the metal-NHC complexes in situ.  This avoided the need for strong 
bases and strict inert conditions.       
 The formation of a silver-NHC by reaction of compound 3.4 with Ag2O 
appeared to be successful, inferred by the absence of the C2 proton in the 
1
H NMR 
spectra. However, the complex could not be fully characterised and the exact 
coordination of the silver to the ligand is unknown. The use of the silver-NHC as a 
ligand transfer agent to palladium did not proceed cleanly and the desired product was 
not identified.           
 The reaction of compound 3.4 with Pd(OAc)2 did not form the desired palladium 
species and instead the palladium(II) was reduced to palladium(0), suggesting that it 
may have been reacting with another part of the molecule other than the imidazolium 
group, most likely the hydroxyl groups. The formation of a copper-NHC by reaction of 
compound 3.4 with Cu2O appeared to be successful, with the mass spectrometry data 
indicating mixtures of copper(I)-NHCs (Figure 3.13). Due to the poor solubility of the 
copper(I)-NHC complexes, combined with their air sensitivity, the reaction mixture 
could not be purified. The copper(I)-NHC complexes were shown to have potential as 
carbene transfer agents, as it appeared that palladium could displace the copper metal. 
The exact nature of the resultant product could not be identified.    
 Due to the acidic nature of the propanol substituents of compound 3.4, a 
predication of the products formed from the metal complexation reactions was not 
straightforward. There are numerous possibilities as to what the structures of these 
complexes could be, and the structure will vary based on the preferred coordination 
geometry of the metal. To date, as no crystal structures of the metal-NHC complexes 
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have been obtained, there is no evidence as to whether the deprotonated hydroxyl 
groups on the propanol tether form any interaction with the metal centres.  
3.4 Future work 
The use of compound 3.4 as an NHC-ligand precursor has been explored through its 
reaction with basic metal precursors. Further work should be done to explore different 
synthetic routes to form metal-NHC complexes of compound 3.4, with the aim of 
isolating discrete metal-complexes that can be fully characterised. The next approach 
should be the reaction of compound 3.4 with a strong base (such as 
n
BuLi), followed by 
the coordination of the free NHC to a metal centre. Following this synthetic route the 
hydroxyl groups are likely to remain deprotonated, and form an interaction with the 
metal centre. Following structure and stability studies, the applications of the metal-
NHC complexes can then be explored to evaluate the influence of the calixarene core 
and propanol tethers on the properties of the metal-NHC complexes.  
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4 Acetate ester and acetic acid tethered methylimidazolium mesityl 
calix[4]arene: Ligand synthesis and metal complexation  
This chapter discusses the synthesis of a novel 1,3-alternate calix[4]arene, where two of 
the functional groups project upwards, and two project downwards, in reference to the 
plane defined by the bridging methylene groups. Acetate ester tethered 
methylimidazolium mesityl calix[4]arene (4.2) has been prepared and examined through 
1
H NMR spectroscopy and X-ray crystallography. The tert-butyl protecting groups were 
removed from the ester by heating the compound in excess HCl, to form the acid (4.3). 
Acetic acid tethered methylimidazolium mesityl calix[4]arene (4.3) offers the potential 
of forming a bidentate chelating metal-NHC complex, through coordination to the metal 
via both the NHC group and the carboxylate ion upon deprotonation of the acid.
1
  
 The use of compound 4.2 as an NHC ligand precursor was explored. It was 
found that the most common approaches reported in the literature for the formation of 
metal-NHC complexes were not suitable for the formation of metal NHC-complexes 
when using compound 4.2 as a ligand precursor.
2-5
 Under the basic conditions that are 
required, it appeared that the base reacted with another part of the compound instead of, 
or in addition to, the C2 proton.        
 An alternative electrochemical method of metal-NHC formation that has been 
developed in the Willans group was attempted, that did not require the need for a strong 
base or a basic metal precursor.
6
 This novel synthetic method was used to prepare a 
copper(I)-NHC complex of our calix[4]arene (4.6). It was found that this copper(I)-
NHC complex could be used as a ligand transfer agent for the formation of a 
palladium(II)-NHC complex (4.7), the structure of which was confirmed by X-ray 
crystallography.
7
 The use of complex 4.6 as a ligand transfer agent to form other 
transition metal NHCs was also explored, resulting in the synthesis of a rhodium(I)-
NHC complex (4.8). To the best of our knowledge, this is the first example of a 
copper(I)-NHC being used as a ligand transfer agent to prepare a rhodium-NHC 
complex.           
 The use of the acetic acid tethered compound 4.3 as an NHC ligand precursor 
was also explored following the well documented Ag2O route.
8-10
 From analysis by 
1
H 
NMR spectroscopy it appeared that Ag2O reacted with the carboxylic acid functionality, 
and did not form a silver-NHC. Compound 4.3 was also tested in the electrochemical 
synthetic procedure but this was not successful. It is likely that the poor solubility of 
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compound 4.3, as it is only soluble in DMSO, combined with the side reactions 
involving the carboxylic acid functionality, resulted in decomposition of the ligand.  
4.1 Synthesis of acetate ester and acetic acid tethered methylimidazolium mesityl 
calix[4]arene (compounds 4.2 and 4.3) 
 
Scheme 4.1  Synthesis of acetate ester (4.2) and acetic acid (4.3) tethered methylimidazolium mesityl 
calix[4]arenes (X = Br, Cl or PF6). 
The preparation of bromomethylated mesityl calix[4]arene (3.2) was carried out as 
described in Chapter 3. Tert-butyl acetate substituted imidazole (4.1) was synthesised 
from the reaction of tert-butyl chloroacetate with imidazole, and the product was 
purified by column chromatography (Silica gel, 10 % MeOH / chloroform, I2 active by 
TLC).
11
 The purification of compound 4.1 by column chromatography was found to be 
necessary to remove any imidazolium species formed via further reaction of tert-butyl 
chloroacetate with the second nitrogen of compound 4.1. This was found to occur even 
when excess imidazole was used. The product was characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass spectrometry and elemental analysis.   
 A THF solution of compound 4.1 was added to a THF solution of compound 
3.2, and the resultant solution was stirred at room temperature for 12 hours under an 
atmosphere of nitrogen. During this time a white solid precipitated from solution. The 
solvent was decanted from the solid, and the solid washed with THF and dried in vacuo. 
Compound 4.2 Br was characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy 
combined with mass spectrometry. A 
1
H NMR spectrum of compound 4.2 Br in 
DMSO-d6 is displayed in Figure 4.1, with the relevant peaks assigned in Table 4.1. 
 The 
1
H NMR spectrum of compound 4.2 Br appears as expected, with a 
characteristic resonance for the imidazolium C2 proton at δ = 8.92 ppm. The backbone 
imidazolium protons appear as two separate resonances at δ = 7.81 ppm and δ = 7.57 
Chapter 4. Acetate ester and acetic acid tethered methylimidazolium mesityl 
calix[4]arene: Ligand synthesis and metal complexation  
  
80 
 
ppm, with the resonances being too broad to show any coupling between the 
inequivalent backbone protons. The methylene bridging protons (H5) were assigned 
using 2D HMBC NMR spectroscopy, which showed the two bond coupling of the 
methylene protons on the acetate tether (H5) to the quaternary acetate carbon, which has 
a characteristic low field resonance in the 
13
C{
1
H} NMR spectrum at δ = 166.1 ppm. 
Notably the methyl groups on the calix[4]arene framework (H7 and H9) appear as two 
separate resonance, with those shielded by the aromatic flux being downfield at δ = 1.14 
ppm (H9), compared to δ = 2.34 ppm for the unshielded methyl groups (H7).  
 The bromide counter ions were exchanged for hexafluorophosphate ions using 
ammonium hexafluorophosphate in water to afford the hexafluorophosphate salt of 4.2 
as a white solid. Compound 4.2 PF6 was characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy, mass spectrometry and elemental analysis. The 
1
H NMR spectrum 
(DMSO-d6) of compound 4.2 PF6 was consistent with the 
1
H NMR data reported for 
compound 4.2 Br. A slight change in the chemical shift was observed for the C2 proton, 
shifting upfield by 0.13 ppm to δ = 8.80 ppm. This is expected due to the change from a 
coordinating anion (Br) to a non-coordinating anion (PF6).  
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Figure 4.1  
1
H NMR spectrum (DMSO-d6) of 4.2 Br at 298 K. 
 
Chemical shift (δ ppm) 1H Assignment 
8.92 (s, 4H) 1 
7.81 (s, 4H)  2 / 3 
7.57 (s, 4H)  2 / 3 
5.62 (s, 8H) 4 
5.13 (s, 8H) 5 
4.01 (s, 8H) 6 
2.34 (s, 24H)  7 
1.43 (s, 36H) 8 
1.14 (s, 12H) 9 
Table 4.1  
1
H NMR assignments of compound 4.2 Br.  
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Colourless crystals of compound 4.2 Br were obtained by slow diffusion of ethyl 
acetate into a DMSO solution. These were analysed by single crystal X-ray diffraction 
and the molecular structure is displayed in Figure 4.2.  The compound crystallised in the 
triclinic crystal system and the structural solution was performed in the space group P-
1. Two calixarene molecules are contained within the asymmetric unit, with one being 
removed for clarity in Figure 4.2. The structure displays the expected 1,3-alternate 
conformation of the calixarene core, with two imidazolium groups projecting upwards, 
and two projecting downwards. The molecule is locked in this conformation due to the 
steric constraints of the mesityl groups. However, the tethered imidazoles can freely 
rotate within that constraint and orientate themselves with different geometries. 
Compound 4.2 Br displays the out-out conformation, with all four imidazolium groups 
orientated away from the calixarene core.
9
       
   
Figure 4.2  Molecular structure of compound 4.2 Br. One molecule in the asymmetric unit has been 
omitted. The hydrogen atoms, solvent molecules and 8 bromide counter anions are omitted for clarity. 
Ellipsoids are displayed at 50% probability.  
N(14)-C(144) 1.341(8) N(14)-C(143)-C(142) 104.1(7) 
N(14)-C(143) 1.385(10) N(14)-C(144)-N(13) 106.3(6) 
C(143)-C(142) 1.385(12)   
O(11)-C(147) 1.452(15)   
Table 4.2  Selected bond distances (Å) and angles (deg) for compound 2.4 Br.  
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The interactions of compound 4.2 with the bromide anions in the asymmetric unit are 
displayed in Figure 4.3. Br1 does not form any interaction with the calixarene and has 
been removed for clarity. It can be seen from the structure that the bromide anions 
interact with various acidic imidazolium protons within the structure, not just the C2 
protons but also the imidazolium backbone protons. The length of the [(C-H)
+
····Br
-
] 
interactions range from 2.612 Å (H112-Br7) to 2.862 Å (C93-Br4), with the full range 
of [(C-H)
+
····Br
-
] bond lengths being reported in Table 4.3. The interactions are weaker 
than  typical [H
+
····Br
-
] hydrogen bonds, which are reported to have a mean bond length 
of 2.415 Å and a range of 2.24-2.66 Å.
12
 The only [(C-H)
+
····Br
-
] interaction in 
compound 4.2 Br falling within the reported range is H112-Br7 with a length of 2.612 
Å. The remaining bonds are best described as weak interactions rather than hydrogen 
bonds. It should be noted that the hydrogen atoms in this structure were not located in 
the diffraction map and were placed in calculated position using a riding model. 
However, the distance between the bromide anions and the calculated hydrogen atoms 
gives an indication of the interactions between the calixarene and the bromide anions.  
 
Figure 4.3  X-ray crystal structure displaying the interactions observed in the solid state structure of 
compound 4.2 Br. Symmetry operations for symmetry generated atoms i: 1-x, 2-y, -z. The solvent 
molecules, anions not bonding to the calixarene (Br1), and the hydrogen atoms not involved in the 
bonding network have been omitted for clarity.  
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H(112)-Br(7) 2.612 C(112)-Br(7) 3.468 
H(82)-Br(7) 2.613 C(82)-Br(7) 3.499 
H(92)-Br(8) 2.813 C(92)-Br(8) 3.588 
H(143)-Br(8) 2.866 C(143)-Br(8) 3.703 
H(114)-Br(3) 2.683 C(114)-Br(3) 3.484 
H(83)-Br(2) 2.884 C(83)-Br(2) 3.662 
H(134)-Br(5) 2.750 C(134)-Br(5) 3.625 
H(124)-Br(6) 2.642 C(124)-Br(6) 3.500 
H(93)-Br(4) 2.862 C(93)-Br(4) 3.723 
Table 4.3  Interatomic distances (Å) for [(C-H)
+
····Br
-
] interactions. 
The tert-butyl groups of the ester were removed by dissolving compound 4.2 Br in 
excess HCl (aq) and heating at reflux (110 °C) for 1 hour. The solvent was removed in 
vacuo, and the resultant solid was purified by washing with acetone and diethyl ether, 
and was dried in vacuo. Compound 4.3 Br was analysed by 
1
H NMR and 
13
C{
1
H} 
NMR spectroscopy combined with mass spectrometry. The bromide counter ions were 
exchanged for hexafluorophosphate using ammonium hexafluorophosphate ions in 
water to afford the hexafluorophosphate salt of 4.3 as a white solid. Compound 4.3 PF6 
was characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, along with mass 
spectrometry. A 
1
H NMR spectrum of compound 4.3 PF6 in DMSO-d6 is displayed in 
Figure 4.5, with the relevant peaks assigned in Table 4.4.     
 The 
1
H NMR spectrum of compound 4.3 PF6 appears as expected, with the only 
difference between this and the 
1
H NMR spectrum of compound 4.2 PF6 being the loss 
of the signal for the tert-butyl groups at δ = 1.43 ppm. The protons of the hydroxyl 
groups were not observed in the 
1
H NMR spectrum in DMSO-d6 at room temperature. 
Crystallisations of compound 4.3 were attempted from a range of solvents / solvent 
systems, but unfortunately no crystals were obtained that were suitable for analysis by 
single crystal X-ray diffraction. It should be noted that compound 4.3 has the potential 
to exist as a zwitterion at basic pH, with the carboxylic acid groups being deprotonated 
(Figure 4.4). However, deliberate attempts to form the zwitterions of 4.3 Br using 
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triethylamine did not appear to be successful. Addition of AgNO3 to the product always 
generated a white precipitate, presumably AgBr, indicating the presence of bromide 
ions.
13
 It is likely that compound 4.3 exists in equilibrium in solution between the 
hydroxyl groups being protonated and deprotonated, and is dependent on the pH of the 
solution and the choice of solvent.   
 
Figure 4.4  Equilibrium between compound 4.3 and the potential zwitterion.  
 
 
 
 
 
 
Chapter 4. Acetate ester and acetic acid tethered methylimidazolium mesityl 
calix[4]arene: Ligand synthesis and metal complexation  
  
86 
 
 
Figure 4.5  
1
H NMR spectrum (DMSO-d6) of 4.3 PF6 at 298 K.  
 
Chemical shift (δ ppm) 1H Assignment 
8.71 (s, 4H) 1 
7.69 (s, 4H) 2 / 3 
7.45 (s, 4H) 2 / 3 
5.54 (s, 8H) 4 
4.87 (s, 8H) 5 
4.02 (s, 8H) 6 
2.35 (s, 24H) 7 
1.13 (s, 12H)  8 
Table 4.4  
1
H NMR assignments of compound 4.3 PF6. 
.
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4.2 Formation of metal-NHC complexes from acetate ester and acetic acid 
tethered methylimidazolium mesityl calix[4]arenes (ligand precursors 4.2 
and 4.3) 
NHC-substituted calixarenes is an area that remains relatively unexplored, with only a 
few examples reported in the literature.
14-18
 As discussed in chapter three, the inclusion 
of four imidazolium groups onto the 1,3-alternate calix[4]arene scaffold introduces the 
potential to form four metal-NHC bonds, affording a unique metal-NHC complex. The 
acetic acid tether was of particular interest (compound 4.3) as it offers the additional 
advantage of forming an anionic interaction to the metal centre through the carboxylate 
ion upon deprotonation of the acid.
19
 It was decided that, in order to simplify the 
number of potential products formed, we would initially explore the formation of metal-
NHC complexes using the acetate ester imidazolium 4.2, where the acetate groups are 
protected by tert-butyl groups.  
4.2.1 Traditional routes attempted for the preparation of metal-NHC complexes 
using NHC-ligand precursor 4.2 Br 
Two of the most common methods for the preparation of metal-NHCs are; a) 
deprotonation of an imidazolium salt and formation of the metal-NHC in situ, using a 
basic metal precursor and b) deprotonation of the imidazolium salt using a base to form 
the free carbene followed by coordination to a metal centre. Both these routes were 
investigated using compound 4.2 Br (Figure 4.6).
2-5
  
 
Figure 4.6  Routes attempted to prepare an NHC complex from ligand precursor 4.2.  
The route using a basic metal precursor is often preferred as it negates the need for 
strong bases and strict inert conditions. The reaction of 4.2 Br with Ag2O was 
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investigated under a range of experimental conditions.
10
 However, starting material was 
always isolated from these reactions, with the C2 proton still present in the 
1
H NMR 
spectra. There are examples in the literature where the Ag2O route has been used to 
synthesise silver-NHC complexes using functionalised NHC ligand precursors, some of 
which incorporate acetate ester groups.
20, 21
 However, under the range of experimental 
conditions we explored, we found no evidence for the formation of a silver-NHC. The 
reaction of compound 4.2 Br with Pd(OAc)2 was also investigated, but again starting 
material was isolated from the reaction mixture.
22
    
 Deprotonation of the imidazolium salt 4.2 Br to form the free carbene, followed 
by coordination to a metal centre was explored. The formation of the free carbene was 
investigated first in an attempt to find a suitable base for the deprotonation step. These 
reactions were conducted under an atmosphere of argon in anhydrous solvents. 
Compound 4.2 Br was dissolved in THF and the solution was cooled to -78 °C. 4.2 
equivalents of 
n
BuLi (1.6 M in hexane) was added and the solution stirred for 1 hour 
whilst being allowed to warm to room temperature slowly. The 
1
H NMR spectrum 
(anhydrous DMSO-d6) exhibited a low field resonance attributed to the C2 proton, 
indicating that the free carbene had not been formed. It was not, however, simply 
starting material that was isolated from the reaction, as the 
1
H NMR spectrum was more 
complicated than this (Figure 4.7). The reaction of compound 4.2 Br with KO
t
Bu was 
also conducted using the same experimental procedure, but again the C2-carbon 
remained protonated, and the 
1
H NMR spectrum appeared more complex than the 
starting material, with additional resonances.   
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Figure 4.7  
1
H NMR spectrum (DMSO-d6) of the product isolated from the reaction of compound 4.2 Br 
with 
n
BuLi at 298 K.  
The reaction was also attempted with the aim of generating the free carbene and 
coordinating to a metal in situ. This removed the possibility that the free carbene was 
generated in the reaction and was too unstable to be isolated and observed by 
1
H NMR 
spectroscopy. Compound 4.2 Br was dissolved in anhydrous THF and the solution was 
cooled to 0 °C. 4.2 equivalents of KOtBu was added and the solution was stirred for 2 
hours, whilst slowly warming to room temperature. 4 equivalents of AgBF4 were added 
and the resultant mixture was stirred at room temperature, in the dark, for 12 hours. The 
mixture was filtered through celite and the solvent removed in vacuo, yielding an off 
white solid. The 
1
H NMR spectrum (DMSO-d6) was complicated, but showed no 
evidence for the formation of a silver-NHC, with the C2 proton being observed in the 
1
H NMR spectrum at δ = 8.93 ppm. The reaction was repeated using PdCl2(MeCN)2 as 
the metal source under the same reaction conditions, which resulted in a brown solid 
being isolated from the reaction mixture. The 
1
H NMR spectrum (DMSO-d6) was again 
complicated, but showed no evidence for the formation of the desired palladium-NHC, 
with the C2 proton being observed at δ = 9.73 ppm. The shift in the signal of the C2 
proton, in addition to the increased complication in the 
1
H NMR spectrum, was 
indicative of a new compound or compounds being formed.    
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 From these reactions it was evident that, under basic conditions, the imidazolium 
C2 carbons of compound 4.2 Br were not being deprotonated, and the increased 
complication in the 
1
H NMR spectra suggests that the base was reacting with another 
part of the compound. It is likely that the methylene groups of the acetate ester 
substituents have a similar acidity to the imidazolium C2 protons (Figure 4.8). We 
estimate the pKa of these protons to be in the region of 20-24, with the pKa of the 
imidazolium proton being reported in the region of 20-25.
23
 We propose that a base may 
react with the methylene protons over the C2 protons, resulting in undesired reactions 
rather than the formation of an NHC.  
 
Figure 4.8  Relative acidity of the protons in compound 4.2.  
In order to confirm this theory, 1-methyl-3-tert-butylacetate imidazolium chloride (4.4) 
was synthesised. Compound 4.4 has a methyl group in place of the calixarene scaffold, 
enabling the acetate ester functionality to be investigated thoroughly, without potential 
interference or complication from the calixarene group. Compound 4.4 was synthesised 
from the reaction of 1-methylimidazole with tert-butyl 2-chloroacetate. The mixture 
was stirred at room temperature under an atmosphere of nitrogen for 12 hours, during 
which time the mixture solidified. The product was recrystallised from DCM / hexane 
and purified further by washing with diethyl ether and dried in vacuo, affording 
compound 4.4 as a white solid. This was characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy, mass spectrometry and elemental analysis. A 
1
H NMR spectrum of 
compound 4.4 in DMSO-d6 is displayed in Figure 4.9, with the relevant peaks assigned 
in Table 4.5.           
 The 
1
H NMR spectrum appears as expected, with the resonance for the C2 
proton appearing downfield at δ = 9.31 ppm. Interestingly, the resonances for the 
imidazolium backbone protons appear as one resonance at δ = 7.78 ppm, suggesting that 
the protons are coincidently in the same environment.   
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Figure 4.9  
1
H NMR spectrum (DMSO-d6) of compound 4.4 at 298 K.  
 
Chemical shift (δ ppm) 1H Assignment 
9.31 (s, 1H) 1 
7.78 (s, 2H) 2 
5.22 (s, 2H) 3 
3.91 (s, 3H) 4 
1.44 (s, 9H) 5 
Table 4.5  
1
H NMR assignments of compound 4.4.  
As with compound 4.2 Br, the traditional routes for forming metal-NHC complexes 
using ligand precursor 4.4 proved unsuccessful (Figure 4.10). The reaction of 
compound 4.4 with Ag2O yielded starting material, with the C2 proton still being 
present in the 
1
H NMR spectrum. Reactions of compound 4.4 with a base, in an attempt 
to form the free carbene, showed increased complication in the 
1
H NMR spectra, with 
multiple resonances being observed in the CH, CH2 and CH3 regions. Furthermore, a 
characteristic low field resonance was observed for the C2 proton, indicating that the 
NHC had not been formed. This confirmed that it was the acetate ester functionality that 
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was causing problems in the synthesis of metal-NHC complexes using compound 4.2 
Br, rather than the calixarene moiety.   
 
Figure 4.10  Routes attempted to prepare metal-NHC complexes using ligand precursor 4.4.  
4.2.2 Electrochemical synthesis of copper(I)-NHC complexes using NHC-ligand 
precursor 4.2 Br 
In 2011, Liu et al. reported an electrochemical procedure for the synthesis of metal-
NHC complexes.
24
 The electrochemical approach relies upon the redox-active nature of 
imidazoliums in order to generate free NHCs in situ. During the electrochemical 
reaction the imidazolium is reduced at the cathode, releasing molecular hydrogen, and 
forming the free NHC (Figure 4.11a). Concomitantly, at the anode the metal is oxidised 
releasing metal ions into solution (Figure 4.11b). The NHC(s) and metal ion(s) then 
combine in solution and form the metal-NHC complex (Figure 4.11c). Lin et al. 
describe the synthesis of Cu(I), Cu(II), Ni(II), and Fe(II) metal-NHC complexes of 
ligands bearing N-pyridine or N-pyrimidine groups using this electrochemical 
approach.
24
 To the best of our knowledge this is the first report of transition metal-NHC 
complexes being synthesised electrochemically, despite the electrochemical reduction 
of imidazoliums to form free NHCs having been previously reported.
25-27
  
 The electrochemical procedure was developed further within the Willans group, 
and has been successful for the synthesis of a wide range of copper(I)-NHC complexes 
of monodentate and bidentate ligands that do not contain pendant donor  arms.
6
 A major 
advantage of this procedure is that it does not rely on the relative acidity of the 
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imidazolium proton, only upon the redox potential, making this a viable synthetic route 
for the synthesis of metal-NHC complexes using imidazolium salts that contain acidic 
functionalities.  
 
Figure 4.11  Process occurring at the (a) cathode, (b) anode  and (c) in solution, during the 
electrochemical synthesis of metal-NHC complexes.
6
 
Compound 4.4 was used in the electrochemical method to investigate if it could be used 
to generate copper(I)-NHC complexes from imidazolium salts that incorporate nitrogen 
substituents with acidic protons (Scheme 4.2).  
 
Scheme 4.2  Electrochemical synthesis of complex 4.5.  
Copper plates were used as both the sacrificial anode and the cathode (1 × 3 cm), and 
the reaction was performed in anhydrous acetonitrile, as this is known to stabilise 
copper(I) species. Compound 4.4 was added to the flask and degassed. Anhydrous 
acetonitrile was added (15 ml) and the solution was degassed for 1 hour by bubbling 
argon through. The electrodes were inserted into the solution and a potential applied 
such as to maintain a constant current of 50 mA. The reaction was monitored using 
1
H 
NMR spectroscopy, and stopped when the resonance attributed to the C2 proton was no 
longer present. The theoretical reaction time can be calculated using Faraday‟s law 
(Figure 4.12), based upon maintaining a constant current throughout the course of the 
reaction. The solution containing compound 4.4 was electrolysed for 50 minutes, which 
was calculated to be 2 Q. After this time, the mixture was filtered to remove suspended 
copper particles, and the solvent removed in vacuo to yield complex 4.5 as an off-white 
solid,  which was characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass 
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spectrometry and elemental analysis. A 
1
H NMR spectrum (CDCl3) of compound 4.5 is 
displayed in Figure 4.13, with the relevant peaks assigned in Table 4.6.    
 
Q = total charge (C or A) 
n = number of electrons transferred 
F = Faraday‟s constant (C mol-1) 
N = moles of starting material (mol) 
I = current (A) 
t = time (s) 
 
 
Figure 4.12  Faraday‟s law 
From the 
1
H NMR spectrum it is evident that a copper-NHC complex has been formed, 
due to the disappearance of the resonance attributed to the C2 proton that was observed 
at δ = 9.15 ppm (DMSO-d6) in the imidazolium starting material. Markedly, the 
backbone imidazolium protons (1 / 2) now appear as two separate resonances at δ = 
6.98 ppm and δ = 6.93 ppm. This could be a result of metal complexation, or it could be 
a solvent effect, as the starting material is not soluble in chloroform so the 
1
H NMR 
spectra of compound 4.4 and complex 4.5 (Figures 4.9 and 4.13) cannot be directly 
compared in this case. The 
13
C{
1
H} NMR spectrum also displays a low field resonance 
at δ = 178 ppm that corresponds to the carbenic carbon atom coordinating to copper. 
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Figure 4.13  
1
H NMR spectrum (CDCl3) of complex 4.5 at 298 K. 
 
Chemical shift (δ ppm) 1H Assignment 
6.98 (s, 1H) 1 / 2 
6.93 (s, 1H) 1 / 2 
4.78 (s, 2H) 3 
3.81 (s, 3H) 4 
1.45 (s, 9H) 5 
Table 4.6  
1
H NMR assignments of complex 4.5. 
The mass spectrometry data confirmed the presence of a copper(I)-NHC complex with 
an m/z observed for [4.5-Cl+MeCN]
+
 at 300.1. It has been established by the Willans 
group that, when using the electrochemical synthetic method, imidazoliums that contain 
a coordinating anion (such as chloride or bromide) form a neutral complex of the type 
Cu(NHC)X, whereas, imidazoliums with a non coordinating anion (such as PF6) form a 
cationic complex of the type [Cu(NHC)2]
+
X
-
.
6
 Consequently the neutral copper(I)-NHC 
was the expected structure for complex 4.5. However, the cationic [Cu(NHC)2]
+
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complex was also observed in the mass spectrometry data with m/z at 455.2. Fluxional 
behaviour between the cationic and neutral complexes is known, and has been observed 
for d
10
 metals previously, with silver complexes [Ag(NHC)X] and [Ag(NHC)2]
+
AgX2
-
 
being observed in equilibrium in solution.
4
 However, the 
1
H NMR and 
13
C{
1
H} NMR 
spectrum of complex 4.5 suggest the formation of one species in acetonitrile, which is 
the solvent used in the mass spectrometry experiments. Therefore it is likely that the 
cationic complex is formed during the mass spectrometry analysis as the complex is 
ionised. A mass is also observed for the imidazolium starting material, suggesting that 
the complex is fragmented during the ionisation process. The formation of the neutral 
complex of the type Cu(NHC)Cl was confirmed by elemental analysis. Complex 4.5 
was found to be extremely air / moisture sensitive, which is often observed for „non 
bulky‟ NHCs, where the nitrogen substituents do not provide sufficient steric protection 
around the carbenic centre.         
 As the electrochemical synthetic method proved to be compatible using ligand 
precursor 4.4, it was explored using our calixarene compound 4.2 Br (Scheme 4.3).  
 
Scheme 4.3. Electrochemical procedure for the synthesis of complex 4.6.  
The reaction was carried out as described previously, using compound 4.2 Br in place 
of compound 4.4 and monitoring the reaction using 
1
H NMR spectroscopy. The mixture 
was electrolysed for 32 hours, (6 Q), at a current of 10 mA. Compound 4.2 Br is a 
poorer electrolyte than compound 4.4 and a current of 10 mA was the highest that could 
be achieved during the reaction. Complete disappearance of the C2 proton resonance 
after 6 Q indicated that the reaction was complete. The reaction time was considerably 
longer than that of the monodentate imidazolium precursor (compound 4.4), which had 
a reaction time of 2 Q. We have not yet determined why these electrochemical reactions 
take longer than the predicated time (i.e. Q).      
 Figure 4.14 shows the 
1
H NMR spectra of the reaction as it progressed. It can be 
seen that, as the mixture was electrolysed, multiple products were formed. For example, 
if we examine the resonance for the C2 imidazolium proton between 0 Q and 6 Q we 
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can see that the signal moves upfield and splits, with multiple resonances being 
observed before disappearing at 6 Q. It is likely that a mixture of the 1-, 2-, 3- and 4-
copper-NHC complexes form as the reaction proceeds, until the reaction is driven to 
completion and the desired 4-copper-NHC complex is formed (4.6).  
 
Figure 4.14  
1
H NMR spectra (MeCN-d3) taken during the electrolysis of compound 4.2 Br, from starting 
material (0 Q), to product 4.6 (6 Q) recorded at 298 K.   
Following the completion of the above reaction the solvent was removed in vacuo, and 
the resultant solid was dissolved in DCM and filtered to remove suspended metal 
particles. The solvent was removed from the filtrate in vacuo to yield complex 4.6 as a 
pale yellow solid, which was characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy combined with mass spectrometry. The 
1
H NMR spectrum is displayed in 
Figure 4.15 with the relevant peaks assigned in Table 4.7. From the 
1
H NMR spectrum 
(MeCN-d3) it is evident that the copper(I)-NHC complex has formed due to the 
disappearance of the resonance attributed to the C2 proton, that was observed at δ = 
8.92 ppm in the starting imidazolium material (4.2 Br). The 
13
C{
1
H} NMR spectrum 
displays a low field resonance at δ = 178. 6 ppm attributed to the C2 carbon bound to 
copper. The mass spectrometry data is consistent with the formation of complex 4.6, 
with the m/z observed at 1879.2 for [4.6+H]
+
.      
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Figure 4.15  
1
H NMR spectrum (MeCN-d3) of complex 4.6 at 298 K.  
 
Chemical shift (δ ppm) 1H Assignment  
7.08 (s, 4H) 1 / 2 
6.69 (s, 4H) 1 / 2 
5.37 (s, 8H) 3 
4.79 (s, 8H) 4 
4.03 (s, 8H) 5 
2.34 (s, 24H) 6 
1.44 (s, 36H) 7 
1.18 (s, 12H) 8 
Table 4.7  
1
H NMR assignments of complex 4.6. 
Complex 4.6 appears more stable than complex 4.5, however it was still found to be air 
/ moisture sensitive. If exposed to air, the complex degrades over a few hours in 
Chapter 4. Acetate ester and acetic acid tethered methylimidazolium mesityl 
calix[4]arene: Ligand synthesis and metal complexation  
  
99 
 
solution, and over a few days in the solid state. Although the calixarene is a large 
molecule it does not provide a large degree of steric protection around the carbenic 
centre, therefore this would still be considered a „non-bulky‟ NHC, accounting for the 
relative instability. Crystallisations of complex 4.6 were attempted in a range of 
solvents / solvent mixtures, however no crystals were obtained that were suitable for 
analysis by single crystal X-ray diffraction.  
4.2.3 Transmetallation from Cu(I)-NHC complex 4.6 to palladium(II) 
An attractive route for the synthesis of a range of transition metal-NHC complexes is to 
use ligand transfer from one metal to another. The most widely used NHC transfer 
agents are silver(I)-NHC complexes, which have been shown to transfer NHC-ligands 
to a wide range of transition metals (Pd(II), Ru(II), Ru(III), Ru(IV), Rh(I), Rh(III), Ir(I), 
Ir(III), Au(I), Ni(II), Cu(I), Cu(II)).
10, 28
 Silver(I)-NHC complexes are widely used due 
to their relative ease of synthesis. The reaction of an imidazolium salt with a basic silver 
reagent forms the silver-NHC in situ, and the procedure circumvents the need for anoxic 
conditions.
8
 Other transition metal-NHC complexes have also been reported as 
transmetallation agents; gold(I)-NHCs have been used to prepare palladium(II)-NHC 
complexes, and nickel(II)-NHCs have recently been used to prepare palladium(II)-, 
platinum(II)-, cobalt(III)- and ruthenium(II)-NHC complexes.
29, 30
 Conveniently, 
copper(I)-NHCs have also been reported as carbene transfer agents and, to the best of 
our knowledge, the transmetallation from copper(I)-NHCs has been limited to 
ruthenium(II), palladium(II), nickel(II) and gold(I).
7, 31, 32
    
 Until recently, the most widely reported method of forming copper(I)-NHC 
complexes was through using a strong base to form the free NHC, then adding a CuX 
salt (where X = halide).
33-35
 These reactions require strict anoxic conditions and 
generate undesirable inorganic salts as by-products. With the development of new 
methodologies for the synthesis of Cu(I)-NHC complexes such as a) using Cu2O in 
analogy to Ag2O or b) the electrochemical synthesis of copper(I)-NHCs, the use of 
copper(I)-NHC complexes as ligand transfer agents is becoming more attractive.
6, 36
 
Cu(I)-NHC complex 4.6 was investigated as a transmetallation agent to prepare a 
palladium(II)-NHC complex.  
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Scheme 4.4  Synthesis of palladium-NHC complex 4.7.  
Complex 4.6 was reacted with four equivalents of PdCl2(MeCN)2, in the presence of 
excess KBr, in anhydrous DCM (Scheme 4.4). The addition of KBr ensured that all the 
halide atoms in the resulting complex were bromide atoms rather than generating a 
mixed chloride / bromide complex. After 12 hours the solvent was removed in vacuo 
and the resulting dark red solid was dissolved in acetonitrile and filtered through celite. 
The product was precipitated from acetonitrile by the addition of diethyl ether, collected 
by gravity filtration, and purified by column chromatography (silica gel, MeCN). 
Complex 4.7 was collected as a dark red solid and analysed by 
1
H NMR and 
13
C{
1
H} 
NMR spectroscopy, mass spectrometry and elemental analysis. The 
1
H NMR spectrum 
is displayed in Figure 4.16 with the relevant peaks assigned in Table 4.8.   
 The 
1
H NMR spectrum (MeCN-d3) is indicative of a metal-NHC complex, as 
there is no high field resonance attributed to the C2 proton. The remaining signals have 
shifted compared to the starting copper(I)-NHC complex, suggesting that transfer to 
palladium has occurred. The 
13
C{
1
H} NMR spectrum (MeCN-d3) no longer displays the 
resonance for the C2-carbon bound to copper at δ = 178.6 ppm, and instead displays a 
low field resonance at δ = 147.3 ppm. This is consistent with palladium(II)-NHC 
complexes that have a trans-coordinating two electron donor ligand such as 
PdX2(NHC)(py) or PdX2(NHC)(MeCN).
37, 38
 This provides evidence that the 
monodentate NHC complex PdX2(NHC)(MeCN) has been formed, rather than the 
bidentate palladium-NHC complex PdX2(NHC)2, which would display a resonance for 
the C2 carbon bound to palladium further downfield at δ = 160 - 170 ppm.14 Mass 
spectrometry data further confirms the presence of the expected palladium-NHC 
complex, with a signal at m/z 992.8 for [4.7-4
t
Bu-2Br-4MeCN]
2+
 (Figure 4.17). 
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Figure 4.16  
1
H NMR spectrum (MeCN-d3) of complex 4.7 at 298 K.  
 
Chemical shift (δ ppm) 1H Assignment 
7.11 (s, 4H) 1 / 2 
6.14 (s, 4H) 1 / 2 
5.6 (s, 8H) 3 
5.2 (s, 8H) 4 
4.05 (s, 8H) 5 
2.3 (s, 24H) 6 
1.46 (s, 36H) 7 
1.24 (s, 12H) 8 
Table 4.8  
1
H NMR assignments of complex 4.7. 
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Figure 4.17  Mass spectrometry data of complex 4.7 (top): calculated for [4.7-4
t
Bu-2Br-4MeCN]
2+
 
(bottom).  
The structure of the palladium-NHC complex was confirmed using single crystal X-ray 
diffraction analysis. Yellow plate crystals were obtained by the slow diffusion of 
pentane into an acetonitrile solution of complex 4.7. The molecule crystallised in the 
monoclinic crystal system, and the structural solution was performed in the space group 
C2/c. Only half the calixarene molecule is contained within the asymmetric unit. The 
crystals were highly sensitive to de-solvation and were weakly diffracting. There was 
significant void space and diffuse electron density which could not be accurately 
modelled, hence the routine SQUEEZE in the interface PLATON was employed.
39
 The 
molecular structure is displayed in Figure 4.18 with selected bond lengths and angles in 
Table 4.9.   
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Figure 4.18  X-ray crystal structure of complex 4.7. Symmetry operations for symmetry generated atoms 
i: 1-x, y, 3/2-z. The acetonitrile molecules not coordinating to the palladium atoms and hydrogen atoms 
have been omitted for clarity. Ellipsoids are displayed at 50 % probability.  
b 
a 
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Pd(1)-C(7) 1.972(10) C(7)-Pd(1)-N(5) 177.5(4) 
Pd(1)-N(5) 2.103(11) C(7)-Pd(1)-Br(1) 86.8(3) 
Pd(1)-Br(1) 2.4412(16) N(5)-Pd(1)-Br(1) 92.0(3) 
Pd(1)-Br(2) 2.4481(16) C(7)-Pd(1)-Br(2) 91.0(3) 
Pd(2)-C(33) 1.973(11) N(5)-Pd(1)-Br(1) 90.2(3) 
Pd(2)-N(6) 2.079(10) Br(1)-Pd(1)-Br(2) 177.73(6) 
Pd(2)-Br(3) 2.4353(17) C(33)-Pd(2)-Br(4) 87.1(3) 
Pd(2)-Br(4) 2.4461(16) N(6)-Pd(2)-Br(3) 91.1(3) 
N(1)-C(7) 1.375(13) N(6)-Pd(2)-Br(3) 92.9(3) 
N(5)-C(42) 1.129(16) C(33)-Pd(2)-Br(3) 88.8(3) 
  N(2)-C(7)-N(1) 105.2(9) 
Table 4.9  Selected bond distances (Å) and angle (deg) for complex 4.7. 
The structure displays the expected 1,3-alternate conformation of the calixarene core, 
with two NHC groups projecting upwards and two projecting downwards. As implied 
by the
 13
C{
1
H} NMR spectroscopy and mass spectrometry data, the monodentate 
palladium-NHC complex of the type PdBr2(NHC)(MeCN) was formed, incorporating 
four palladium(II) centres per calixarene molecule. The coordination geometry around 
the palladium is square planar, with two coordinating bromide atoms and an acetonitrile 
molecule trans to the NHC ligand (max deviation from the square planar geometry C7-
Pd1-Br1 angle 86.8 °). The acetonitrile molecule is weakly bound owing to the trans 
effect of the NHC ligand, with the bond length of Pd1-N5 being 2.103(10) Å, and Pd2-
N6 being 2.079(10) Å. The Pd-C bond lengths, Pd1-C7 1.972(10) Å and Pd2-C33 
1.973(11) Å, are in the range of the literature values for palladium-NHC complexes of 
the type PdX2(NHC)(MeCN).
5, 38
       
 Each palladium atom is orientated towards one side of the cavity, with opposite 
palladium atoms positioned on opposite sides (Figure 4.18b). The packing diagram for 
complex 4.7 shows that the calixarene molecules are arranged in 2D layers, with 
acetonitrile groups positioned between the layers (Figure 4.19). The 2D channels 
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between the acetonitrile molecules measure approximately 9 Å by 11 Å, and the smaller 
channels observed between the neighbouring calixarene molecules measure 
approximately 3 Å by 11 Å. The structure shows that the palladium centres are buried 
within the molecule and are not very exposed. This may be advantageous for the use of 
the complex as a catalyst, as it may stabilise the active species (Chapter 5).  
 
Figure 4.19  X-ray crystal packing diagram of complex 4.7 showing the palladium atoms are buried 
within the molecule. 
4.2.4 Transmetallation from Cu(I)-NHC complex 4.6 to other transition metals  
The transmetallation of the NHC ligand in complex 4.6 to Ru(II) was explored 
following a procedure outlined by Albrecht et al.
31
 Complex 4.6 was reacted with two 
equivalents of [RuCl2(cymene)]2, in the presence of KBr, in anhydrous DCM (Scheme 
4.5). The solution was filtered through celite and the solvent removed in vacuo to yield 
a red solid that was analysed by 
1
H NMR and
 13
C{
1
H} NMR spectroscopy combined 
with mass spectrometry.  The 
1
H NMR and
 13
C{
1
H} NMR spectra (DCM-d2 / CDCl3) 
were broad and gave no insight as to the identity of the product. The mass spectrometry 
data showed the presence of ruthenium containing species from the observed splitting 
pattern, but the m/z signals were not large enough to incorporate the calixarene 
framework. Crystallisations were attempted in a range of solvents / solvent mixtures, 
3 Å by 11 Å 
9 Å by 11 Å 
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but only the ruthenium precursor, [RuCl2(cymene)]2 or RuCl2(MeCN)4 (crystallisations 
set in up MeCN) crystallised from solution, suggesting that the ligand was not 
transferred. The reaction was repeated in a sealed ampoule with the temperature raised 
to 40 °C, in an attempt to promote the transmetallation reaction. The same result was 
observed as previously, with [RuCl2(cymene)]2 crystallising from solution (DCM / 
diethyl ether).  
 
Scheme 4.5  Reaction Scheme for the attempted carbene transfer reaction from copper(I) (complex 4.6) to 
ruthenium(II).  
The transmetallation of the NHC ligand in complex 4.6 to nickel(II) was explored. 
Complex 4.6 was reacted with four equivalents of NiBr2(PPh3) in anhydrous DCM 
(Scheme 4.6). The solution was filtered through celite and the solvent removed in vacuo 
to yield a yellow solid. The solid was washed with diethyl ether, dried in vacuo, and the 
product analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with mass 
spectrometry. There was no evidence from the analytical data that any product had 
formed, with only simple nickel salts being identified by X-ray crystallography (e.g. 
NiBr(PPh3)3). The reaction was repeated in a range of solvents, but a nickel-NHC 
complex was never identified. 
 
Scheme 4.6  Reaction scheme for the attempted carbene transfer reaction from copper(I) (complex 4.6) to 
nickel(II).  
The transmetallation of the NHC ligand in complex 4.6 to rhodium(I) was also 
explored. To the best of our knowledge a transmetallation reaction from copper(I) to 
rhodium(I) has not been previously reported. Complex 4.6 was reacted with two 
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equivalents of [Rh(COD)Cl]2 in anhydrous chloroform (Scheme 4.7). The solution was 
filtered and the solvent removed from the filtrate in vacuo to yield a yellow solid. The 
product was analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with 
mass spectrometry.   
 
Scheme 4.7   Proposed product from the attempted carbene transfer reaction from copper(I) (complex 
4.6) to rhodium(I).  
Figure 4.20 displays the 
1
H NMR spectra (CDCl3) starting from the Cu(I)-NHC 
complex 4.6 (A), 10 minutes after addition of [Rh(COD)Cl]2 (B), and after 12 hours of 
reaction (C). The spectrum of the final product (C) is too broad to be fully assigned, 
though signals can be observed in the correct regions for the CH, CH2 and CH3 groups, 
and no low field resonance for the C2 imidazolium proton is present suggesting the 
formation of a new carbene complex.       
 The 
13
C{
1
H} NMR spectrum of the product does not exhibit the resonance at δ = 
178.6 ppm attributed to the C2 carbon bound to copper in complex 4.6, and instead 
displays a low field doublet resonances at δ = 182.15 ppm. This can be assigned to the 
C2 carbon coordinated to rhodium(I), with a Rh-C coupling constant of 50.1 Hz, which 
is typical for rhodium(I)-NHC complexes.
40
 The formation of the rhodium(I) complex 
(4.8) was confirmed by mass spectrometry, which displays a signal at m/z 2389.4 
assigned to [4.8-Br]
+
 and at m/z 1154.8 assigned to [4.8-2Br]
2+
 (Figure 4.21).  
 Crystallisations of complex 4.8 were attempted from a range of solvents / 
solvent systems but no crystals were obtained that were suitable for analysis by single 
crystal X-ray diffraction. However, the analytical data obtained strongly indicates the 
synthesis of the Rh(I)-NHC complex 4.8, and confirms that copper(I)-NHC complexes 
can be used as ligand transfer agents to form rhodium(I)-NHC complexes. 
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Figure 4.20  
1
H NMR spectra (CDCl3) from the reaction of complex 4.6 with [Rh(COD)Cl]2; (A) Cu(I)-
NHC complex 4.6,  (B) complex 4.6 10 minutes after the addition of [Rh(COD)Cl]2, (C) complex 4.6 12 
hours after addition of [Rh(COD)Cl]2.  
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Figure 4.21  Mass spectrometry data of complex 4.8 (top), and calculated for [4.8-2Br]
2+
 (bottom).  
4.2.5 Formation of metal-NHC complexes using acetic acid tethered NHC-ligand 
precursor 4.3  
Compound 4.3 (Scheme 4.1) is functionalised with acetic acid substituents, which offers 
the potential of forming a bidentate chelating metal-NHC complex, through 
coordination to the metal via both the NHC groups and the carboxylate groups.
1
 The 
methylene protons of the acetic acid tethers are less acidic than those of the acetate 
tethers in compound 4.2. Therefore, under basic reaction conditions, the methylene 
protons would not be deprotonated as readily. However, the hydroxyl groups are very 
acidic due to the short alkyl chain length of the carboxylic acid, with the pKa expected 
to be in the region of 1.90-2.50 depending on the counter anion, and would be expected 
to deprotonate under basic reaction conditions.
13
     
 As discussed previously, an attractive route for the synthesis of a wide range of 
transition metal-NHC complexes is through transmetallation from a silver-NHC 
complex.
8, 28
 Albrecht et al. have reported the synthesis of a ruthenium(II)-NHC 
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complex with a tethered carboxylate donor that was synthesised through the in situ 
formation of the silver-NHC complex, followed by transmetallation from silver(I) to 
ruthenium(II) using [RuCl(Cp)(PPh3)2] (Figure 4.22).
1
   
 
Figure 4.22  Reported product from the reaction of a carboxylate functionalised imidazolium  zwitterion 
with Ag2O, followed by transmetallation from Ag(I) to Ru(II) using [RuCl(Cp)(PPh3)2] precursor.
1
 
The reaction of compound 4.3 Br with two equivalents of Ag2O was investigated in 
different solvents (MeOH, DCM), varying the temperature of the reaction (from room 
temperature to 70 °C), and varying the reaction time (24-72 hours). Analysis by 1H 
NMR spectroscopy of the products formed in the reactions revealed that, in all cases, 
the imidazolium C2 carbon remained protonated, indicating that a silver-NHC complex 
had not been formed. Notably, the resonance for the methylene protons of the acetic 
acid tether had shifted upfield from δ = 5.15 to δ = 4.39 ppm. To investigate this more 
thoroughly, 1-methyl-3-acetic acid imidazolium chloride (4.9) was synthesised. 
Compound 4.9 has a methyl group in place of the calixarene scaffold, enabling the 
acetic acid functionality to be investigated thoroughly without potential interference or 
complications from the calixarene group.      
 Compound 4.9 was synthesised by heating compound 4.4 in excess HCl (aq) at 
reflux (110 °C). The product was purified by washing with acetone and diethyl ether, 
and was dried in vacuo, affording compound 4.9 as an off white solid which was 
analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with mass 
spectrometry. A 
1
H NMR spectrum of compound 4.9 (DMSO-d6) is displayed in Figure 
4.23 with the relevant peaks assigned in Table 4.10. The 
1
H NMR spectrum appears as 
expected, with the resonance for the C2 imidazolium proton appearing downfield at δ = 
9.33 ppm. The backbone imidazolium protons now appear as two separate resonances at 
δ = 7.80 ppm and δ = 7.78 ppm, whereas in compound 4.4 these protons appeared as 
one resonance at δ = 7.78 ppm. Notably, the residual water peak is not observed in the 
1
H NMR spectrum of compound 4.9, even though the spectrum was recorded in DMSO-
d6. Any water protons in solution will most likely be exchanging with the hydroxyl 
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group protons of the acetic acid tethers, which would cause the water signal to broaden, 
and is likely to account for the absence of the water peak. However, a water peak was 
observed in the 
1
H NMR spectrum of the calixarene that incorporates the acetic acid 
substituents (compound 4.3, Figure 4.4). Adding 10 µL aliquots of D2O to the NMR 
sample of compound 4.9 (DMSO-d6) resulted in the proton signals shifting upfield. For 
example, the C2 proton resonance shifted from δ = 9.33 ppm to δ = 9.16 ppm after 40 
µL of D2O was added. This evidence suggests that compound 4.9 may be interacting 
with water molecules in solution. 
 
 Figure 4.23  
1
H NMR spectrum (DMSO-d6) of compound 4.9 at 298 K. 
  
Chemical shift (δ ppm) 1H Assignment 
9.33 (s, 1H) 1 
7.80 (s, 1H) 2 / 3 
7.78 (s, 1H) 2 / 3 
5.24 (s, 2H) 4 
3.93 (s, 3H) 5 
Table 4.10  
1
H NMR assignment of compound 4.9.  
Compound 4.9 was reacted with two equivalents of Ag2O in anhydrous DCM, at 40 °C 
for 12 hours. 4 Å molecular sieves were added to the reaction to remove the water 
formed in the reaction. The mixture was filtered through celite and the solvent removed 
in vacuo, but only a few mgs of solid was isolated. This was most likely due to the poor 
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solubility of compound 4.9 in DCM.        
 The reaction was repeated in a DCM / methanol mixture (2:1), with enough 
methanol added to solubilise compound 4.9, and the mixture was heated at reflux (70 
°C). The isolated product was analysed by 1H NMR and 13C{1H} NMR spectroscopy 
combined with mass spectrometry. The 
1
H NMR spectrum (MeOD-d4) does not exhibit 
a low field resonance attributed to the C2 proton, suggesting the formation of a silver-
NHC complex (Figure 4.24). It should be noted that in protic solvents, such as 
methanol, imidazolium compounds do not always exhibit a resonance for the C2 proton. 
This is attributed to the exchange of the acidic C2 proton with the deuterium atoms of 
the solvent. However, a 
1
H NMR spectrum of compound 4.9 taken in methanol displays 
a resonance at δ = 9.03 ppm, attributed to the C2 proton. This suggests that proton 
exchange does not account for the absence of the C2 proton resonance in Figure 4.24. 
The 
13
C{
1
H} NMR spectrum (MeOD-d4) does not display a resonance attributed to the 
C2 carbon bound to silver, which is usually observed at around 180 ppm. Intriguingly, 
there is also no resonance observed for the methylene carbons on the acetic acid group 
(at δ = 49.8 ppm in compound 4.9), even though the methylene protons can be seen in 
the 
1
H NMR spectrum at δ = 4.74 ppm (MeOD-d4) (Figure 4.24). The mass 
spectrometry data does not show evidence for the formation of a silver-NHC complex, 
with the major signal seen at m/z 141.1 assigned to the starting imidazolium ligand 
(4.9).  
 
Figure 4.24  
1
H NMR spectrum (MeOD-d4) of the product formed in the reaction of compound 4.9 with 
Ag2O in DCM at 298 K.  
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The reaction of compound 4.9 with Ag2O was repeated in methanol alone. Again, a low 
field resonance was not observed for the C2 imidazolium proton in the 
1
H NMR 
spectrum (MeOD-d4), and at least two products appeared to be present in a ratio of ~3:1 
(blue triangle: green circle, Figure 4.25). Upon closer examination of the 
1
H NMR 
spectrum, additional smaller resonances can be seen in the region of these peaks, 
suggesting further minor products have also formed. Again, the 
13
C{
1
H} NMR spectrum 
does not display evidence for the C2 carbon bound to silver. The mass spectrometry 
data displays a signal at m/z 141.1, assigned to the starting imidazolium salt (4.9), in 
addition to some larger mass peaks that appeared to incorporate silver(I) by the 
observed splitting patterns at m/z 433.9, 492.0, 566.9. These signals could not be 
assigned to a desirable product. From the mass spectrometry data it did not appear that a 
simple monodentate or bidentate silver-NHC complex, or a mixture of the two, had 
been formed in the reaction.  
 
Figure 4.25  
1
H NMR spectrum (MeOD-d4) of the products formed in the reaction of compound 4.9 with 
Ag2O in methanol at 298 K. 
Single crystals suitable for analysis by single crystal X-ray diffraction were grown by 
slow diffusion of diethyl ether into a methanol solution of the product from the reaction 
of compound 4.9 with Ag2O in methanol. The X-ray crystal structure revealed a 
zwitterion, with the hydroxyl group deprotonated (compound 4.10, Figure 4.26). The 
carbon to oxygen bond lengths, O1-C6 and O2-C6, are identical (1.268 Å), showing the 
electron density is delocalised across the O(1)-C(6)-O(2) bonds. The carbon to oxygen 
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bond lengths are shorter than a C-O single bond (1.318 Å) and longer than a C=O bond 
(1.206 Å) providing further evidence that the electron density is delocalised.
13
 The 
molecule packs as a 1D chain, propagated through a hydrogen bond from the  
deprotonated hydroxyl group (O2) to one of the backbone imidazolium protons (H2), 
with the length of the [O
-
····C] bonds being 3.147 Å (Figure 4.27).   
 It has not been confirmed as to whether a silver-NHC complex was formed in 
the reaction of compound 4.9 with Ag2O and decomposed in solution, liberating silver 
chloride and reprotonating the C2 carbon, or if the zwitterion was formed during the 
reaction. However, the
 1
H NMR spectrum does not show any evidence for the presence 
of the C2 imidazolium proton, which would be expected to appear downfield at around 
9 ppm in the zwitterion, suggesting that the zwitterion was not the major product of the 
reaction (Figure 4.25). It is likely that the silver-NHC, or silver adduct, was formed in 
the reaction and decomposed in solution to form the zwitterion that crystallised from 
solution.  
 
Figure 4.26  Molcular structure of compound 4.10. Ellipsoids are displayed at 50 % probability.  
 
C(4)-H(4) 0.9500 C(4)-N(1)-C(2) 109.1(2) 
C(3)-H(3) 0.9500 O(2)-C(6)-O(1) 126.9(2) 
N(2)-C(4) 1.341(3) O(1)-C(6)-C(5) 118.9(2) 
C(6)-O(1) 1.268(3) N(2)-C(4)-N(1) 108.3(2) 
C(6)-O(2) 1.268(3)   
Table 4.11  Selected bond distances (Å) and angles (deg) for compound 4.10.  
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Figure 4.27  X-ray crystal structure displaying the bonding interactions observed in the solid state 
structure of 4.10. Symmetry operations for symmetry generated atoms i: x-1/2, 1-y, z; ii: 1/2+x, 1-y, z; iii: 
1+x, y, z; iv: 3/2+x, 1-y, z. Ellipsoids are displayed at 50 % probability.  
The in situ transmetallation of the product formed in the reaction between compound 
4.9 and Ag2O to ruthenium(II) (using [RuCl2(cymene)]2) and palladium(II) (using 
PdCl2(MeCN)2) was explored, to see if a stable product could be isolated from the 
reaction. Neither reaction was successful.       
 From this investigation it is clear that Ag2O is reacting with the carboxylic acid 
group of compound 4.9 as well as, or instead of, reacting with the imidazolium C2 
proton. The 
1
H NMR spectroscopy data suggests that, in methanol / DCM or in just 
methanol, the reaction between compound 4.9 and Ag2O forms a silver-NHC complex 
due to the absence of the resonance assigned to the C2 imidazolium proton in the 
1
H 
NMR spectrum. However, no desirable product could be identified by mass 
spectrometry.  When compound 4.3 Br was reacted with Ag2O, analysis of the products 
formed by 
1
H NMR spectroscopy revealed that the imidazolium C2 carbon remained 
protonated and that the acetic acid methylene protons had shifted upfield from δ = 5.15 
to δ = 4.39 ppm. It is likely that, in this reaction, the Ag2O has reacted with the 
carboxylic acid group and not the C2 imidazolium proton, deprotonating the hydroxyl 
groups and forming the zwitterion, or forming a silver network structure bonded 
through the carboxylate groups.  
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4.2.6 Electrochemical synthesis of copper(I)-NHC complexes using NHC-ligand 
precursor 4.3  
The electrochemical synthesis of Cu(I)-NHC complexes was explored using compound 
4.9 (Scheme 4.8).   
 
Scheme 4.8  Electrochemical reaction using NHC-ligand precursor 4.9. 
Copper plates were used as both the sacrificial anode and cathode (1 × 3 cm), and the 
reaction was performed in anhydrous acetonitrile. Compound 4.9 was added to the flask 
and degassed. Anhydrous acetonitrile was added (15 ml) and the solution was degassed 
for 1 hour by bubbling argon through. The electrodes were inserted into the solution and 
a potential applied such to maintain a constant current of 30 mA. The reaction was 
monitored by 
1
H NMR spectroscopy and the theoretical reaction time was calculated 
using Faraday‟s law (Figure 4.12). The mixture was electrolysed for 106 minutes, 
calculated as 2 Q. The mixture was filtered to remove suspended copper particles and 
the solvent was removed in vacuo. The product was analysed by 
1
H NMR and 
13
C{
1
H} 
NMR spectroscopy combined with mass spectrometry. A 
1
H NMR spectrum (DMSO-
d6) of the product formed in the reaction is displayed in Figure 4.28, and compared with 
the starting imidazolium ligand 4.9.        
 The product formed in the electrochemical reaction using ligand precursor 4.9 
displays a low field resonance attributed to the C2 proton at δ = 8.92 ppm in the 1H 
NMR spectrum. This resonance has broadened and shifted slightly upfield compared to 
compound 4.9. Electrolysing the mixture for a further 2 Q did not result in any further 
change in the 
1
H NMR spectrum. The most striking difference between the 
1
H NMR 
spectrum of the starting imidazolium ligand and that of the product is the absence of the 
methylene protons signal of the acetic acid tether, that were observed at δ = 5.24 ppm in 
the spectrum of compound 4.9. The 
1
H NMR spectrum of the product was recorded in 
MeCN-d3 to allow low temperature studies to be conducted. However, at 263.2 K a 
resonance for the methylene protons was still not observed.  The 
13
C{
1
H} NMR 
spectrum (MeCN-d3) displays resonances at δ = 36.95 ppm (CH3), 123.62 ppm (CH), 
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124.74 ppm (CH), 138.10 ppm (CH) and 172.9 ppm (quaternary), with the resonances 
being assigned with the assistance of 
13
C{
1
H} DEPT 135 NMR spectroscopy. As 
observed in the 
1
H NMR spectrum there is no CH2 resonance attributed to the 
methylene carbons of the acetic acid tether, which was observed at δ = 49.8 ppm in the 
13
C{
1
H} NMR  spectrum of the starting imidazolium ligand. The low field resonance at 
δ = 172.9 ppm was assigned as a quaternary carbon and could be the quaternary carbon 
of the acetic acid substituent (COOH), or the C2 carbon coordinating to copper. As the 
C2 carbon appeared to remain protonated, suggested by the 
1
H NMR spectrum, it is 
likely that the low field resonance is attributed to the quaternary acetic acid carbon 
(COOH). However, this would suggest that the acetic acid group was not eliminated 
during the reaction and would not account for the absence of the CH2 resonance for the 
methylene protons of the acetic acid tether.   
 
Figure 4.28  
1
H NMR spectra (DMSO-d6) displaying compound 4.9 (bottom) and the product formed in 
the electrochemical reaction using ligand precursor 4.9 (top).  
Unexpectedly the mass spectrometry data suggests the presence of the monodentate 
copper complex [4.9-H+Cu-Cl+NCMe]
+
 at m/z 244.0, and the bidentate copper complex 
[(2×4.9)-2H+Cu-2Cl]
+ 
at 343.0. However, decomposition products were also observed 
in the mass spectrum at m/z 145.0 and at m/z 132.0, with the suggested structures of 
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these compounds being displayed in Figure 4.29 (m/z 145.0 A and B; m/z 132.0 C and 
D). Both of these decomposition products have two possible structures, either 
coordinating to copper(I) through the C2 proton to form the carbene (B and D), or 
coordinating through the nitrogen leaving the C2 carbon protonated (A and C). In both 
of these scenarios it appears that decomposition has occurred through loss of the acetic 
acid group.  
 
Figure 4.29  Suggested structures for the decomposition compounds seen in the mass spectrum following 
the electrochemical procedure using ligand precursor 4.9.  
The 
1
H NMR, 
13
C{
1
H} NMR and mass spectrometry data appeared to contradict each 
other, but it is clear that the electrochemical route did not produce the desired copper(I)-
NHC complex selectively, and it appears that more than one product has been formed. 
Examination of the literature shows that when an acetate ion is electrolysed it breaks 
down to CO2 and C2H6, with the half-reactions for this and H
+
 being displayed in Figure 
4.30.
41, 42
 In our electrochemical reaction, the acetic acid may deprotonate to form the 
acetate and decompose in a similar manner, which would account for the moiety not 
being observed in the 
1
H NMR spectrum.  
 
Figure 4.30  Overall electrode reactions of an acetate ion and its corresponding proton.
42
 
The electrochemical reaction was explored using the acetic acid tethered calixarene 4.3 
Br (Scheme 4.9), with the experimental procedure being repeated as described 
previously.  
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Scheme 4.9  Proposed product in the electrochemical reaction using compound 4.3. 
The highest current that could be achieved when using compound 4.3 Br as the ligand 
precursor was 10 mA, with the current falling below 10 mA at intervals during the 
reaction. Complex 4.3 Br formed a suspension in acetonitrile and it is likely that the 
poor solubility resulted in a low current. After 2 Q an aliquot of the reaction mixture 
was removed and the isolated product examined by 
1
H NMR spectroscopy (DMSO-d6). 
The 
1
H NMR spectrum displayed only starting material, with no reduction observed in 
the integral for the C2 proton. The reaction was electrolysed for a further 2 Q but no 
change in the 
1
H NMR spectrum was observed. The use of another electrolyte was not 
desirable as it is likely that this would cause complications in the purification of the 
final product. The reaction was repeated using compound 4.3 PF6 in the hope that this 
would have increased solubility in acetonitrile. However, the product was still not 
sufficiently soluble for a good current to be achieved.     
 The electrochemical reaction was repeated with 4.3 PF6, with anhydrous DMSO 
added to the reaction to solubilise the compound (5 ml).  The reaction was electrolysed 
at 20 mA for 270 minutes (3 Q). The solution was filtered to remove suspended copper 
particles, and the product precipitated from solution by the addition of DCM (30 ml). 
The precipitate was isolated by filtration and dried in vacuo. The isolated solid was 
analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, combined with mass 
spectrometry. The 
1
H NMR spectrum (DMSO-d6) is very broad (Figure 4.31), with the 
resonance assigned to the C2 proton being observed at δ = 8.65 ppm, suggesting that a 
copper-NHC complex did not form. The C2 proton resonance has broadened and shifted 
slightly upfield when compared with compound 4.3 PF6. A CH2 peak is absent, with 
only two CH2 resonances seen in the 
1
H NMR spectrum of the product. However, as the 
spectrum is very broad this resonance may be in the baseline. The 
13
C{
1
H} NMR 
spectrum displays no low field resonances, with no resonance being attributed to the 
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quaternary acetic acid carbon (COOH), which was observed at δ = 167.7 ppm in 
compound 4.3 PF6. In addition, there is no evidence of any copper containing species in 
the mass spectrum, with the major signal seen at m/z 1103.6 assigned to the zwitterion 
[4.3-4Br-4H+Na]
+
. It is clear that the copper(I)-NHC complex displayed in Scheme 4.9 
was not formed during the electrochemical reaction, and the acetic acid substituent may 
have been eliminated, or altered, during the reaction.  
 
Figure 4.31  
1
H NMR spectra (DMSO-d6) displaying compound 4.3 PF6 (bottom) and the product formed 
in the electrochemical reaction of 4.3 PF6 (top). 
From this study it can be concluded that the electrochemical reaction is not a viable 
route for the synthesis of copper(I)-NHCs using ligand precursor 4.3. The acetic acid 
functionality limits the solubility of compound 4.3, with it only being soluble in DMSO, 
and it appears that the carboxylic acid group is eliminated or altered during the 
electrochemical reaction, which results in decomposition of the ligand.  
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4.3 Conclusion  
In conclusion, a synthetic method has been developed for the synthesis of the novel 
acetate ester tethered methylimidazolium calix[4]arene (4.2), and the compound has 
been fully characterised. The solid state properties of 4.2 Br were examined by single 
crystal X-ray diffraction. It was found that the bromide anions form weak interactions 
with both the C2 imidazolium protons and the imidazolium backbone protons of the 
calix[4]arene. The tert-butyl ester groups of 4.2 were removed by heating at reflux in 
acid, to form the acetic acid tethered methylimidazolium mesityl calix[4]arene (4.3). 
Compound 4.3 was fully characterised.       
 The use of compound 4.2 Br as an NHC ligand precursor to form metal-NHC 
complexes was explored. It was found that the most widely reported synthetic routes for 
the formation of metal-NHC complexes were not compatible with this ligand. When 
using a basic metal precursor a reaction was not observed. Under basic conditions, the 
C2 carbon remained protonated and the base reacted with other acidic protons in the 
ligand. Further investigation showed that the base was most likely reacting with the 
methylene protons of the acetate substituent, resulting in decomposition of the ligand. 
An alternative electrochemical method was explored that did not require the need for 
basic conditions.
6
 It was found that the electrochemical method is compatible for the 
synthesis of copper(I)-NHC complexes from imidazolium ligands that incorporate base 
sensitive groups. The electrochemical method was used to synthesise two copper(I)-
NHC complexes (4.5 and 4.6). Complex 4.6 was used as a carbene transfer agent for the 
formation of a palladium(II)-NHC complex (4.7) and a rhodium(I)-NHC complex (4.8). 
Both of these complexes are expected to have application as catalysts. Other 
transmetallation reactions (Ru(II), Ni(II)) were explored but these were unsuccessful, 
most likely due to the steric constraints imposed by the calix[4]arene framework.  
 The use of compound 4.3 as an NHC ligand precursor to form metal-NHC 
complexes was explored. Compound 4.3 offers the potential of forming a bidenate 
chelating metal-NHC complex coordinated to the metal through the NHC groups and 
the carboxylate donors. The reaction of 4.3 with Ag2O was unsuccessful, inferred by the 
C2 proton remaining in the 
1
H NMR spectrum. However, a shift was observed in the 
1
H 
NMR spectrum for the resonance assigned to the methylene protons of the acetic acid 
substituents. Following further investigation, it was found to be highly likely that Ag2O 
reacts with the carboxylic acid substituents of 4.3 over the C2 imidazolium protons, 
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deprotonating the hydroxyl groups and forming the zwitterion, or forming a silver 
network structure through the carboxylate. Either of these scenarios would account for 
the shift observed in the methylene protons. The electrochemical reaction was explored 
with compound 4.3, but was found not to be compatible with the acetic acid substituent. 
It appeared the acetic acid group was eliminated or altered during the reaction.  
4.4 Future work  
Future work in this area should involve extending the electrochemical method to other 
transition metals. This would allow a range of transition-metal NHC complexes to be 
synthesised from imidazolium ligands that incorporate base sensitive groups, such as 
compound 4.2. The applications of the resulting metal-NHC complexes in catalysis can 
then be explored, to determine if having four metal centres per calix[4]arene ligand 
improves their performance as a catalyst, or if a macrocyclic / cavity effect aids in the 
catalysis. The palladium-NHC complex synthesised (4.7) is expected to be an effective 
catalyst in cross coupling reactions, which is discussed in Chapter 5. The carbene 
transfer reaction from complex 4.6 to other transition metals can be explored, using 
metal precursors that do not contain bulky groups, as another approach to synthesising a 
range of metal-NHC complexes.       
 Further work can involve different synthetic routes to forming metal-NHC 
complexes using ligand precursor 4.3, with the aim of isolating discrete metal 
complexes that can be fully characterised. The next approach taken should be the 
reaction of 4.3 with a base, followed by the coordination of the free NHC to a metal 
centre. Further work can also be done to determine if the acetic acid tether is lost during 
the electrochemical reaction. This could be done by probing the composition of the gas 
that is produced during the experiment to see if CO2 and C2H6 are detected as well as 
H2. 
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5 Activity of tetrakis-(p-palladium-NHC) mesityl calix[4]arene in the Suzuki-
Miyaura cross-coupling reaction  
This chapter focuses on the study of tetrakis-(p-palladium-NHC) mesityl calix[4]arene 
(compound 4.7), reported in Chapter four, in the Suzuki-Miyaura cross-coupling 
reaction. The Suzuki-Miyaura reaction is a cross-coupling process between an 
organoboron reagent and an aryl halide, catalysed by a palladium complex (or source), 
to form a new carbon-carbon bond.
1
 Cross-coupling reactions play an important part in 
the synthesis of a wide range of drugs, natural products, and industrially important 
starting materials.
2
 Therefore, the development of more efficient and selective catalysts 
is of industrial importance.
3
 The scientific importance of the cross-coupling reaction 
was recognised in 2010 when Heck, Negishi and Suzuki were jointly awarded the Nobel 
Prize in chemistry for their work on cross-coupling reactions.
4
   
 Schatz et al. were the first group to report that imidazolium salts tethered to a 
calix[4]arene framework were promising ligand precursors in palladium catalysed 
Suzuki-Miyaura reactions.
5
 They synthesised a calix[4]arene in the cone conformation, 
functionalised with two imidazolium groups on the 1,3-positions of the upper rim. The 
reaction of this ligand with Pd(OAc)2 in dioxane formed a chelating bis-NHC complex, 
with cis geometry around the palladium centre. They investigated the catalytic activity 
of this ligand using an in situ protocol and reported reasonable activity. Dinarès et al. 
later compared the activity of a well defined, pre-formed complex, with an in situ 
generated catalyst.
6
 They found the catalytic activity to be significantly different at the 
same catalyst loadings, and highlighted the need to be careful when postulating the 
nature of the active species from in situ formed systems. Schatz et al. found that 
catalytic activity was independent of whether the bis-NHC units are cis or trans with 
respect to each other on a palladium centre, suggesting that a mono-ligated NHC 
complex is the catalytically active species in these cross-coupling reactions.
7
 They also 
reported that the activity of a pre-formed catalyst was superior to an in situ generated 
catalyst. The aforementioned catalysts all consist of two NHC moieties at the 1,3-
positions on the upper rim of a cone-type calix[4]arene.     
 Brenner et al. synthesised a calix[4]arene in the cone conformation that was 
functionalised with a single imidazolium group on the upper rim. They prepared a 
palladium-NHC complex from this ligand, with the palladium centre bearing one NHC 
group, two bromide atoms, and a pyridine molecule (Figure 5.2).
8
 They also synthesised 
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a bis-NHC complex with the NHC groups on the 1,2-positions of the upper rim of the 
calix[4]arene, with trans geometry about the palladium centre. They found that the 
mono-NHC complex displayed good activity in the Suzuki-Miyaura reaction, whereas 
the bis-NHC complex showed poor activity. This evidence again suggests that a mono-
ligated palladium complex is the catalytically active species, with the poor activity of 
the bis-NHC complex being attributed to the difficulty of forming catalytically active 
species from the rigid chelating complex. Comparison of the activity of a related mono-
NHC palladium complex without the calix[4]arene core suggested that no 
supramolecular effect was involved in this calix[4]arene system.   
 Tetrakis-(p-palladium-NHC) mesityl calix[4]arene (4.7) has been prepared and 
the structure examined through single crystal X-ray crystallography. The structure 
shows a tetrakis-NHC complex, incorporating four palladium(II) centres per 
calix[4]arene molecule, with the calix[4]arene adopting the 1,3-alternate conformation. 
The coordination geometry around each palladium is square planar, with two 
coordinating bromide atoms and an acetonitrile molecule trans to the NHC. As a 
monodentate palladium-NHC is thought to be the active species in several palladium-
NHC catalysts, we were keen to test our mono-ligated complex 4.7 in the Suzuki-
Miyuara cross-coupling reaction of p-tolyl halides with phenyl boronic acid to yield 4-
methyl-biphenyl. We were interested in looking at the effect of having four palladium 
centres per calix[4]arene molecule, as this has not been previously explored, in addition 
to the effect of having a 1,3-alternate conformation. The conditions were varied 
(catalyst loading, solvent, reaction time) and the results compared. In addition, other 
palladium sources (Pd2(dba)3 and Pd(OAc)2) and an in situ generated catalyst 
(4Pd(OAc)2 + Ligand 4.2) were tested. The reactions were conducted in parallel in a 
carousel reactor to ensure the conditions were kept constant.  
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5.1 Suzuki-Miyaura cross-coupling reaction catalysed by complex 4.7    
The conditions applied for the catalytic reactions were the same as those reported by 
Brenner et al. and Dinarès et al., allowing for direct comparison of our results with 
those reported.
8,6
 Phenylboronic acid was reacted with either 4-chlorotoluene or 4-
bromotoluene, with Cs2CO3 used as the base. The yields were determined by 
1
H NMR 
spectroscopy using 1,4-dimethoxybenzene as a standard (Scheme 5.1).  
 
Scheme 5.1  Cross-coupling reaction of phenylboronic acid and aryl halide to yield 4-methyl-biphenyl (X 
= Cl, Br).  
Phenylboronic acid (1.5 mmol), Cs2CO3 (2 mmol) and an acetonitrile solution of 
complex 4.7 (or a palladium source with ligand precursor 4.2) were added to a carousel 
reactor and the solvent removed in vacuo. The reaction solvent was added (3 ml) 
followed by the aryl halide (1 mmol). The mixture was stirred vigorously at 80 °C for 2 
hours, under an atmosphere of nitrogen. The hot mixture was filtered through a pad of 
celite, and the celite washed with the reaction solvent (2 ml). 1,4-dimethoxybenzene 
(0.5 mmol) was added to the filtrate and the solvent removed in vacuo.  The mixture 
was analysed by 
1
H NMR spectroscopy, comparing the intensity of the methyl signal of 
the product (δ = 2.41 ppm) with that of 1,4-dimethoxybenzene (δ = 3.78 ppm) (Figure 
5.1).  
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Figure 5.1 
1
H NMR spectrum (CDCl3) of the products formed in the Suzuki-Miyaura cross-coupling 
reaction between 4-bromotoluene and phenylboronic acid, catalysed by complex 4.7 at a Pd loading of 
0.25 mol %, in acetonitrile, with 1,4-dimethoxybenzene added as a standard.  
The results for the coupling of aryl bromide and phenylboronic acid catalysed by 
complex 4.7 are displayed in Table 5.1. The table shows the catalyst loading used in 
each run, and the palladium mol % which is four times the catalyst loading, taking into 
account that complex 4.7 has four palladium centres per ligand. The results show that 
complex 4.7 displays good activity for the coupling reaction with aryl bromide.  
 In dioxane, the yield increases as the catalyst concentration is decreased (Entries 
1-5), with a maximum yield of 89 % at a catalyst loading of 0.0625 mol %. The yield 
then decreases as the catalyst loading is lowered further, to 74 % at 0.03125 mol % of 
catalyst (Entry 6). The increased yield with decreasing catalyst concentration is 
attributed to the „homeopathic palladium‟ effect, which is thought to be due to the 
reduced palladium forming palladium(0)-nanoclusters which, at higher concentrations, 
aggregate to form inactive palladium black.
9-11
 By lowering the palladium 
concentration, the oxidative addition of the aryl bromide can compete against cluster 
formation, resulting in an improved yield.  This indicates that the catalytically active 
species is unstable, and the calix[4]arene does not offer any protection against 
aggregation. The same trend is also observed when the reaction was performed in 
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acetonitrile, with the yield increasing as the catalyst loading was decreased (Entries 7-
9). The maximum yield of 73 % was observed at 0.03125 mol % of catalyst.  The 
reaction was also carried out in more environmentally friendly solvents, and found to 
give moderate yields in ethanol and in a mixture of H2O / dioxane (1:1) (Entries 10 and 
11). However, when the catalytic reaction was performed in H2O alone, the cross-
coupled product was not formed.  
Entry Catalyst X Solvent Catalyst 
loading 
(mol %) 
Pd 
loading 
(mol %)  
Yield (%)  
1 Complex 4.7  Br Dioxane 2.5 10 40 
2 Complex 4.7 Br Dioxane 1.25 5 59 
3 Complex 4.7 Br Dioxane 0.25 1 64 
4 Complex 4.7  Br Dioxane 0.125 0.5 80 
5 Complex 4.7 Br Dioxane 0.0625 0.25 89 
6 Complex 4.7 Br Dioxane 0.03125 0.125 73 
7 Complex 4.7 Br Acetonitrile 0.125 0.5 49 
8 Complex 4.7 Br Acetonitrile 0.0625 0.25 60 
9 Complex 4.7 Br Acetonitrile 0.03125 0.125 73 
10 Complex 4.7 Br Ethanol 0.125 0.5 53 
11 Complex 4.7 Br H2O / Dioxane 0.125 0.5 42 
Table 5.1  4-bromotoluene (1 mmol), phenylboronic acid (1.5 mmol), Cs2CO3 (2 mmol), solvent (3 ml), 
reaction time 2 hours. Yields determined by 
1
H NMR spectroscopy using 1,4-dimethoxybenzene as an 
internal standard.  
Comparison of the catalytic activity of complex 4.7 with the mono-NHC palladium 
calix[4]arene complex reported by Brenner et al., (Figure 5.2, complex 5.1), shows that 
the opposite trend in activity was observed.
8
 In dioxane, the yield increases as the 
catalyst loading is increased, with a 100 % yield being observed at 0.1 mol % catalyst 
(Table 5.2). This suggests that the catalytically active species formed from complex 5.1 
is more stable, and the calix[4]arene ligand helps prevent the aggregation of inactive 
palladium(0)-nanoclusters. However, it should be noted that they do not increase the 
Chapter 5. Activity of tetrakis-(p-palladium-NHC) mesityl calix[4]arene in the Suzuki-
Miyaura cross-coupling reaction  
  
130 
 
catalyst loading above 0.1 mol %, which is where we observe the largest effect of 
palladium aggregation on yield.       
 Upon comparison of Tables 5.1 and 5.2, it can be seen that at lower catalyst 
loadings complex 4.7 shows comparable activity to complex 5.1. At 0.03125 mol % of 
complex 4.7, a yield of 73 % is achieved, and at 0.05 mol % of complex 5.1 a yield of 
85 % is achieved. However, if we include the fact that our complex has four palladium 
centres per calix[4]arene, at 0.03125 mol % of catalyst there is 0.125 mol % of 
palladium. At a similar catalyst loading (0.1 mol %) Brenner et al. report a 100 % yield 
compared to our 73 % yield.
8
 
 
Figure 5.2  Palladium complex 5.1 synthesised by Brenner et al.
8
 
X Catalyst Catalyst loading (mol %) Yield (%) 
Br Complex 5.1 0.1 100 
Br Complex 5.1 0.05 84 
Br Complex 5.1 0.01 2 
Table 5.2  Catalytic results reported by Brenner et al. 4-bromotoluene (1 mmol), phenylboronic acid (1.5 
mmol), Cs2CO3 (2 mmol), dioxane (3 ml), reaction time 2 hours. Yields determined by 
1
H NMR 
spectroscopy using 1,4-dimethoxybenzene as an internal standard.
8
 
Metal-free catalytic pathways were ruled out by performing the reaction with 
imidazolium compound 4.2 and no metal source, which did not result in any cross- 
coupled product. A palladium(0) source (Pd2(dba)3) and a palladium(II) source 
(Pd(OAc)2) were also tested and were found to be less active than complex 4.7, showing 
that the NHC group enhances catalytic activity (Table 5.3).  
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Entry X Catalyst Catalyst loading 
(mol %) 
Pd Loading  
(mol %) 
Yield (%) 
12 Br Compound 4.2 0.0025 0 0 
13 Br Pd2(dba)3 0.5 1 10 
14 Br Pd(OAc)2 1 1 57 
15 Br Pd(OAc)2 0.25 0.25 72 
Table 5.3  4-bromotoluene (1 mmol), phenylboronic acid (1.5 mmol), Cs2CO3 (2 mmol), dioxane (3 ml), 
reaction time 2 hours. Yields determined by 
1
H NMR spectroscopy using 1,4-dimethoxybenzene as an 
internal standard.  
The catalytic reaction was carried out for the coupling of aryl chloride and 
phenylboronic acid. Aryl chlorides are known to be more difficult to activate than aryl 
bromides due to the stronger carbon-chloride bond. However, some palladium-NHC 
complexes have been shown to be very active catalysts for the coupling of aryl 
chlorides.
12-14
 The catalytic results for the coupling of aryl chloride and phenylboronic 
acid, catalysed by complex 4.7, are displayed in Table 5.4. As expected, the reactivity 
towards the chloride is lower than the reactivity towards the bromide, with the reported 
yields for the reactions carried out in dioxane for 2 hours (Entries 16-18) being 
negligible (3-13 %). Pd(OAc)2 was investigated under these conditions and was also 
shown to be fairly inactive, giving a 16 % yield at 1 mol % of catalyst. It was found that 
increasing the reaction time from 2 hours to 24 hours dramatically improved the yield, 
and a 39 % yield was obtained at 1 mol % catalyst loading after 24 hours (Entry 19), 
compared to a 13 % yield after 2 hours (Entry 17).      
 The formation of the active Pd(0) species from the Pd(II) pre-catalyst is an 
essential step in the catalytic reaction. The choice of solvent and base has been reported 
to aid the formation of the active species, and improve the efficiency of the reaction. It 
has previously been reported that alcoholic solvents can improve the yield of Suzuki-
Miyaura cross-coupling reactions when using NHC ligand precursors, presumably the 
change to a more polar solvent aids the formation of the active species.
14
 We found that 
changing the solvent to ethanol (from dioxane) increased the yield when using 
chlorotoluene, and a 39 % yield was obtained at a catalyst loading of 0.125 mol %, after 
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2 hours (Entry 20). Pd(OAc)2 was also investigated under these conditions and was 
shown to be inactive.  
Entry X Catalyst Solvent Catalyst 
loading  
(mol %) 
Pd Loading  
(mol %) 
Yield 
(%) 
16 Cl Complex 4.7 Dioxane 2.5 10 7 
17 Cl Complex 4.7 Dioxane 1 4 13 
18 Cl Complex 4.7 Dioxane 0.25 1.0 3 
19 Cl Complex 4.7 Dioxane 1 4 39
a
 
20 Cl Complex 4.7 Ethanol 0.125 0.5 39 
Table 5.4  4-chlorotoluene (1 mmol), phenylboronic acid (1.5 mmol), Cs2CO3 (2 mmol), solvent (3 ml), 
reaction time 2 hours. Yields determined by 
1
H NMR spectroscopy using 1,4-dimethoxybenzene as an 
internal standard.
a
 Reaction time 24 hours.   
As discussed previously, it has been reported by Schatz et al. that an in situ generated 
catalyst did not always give the same catalytic activity as a pre-formed catalyst, when 
using a calix[4]arene scaffold.
7
 We wanted to investigate the activity of an in situ 
generated catalyst, formed from compound 4.2 and Pd(OAc)2 (Table 5.5). It was found 
that the catalytic activity of the in situ formed catalyst was higher than that of the pre-
formed catalyst, with the highest yield of 97 % being achieved at 0.25 mol % catalyst 
loading in dioxane (Entry 22). The in situ reaction was also carried out in the more 
economical solvent mixture of dioxane / H2O (1:1), giving a 58 % yield. As the pre-
formed and in situ generated catalysts do not display the same catalytic activity under 
the same experimental conditions, it is likely that the structure of the catalytically active 
species, generated from these two pre-catalysts, is different.  
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Entry X Catalyst Solvent Catalyst  
loading  
(mol %) 
Pd  
Loading  
(mol %) 
Yield 
(%) 
21 Br Pd(OAc)2 + compound 
4.2  
Dioxane 1 1 93 
22 Br Pd(OAc)2 + compound 
4.2 
Dioxane 0.25 0.25 97 
23 Br Pd(OAc)2 + compound 
4.2 
H2O / 
Dioxane 
1 1 58 
Table 5.5  4-bromotoluene (1 mmol), phenylboronic acid (1.5 mmol), Cs2CO3 (2 mmol), solvent (3 ml), 
reaction time 2 hours. Yields determined by 
1
H NMR spectroscopy using 1,4-dimethoxybenzene as an 
internal standard. 
5.2 Conclusion  
In conclusion, the catalytic activity of tetrakis-(p-palladium-NHC) mesityl calix[4]arene 
(complex 4.7) has been investigated in the Suzuki-Miyaura cross-coupling reaction. 
Complex 4.7 was shown to be active for the coupling of aryl bromides and 
phenylboronic acid, with the best yields of the cross-coupled product being obtained at 
lower catalyst loadings. Complex 4.7 was shown to be more active for the coupling of 
aryl bromides than aryl chlorides. However, moderate yields of the cross-coupled 
product could be obtained from aryl chloride and phenylboronic acid when performing 
the reaction in ethanol. The catalytic activity of complex 4.7 was compared with 
Pd(OAc)2, and Pd2(dba)3. Complex 4.7 was shown to be more active, confirming that 
the NHC group improved the activity of the catalyst.     
 The cross-coupling reaction with an in situ generated catalyst (compound 4.2 
and Pd(OAc)2) was also explored. It was found that the in situ generated catalyst had 
improved activity over complex 4.7, suggesting that the active species generated from 
these two pre-catalysts was different.  
5.3 Future work  
Following the preparation of the palladium complexes of propanol-tethered 
methylimidazolium mesityl calix[4]arene (compound 3.4)  and acetic acid tethered 
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methylimidazolium mesityl calix[4]arene (compound 4.3), the catalytic activity of these 
complexes should be explored, and the results compared. This will indicate if the 
nitrogen substituent of the imidazolium group has any effect on the catalytic activity of 
the complex.  If the nitrogen substituent on the imidazolium groups of compound 3.4 or 
compound 4.3 form an interaction with the palladium centre, this could help stabilise 
the catalytically active species, and improve the catalytic activity.    
 Further work should also been done to probe the nature of the catalytically 
active species from the well defined, pre-formed catalyst, and the in situ protocol. This 
may help the design of more efficient catalyst systems.     
           
  
 
Chapter 5. Activity of tetrakis-(p-palladium-NHC) mesityl calix[4]arene in the Suzuki-
Miyaura cross-coupling reaction  
  
135 
 
5.4 References  
1. A. Suzuki, J. Organomet. Chem., 1999, 576, 147-168. 
2. G. C. Fortman and S. P. Nolan, Chem. Soc. Rev., 2011, 40, 5151-5169. 
3. J.-P. Corbet and G. Mignani, Chem. Rev., 2006, 106, 2651-2710. 
4. Nobelprize.org. http://nobelprize.org/nobel_prizes/chemistry/laureates/2010/press.html 
5. M. Frank, G. Maas and J. Schatz, Eur. J. Org. Chem., 2004, 607-613. 
6. I. Dinares, M. C. Garcia, M. Font-Bardia, X. Solans and E. Alcalde, Organometallics, 
2007, 26, 5125-5128. 
7. T. Fahlbusch, M. Frank, G. Maas and J. Schatz, Organometallics, 2009, 28, 6183-6193. 
8. E. Brenner, D. Matt, M. Henrion, M. Teci and L. Toupet, Dalton Trans., 2011, 40, 
9889-9898. 
9. C. E. Willans, J. M. C. A. Mulders, A. H. M. de Vries and J. G. de Vries, J. Organomet. 
Chem., 2003, 687, 494-497. 
10. A. Alimardanov, V. L. Schmieder-van, A. H. M. de Vries and J. G. de Vries, Adv. 
Synth. Catal., 2004, 346, 1812-1817. 
11. V. F. Slagt, A. H. M. de Vries, J. G. de Vries and R. M. Kellogg, Org. Process Res. 
Dev., 2010, 14, 30-47. 
12. I. Ozdemir, S. Yasar, S. Demir and B. Cetinkaya, Heteroat. Chem., 2005, 16, 557-561. 
13. Y.-Q. Tang, J.-M. Lu and L.-X. Shao, J. Organomet. Chem., 2011, 696, 3741-3744. 
14. O. Diebolt, P. Braunstein, S. P. Nolan and C. S. J. Cazin, Chem. Commun., 2008, 3190-
3192. 
 
   
Chapter 6. Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DTPA 
  
136 
 
6 Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DTPA: Ligand synthesis and metal complexation  
Diethylenetriaminepentaacetic acid (DTPA) is a linear octadentate ligand that 
incorporates three tertiary nitrogen atom donors, and five carboxylic acid donor groups 
(Figure 6.1, A).
1
 The ligand chelates to metals, forming complexes with enhanced 
stability over similar complexes with non-chelating ligands. This enhanced stability is a 
consequence of the chelate effect, which is attributed to an increase in entropy upon 
chelation.
2
 A major application for the DTPA ligand is in MRI (magnetic resonance 
imaging), where DTPA is coordinated to gadolinium and the complex is used as a 
contrast agent. Gadolinium-DTPA, commercially known as Magnevist® (Bayer 
Heathcare), was the first example of a contrast agent used to aid medical diagnostics in 
MRI, and is still used in practice today. Contrast agents consist of a paramagnetic metal 
ion (usually Gd
3+
) bound by an organic ligand. The paramagnetic metal ion accelerates 
the relaxational properties of surrounding water molecules, which enhances the image 
produced in MRI. The organic ligand encases the gadolinium and allows for the 
complex to be easily excreted from the body following the procedure.
3
 Ligands that 
bind to Gd
3+ 
and form stable complexes are vital, as dechelation of the metal has been 
linked to a disease called nephrogenic systemic fibrosis (NSF), which can lead to 
serious complications or in some cases death.
4, 5
 The DTPA ligand has also been used in 
chelation therapy, where it has been used to remove actinides from the body after 
contamination.
6, 7
          
 An NHC-ligand precursor was designed that is inspired by the structural motif 
of DTPA, with a view to forming metal-NHC complexes with enhanced stability 
(Figure 6.1, 6.3). In the target DTPA-type ligand, two of the tertiary nitrogen atoms 
have been replaced by imidazolium groups, offering the potential to prepare metal-NHC 
complexes using this type of ligand. The synthesis of the ligand, which incorporates two 
imidazolium groups and three carboxylic acid groups, was unsuccessful. However, three 
novel bis-imidazolium amine salts based upon a similar structure were prepared 
(compounds 6.5, 6.6, 6.11). The coordination of compound 6.5 to copper was explored 
using an electrochemical synthetic procedure to prepare complex 6.16. The use of 
complex 6.16 as a transmetallation agent to form a palladium-NHC complex was 
investigated. 
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Figure 6.1  Structure of (A) DTPA, and (6.3) the novel DTPA-inspired NHC-ligand precursor, (X = Cl or 
Br).  
6.1 Synthesis of DTPA-inspired NHC ligand precursors  
 
Scheme 6.1  Proposed synthesis of DTPA-inspired NHC ligand precursor 6.3.   
The preparation of amino(dichloromethyl) tert-butyl acetate (6.1) was achieved through 
the reaction of glycine tert-butyl ester hydrochloride, paraformaldehyde, and thionyl 
chloride.
8
 Triethylamine was added to the reaction to neutralise the eliminated HCl, and 
protect the tert-butyl group. Compound 6.1 was characterised by 
1
H NMR and 
13
C{
1
H} 
NMR spectroscopy and mass spectrometry.     
 Compound 6.1 was reacted with excess imidazole in methanol at reflux (75 °C). 
A base is not usually required in these nucleophilic reactions as imidazole itself acts as a 
base.
9
 The reaction was unsuccessful, with none of the desired product being identified 
from the reaction mixture. The reaction was repeated in different solvents (CH3Cl, 
THF), but still none of the desired product was obtained. Compound 6.1 is a type of 
nitrogen mustard and, as expected, was found to be unstable, requiring careful handling 
and storage at 4 °C. It has the potential to decompose, with the lone pair on the tertiary 
nitrogen attacking the adjacent carbon to generate an imine (Figure 6.2).  
Chapter 6. Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DTPA 
  
138 
 
 
 
Figure 6.2  Possible degradation pathway for compound 6.1.  
The analytical data for compound 6.1 was re-examined and a signal was observed in the 
mass spectrum at 192.1 ([C8H15NO2Cl]
+), which could be an indication that the imine 
had formed. However, it is also possible that compound 6.1 could have fragmented 
during the mass spectrometry experiment. An infrared spectrum of compound 6.1 was 
collected and a signal was observed at 1600 cm
-1
, which is in the reported range for an 
imine bond (around 1480-1690 cm
-1
).
10
 This was not present in the infrared spectrum of 
the starting material (glycine tert-butyl ester hydrochloride) and implies that compound 
6.1 degrades to form the imine.          
 The synthesis of compound 6.2 was therefore attempted directly from glycine 
tert-butyl ester hydrochloride with two equivalents of formaldehyde and excess 
imidazole. The product was purified by recrystallisation from diethyl ether (4 °C) to 
yield compound 6.2 as a white solid. Compound 6.2 was analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass spectrometry and elemental analysis. The 
1
H NMR 
spectrum appears as expected, with the resonance for the imidazole proton at δ = 7.63 
ppm. The two backbone imidazole protons appear as two separate resonance at δ = 7.12 
ppm and δ = 6.97 ppm, with the resonances being too broad to show any coupling 
between the inequivalent backbone protons (Figure 6.6, A).    
 Colourless needle crystals were obtained by slow evaporation of a saturated 
chloroform solution of compound 6.2. These were analysed by single crystal X-ray 
diffraction and the molecular structure is displayed in Figure 6.3. The compound 
crystallised in the monoclinic crystal system, and the structural solution was performed 
in the space group P21/c. The structure displays the expected compound, with a tertiary 
amine bearing two methyl imidazoles and a tert-butyl acetate group.    
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Figure 6.3  Molecular structure of compound 6.2. The hydrogen atoms have been omitted for clarity. 
Ellipsoids are displayed at 50 % probability.  
 
N(1)-C(1) 1.459(6) N(1)-C(1)-N(2) 114.63(11) 
N(5)-C(6) 1.325(2) N(4)-C(5)-N(1) 110.90(11) 
C(7)-C(8) 1.362(2) C(8)-N(4)-C(5) 126.58(12) 
C(2)-N(2) 1.381(2) C(4)-N(2)-C(1) 126.79(13) 
C(1)-N(2) 1.4781(19) O(1)-C(10)-O(2) 125.77(13) 
Table 6.1  Selected bond distances (Å) and angles (deg) for compound 6.2. 
The next step in the synthesis of the DTPA-type ligand (compound 6.3) was the 
quaternization of the neural imidazole in compound 6.2 to form the imidazolium 
species. Compound 6.2 was reacted with a small excess of chloroacetic acid as a dry 
melt.  The mixture was heated at 60 °C for 12 hours under a nitrogen atmosphere. A 
brown oil formed which, when washed with acetone, became a yellow solid. Low field 
resonances were observed in the 
1
H NMR spectrum between δ = 7.45 ppm and δ = 8.82 
ppm, which suggests the presence of imidazolium species. However, there were 
multiple products that, owing to their similar chemical properties, could not be easily 
separated. Attempts were made to improve the selectivity of the reaction by altering the 
reaction conditions. Initially, the same dry melt procedure was employed with the 
temperature being varied between 40-110 °C. Analysis by 1H NMR spectroscopy of the 
product(s) formed again showed low field resonances, indicative of imidazolium salts, 
but no increased purity was observed at either lower or higher temperatures. The 
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reaction was carried out in solution (DCM / THF) both at reflux and at room 
temperature. No reaction occurred in solution and analysis by 
1
H NMR spectroscopy 
showed only starting material.        
 A study was conducted to aid in the assignment of the different species that were 
formed in the reaction. A similar reaction was investigated following a literature 
procedure by Yi et al., where the simpler 1-methylimidazole is reacted with chloroacetic 
acid as a dry melt to form the acetic acid tethered imidazolium salt, which they isolate 
as the BF4 salt (Scheme 6.2).
11
 
 
Scheme 6.2  Synthesis of 1-methyl acetic acid imidazolium tetrafluoroborate.
11
 
The reaction was repeated following the procedure outlined in the literature, and the 
product was analysed by 
1
H NMR spectroscopy combined with mass spectrometry. The 
1
H NMR spectrum (DMSO-d6) shows the formation of multiple imidazolium salts 
which include 1-methyl acetic acid imidazolium tetrafluoroborate and at least two other 
major imidazolium products (Figure 6.5). The mass spectrometry data confirmed the 
formation of multiple imidazolium species, namely; A; 1-methylimidazolium 
chloroacetate, B; 1-methyl-3-acetic acid imidazolium tetrafluoroborate, C; 1-methyl-3-
acetyloxy acetic acid imidazolium tetrafluoroborate, the structures of which can be seen 
in Figure 6.4. Mass spectrometry data also showed evidence for the presence of D 
where n = 2-6.  
 
Figure 6.4  Products formed in the reaction of N-methyl imidazole and chloroacetate.  
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Figure 6.5  
1
H NMR spectrum (DMSO-d6) displaying the products formed in the reaction of 1-methyl 
imidazole and chloroacetate at 298 K. A; 1-methylimidazolium chloroacetate, B; 1-methyl-3-acetic acid 
imidazolium tetrafluoroborate, C; 1-methyl-3-acetyloxy acetic acid imidazolium tetrafluoroborate. 
The analytical data collected from the reaction of compound 6.2 with chloroacetate was 
re-examined to determine if similar species could be identified. The data was not as 
straight forward due to the complexity of the starting material and the presence of two 
imidazole moieties. However, it is likely that similar species were formed. In order to 
try and prevent these side reactions occurring, the same procedure was followed using 
tert-butyl chloroacetate, hence removing the acidic proton and protecting the oxygen 
from undergoing further reactions (Scheme 6.3). This reaction had already been 
successful with the simpler 1-methylimidazole, allowing for the selective synthesis of 1-
methyl-3-tert-butylacetate imidazolium chloride (compound 4.4), reported in Chapter 4. 
The tert-butyl protecting could then be removed to form the target compound 6.3
 
 
Scheme 6.3  Proposed product from the reaction of compound 6.2 with tert-butyl chloroacetate.  
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Compound 6.2 was reacted with an excess of tert-butyl chloroacetate (2.2 equivalents) 
as a dry melt. The mixture was heated at 45 °C for 12 hours, under a nitrogen 
atmosphere. A brown oil formed which, when washed with acetone, became an off-
white solid. Low field resonances were observed in the 
1
H NMR spectrum (DMSO-d6), 
indicative of the formation of imidazolium species (Figure 6.6, B). However, a mixture 
of products still formed which appear to include imidazolium species and potentially 
some neutral imidazole species. The mass spectrometry data was complicated, and the 
signals could not be assigned to a desirable product.  
 
Figure 6.6. 
1
H NMR spectra (DMSO-d6) of  (A) compound 6.2, and (B) the products formed in the 
reaction of compound 6.2 with tert-butyl chloroacetate as a dry melt.  
This result was somewhat surprising, as the reaction of 1-methylimidazole with tert-
butyl chloroacetate had been found to proceed cleanly, yielding 1-methyl-3-tert-
butylacetate imidazolium chloride. Compound 6.2 differs from 1-methylimidazole as it 
has an additional tertiary nitrogen atom which also has an available lone pair of 
electrons. It is possible that the lone pair on the tertiary nitrogen could attack the tert-
butyl chloroacetate to form a quaternary nitrogen species (Figure 6.7). This product may 
then decompose into further species, accounting for the mixture of products that were 
formed. Alternatively, the tertiary nitrogen could be causing the product to decompose 
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once the imidazolium species has been generated, again accounting for the mixture of 
products that were formed.  
 
Figure 6.7  Proposed side product from the reaction of compound 6.2 with tert-butyl chloroacetate. 
It was thought that reacting compound 6.1 with the already N-substituted imidazole, 
rather than proceeding through compound 6.2, may reduce the problems associated with 
adding the acetate ester group to compound 6.2. However, previous reactions with 
compound 6.1 had proved unsuccessful, due to its instability. Douthwaite et al. reported 
the preparation of amino(dichloroethyl) methyl benzene (compound 6.4) as an 
intermediate in the formation of bis-imidazolium tertiary amine salts.
12
 They reacted 
compound 6.4 with two equivalents of tert-butyl imidazole to yield the desired bis-
imidazolium tertiary amine cleanly (Scheme 6.4).  They found that it was necessary to 
protect the secondary amine of bis(2-dichloroethyl)amine with a benzyl group to 
prevent oligomerisation of the amine.  
 
Scheme 6.4  Reported synthesis of bis-imidazolium tertiary amines.
12
 
Compound 6.4 contains an extra CH2 bridge between the tertiary amine and the chloride 
atoms compared to compound 6.1. This alteration should increase the stability, as it is 
less likely that the imine will form. Compound 6.4 also incorporates the benzyl group 
on the amine rather than a tert-butyl acetate group, which would increase the number of 
synthetic steps to reach our (new) target compound (Scheme 6.5, compound 6.8). We 
therefore attempted to add a tert-butyl acetate group to bis(2-dichloroethyl)amine, but 
the reaction was unsuccessful with none of the desired product being identified.  
 A proposed synthetic route to the new target compound (6.8) is shown in 
Scheme 6.5. The compound contains two CH2 groups between the tertiary amine and 
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imidazolium groups, similar to DTPA, which contains two CH2 groups between the 
nitrogen atoms.  
 
Scheme 6.5  Proposed synthesis of DTPA-inspired NHC ligand precursor 6.8 (X = Cl, Br, I, PF6). 
Compound 6.4 was synthesised in accordance with literature procedure.
12
 Bis(2-
chloroethylamine) hydrochloride was treated with sodium hydroxide to form the free 
amine, which was treated with benzyl bromide in the presence of excess potassium 
carbonate. The solution was filtered to remove the inorganic salts, and the solvent 
removed in vacuo to yield compound 6.4 as a yellow oil. When following the procedure 
outlined above, there was a large excess of benzyl bromide that remained in the reaction 
mixture, despite only a small excess (1.08 equivalents) initially being used. During the 
next step, reaction of this mixture with 1-tert-butyl acetate imidazole (4.1), lead to the 
formation of an undesired imidazolium salt, compound 6.9 (Figure 6.8). 
 
Figure 6.8  Product formed through the reaction of benzyl bromide with 1-methylimidazole tert-butyl 
chloroacetate. 
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It was therefore necessary to purify compound 6.4 further to remove any unreacted 
benzyl bromide. Firstly, the amount of benzyl bromide used in the reaction was reduced 
to less than one equivalent, as it was evident that an increased amount did not force the 
reaction to completion. In addition, once the reaction was complete, triethylamine was 
added which reacted with any remaining benzyl bromide to form the (N, N, N-
triethylbenzyl)ammonium bromide salt. The triethylamine salt was precipitated from 
solution (DCM / petroleum ether), removed by filtration, and the solvent of the filtrate 
removed in vacuo to yield compound 6.4 as a colourless oil. Compound 6.4 was 
characterised by 
1
H NMR and 
13
C{
1
H}NMR spectroscopy, combined with mass 
spectrometry, and was in accordance with the reported literature data.
12
 
 Compound 6.4 was reacted with 1-tert-butyl acetate imidazole (compound 4.1) 
following the procedure outlined by Douthwaite et al. for the synthesis of bis-
imidazolium tertiary amine salts.
12
 Compound 6.4 and two equivalents of compound 4.1 
were dissolved in 1,4-dioxane and the solution was heated at reflux (105 °C) for 12 
hours. The solution was cooled to room temperature and the solvent removed in vacuo, 
to yield a yellow oil. The product was extracted into water and the water layer was 
washed with DCM followed by petroleum ether. The water was removed in vacuo to 
yield a pale yellow oil that solidified on washing with diethyl ether. Compound 6.5 was 
characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with mass 
spectrometry. The chloride counter ions were exchanged by reaction with ammonium 
hexafluorophosphate in water to afford the hexafluorophosphate salt of 6.5 as a white 
solid. Compound 6.5 PF6 was characterised by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy, mass spectrometry and elemental analysis.     
 The 
1
H NMR spectrum of compound 6.5 Cl in MeOD-d4 is displayed in Figure 
6.9, with the relevant peaks assigned in Table 6.2. The 
1
H NMR spectrum is as 
expected, with a characteristic resonance for the imidazolium C2 proton appearing 
downfield at δ = 9.10 ppm. The backbone imidazolium protons are observed as two 
separate resonances at δ = 7.61 ppm and δ = 7.59 ppm, with the resonances being too 
broad to display any resolved coupling between the inequivalent backbone imidazolium 
protons. The benzyl protons are observed as multiple resonances in the region of δ = 
7.29 ppm to δ = 7.15 ppm. The CH2 groups of the ethylene bridge appear as two 
separate triplet resonances at δ = 4.40 ppm and δ = 3.07 ppm, coupling with the 
inequivalent neighbouring CH2 protons (
3
JHH = 6 Hz).  
Chapter 6. Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DTPA 
  
146 
 
 
 
 
 
Figure 6.9  
1
H NMR spectrum (MeOD-d4) of compound 6.5 Cl at 298 K (top). Expansion in the region δ 
= 3.0 ppm to δ = 4.5 ppm (middle). Expansion in the region δ = 7.1 ppm to δ = 9.2 ppm (bottom).  
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Chemical shift (δ ppm) 1H Assignment 
9.10 (s, 2H) 1 
7.61 (s, 2H) 2 / 3 
7.59 (s, 2H) 2 / 3 
7.29 - 7.15 (m, 5H) 4-8 
5.16 (s, 4H) 9 
4.40 (t, 4H, 
3
JHH = 6 Hz) 10 
3.74 (s, 2H) 11 
3.07 (t, 4H, 
3
JHH = 6 Hz) 12 
1.54 (s, 18H) 13 
Table 6.2  
1
H NMR assignments for compound 6.5 Cl.  
The 
1
H NMR spectrum of compound 6.5 PF6 (MeOD-d4) is consistent with the 
1
H 
NMR data for 6.5 Cl (MeOD-d4). A change in the chemical shift is observed for the C2 
protons, which is shifted upfield by 0.44 ppm to δ = 8.68 ppm. The hydrogen bonding 
interactions between the C2 proton and the non-coordinating anion (PF6) are weaker 
than with the coordinating anion (Cl), resulting in the C2 proton experiencing a reduced 
deshielding effect. The formation of compound 6.5 was confirmed by mass 
spectrometry, with m/z observed for [6.5-Cl]
+ 
at 560.3, and [6.5-2Cl-H]
+
 at 524.3. 
Similarly 6.5 PF6 displayed m/z for [6.5-PF6]
+ 
at 670.3.      
 The benzyl group on the amine of compound 6.5 Cl was removed using Pd / C 
in ethanol at 70 °C for 24 hours. The mixture was filtered through celite and the solvent 
was removed in vacuo to yield compound 6.6 as a white hygroscopic solid, which was 
analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy and mass spectrometry. The 
1
H 
NMR spectrum of compound 6.5 Cl in D2O is displayed in Figure 6.10, with the 
relevant peaks assigned in Table 6.3.   
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Figure 6.10  
1
H NMR spectrum (D2O) of compound 6.6 Cl at 298 K.  
 
Chemical shift (δ ppm) 1H Assignment 
8.98 (s, 2H) 1 
7.68 (s, 2H) 2 / 3 
7.63 (s, 2H) 2 / 3 
5.19 (s, 4H) 9 
4.46 (t, 4H, 
3
JHH = 6 Hz) 10 
3.24 (t, 4H, 
3
JHH = 6 Hz) 12 
1.61 (s, 18H) 13 
Table 6.3  
1
H NMR assignments for compound 6.6 Cl.  
The 
1
H NMR spectrum of compound 6.6 appears as expected, with loss of the proton 
resonances of the benzyl group between δ = 7.29 ppm and δ = 7.15 ppm, and δ = 3.74 
ppm. The 
13
C{
1
H} NMR spectrum also appeared as expected with no low field 
resonances observed in the region for the benzylic carbons (δ = 130.5 ppm to  δ = 128.6 
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ppm in compound 6.5). The formation of compound 6.6 was confirmed by mass 
spectrometry with m/z for [6.6-2Cl-H]
+
 observed at 470.3.     
 The same reaction was also attempted with compound 6.5 PF6. Once again the 
benzyl group was successfully removed, confirmed by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy. Interestingly, in this reaction, it appears that some of the tert-butyl groups 
of the acetate esters were also removed, with the proton resonance attributed to the tert-
butyl groups at δ = 1.52 ppm being significantly reduced in intensity (Figure 6.11). 
 
Figure 6.11  
1
H NMR spectrum (DMSO-d6) of the product formed from the reaction of 6.5 PF6 with 
Pd/C under a H2 atmosphere.  
The mass spectrometry data displayed a signal for the desired compound [6.6-PF6]
+
 at 
m/z 580.2. However, a signal was also observed for [6.6-2
t
Bu-2PF6]
2+
 at m/z 161.6. 
Compounds often fragment during mass spectrometry experiments and it is not unusual 
to see the loss of tert-butyl groups. However, the significant reduction of the tert-butyl 
resonance in the 
1
H NMR spectrum suggests that, in this case, it is likely that the tert-
butyl groups have been removed from some of the material during this reaction. 
Therefore, compound 6.6 Cl was used for further reactions.    
 Compound 6.6 Cl was reacted with tert-butyl chloroacetate in an attempt to add 
the third tert-butyl acetate group to the secondary amine, to form compound 6.7 Cl. The 
reaction was performed in acetonitrile and in the presence of potassium carbonate to 
„mop up‟ the eliminated HCl and protect the tert-butyl groups of the acetate ester 
substituents. The product was analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, 
combined with mass spectrometry, but only starting material was identified from the 
reaction. The reaction was repeated using tert-butyl bromoacetate, as bromide is a better 
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leaving group than chloride, and the product was analysed by 
1
H NMR spectroscopy 
and mass spectrometry. The major product of the reaction appeared to be the undesired 
imidazolium salt (Figure 6.12), indicating that fragmentation had occurred. The 
synthesis of compound 6.7 Cl proved to be unsuccessful with none of the desired 
product being identified.  
 
Figure 6.12  Product formed from the reaction of 6.7 Cl with tert-butyl bromoacetate (X = Cl, Br).  
Unfortunately, as the addition of the third tert-butyl acetate group to compound 6.6 Cl 
was unsuccessful, the target ligand 6.8 was not synthesised. However, two novel NHC-
ligand precursors were prepared (compounds 6.5 and 6.6) that could be investigated as 
NHC ligand precursors. A third imidazolium amine ligand was also prepared by 
removing the tert-butyl groups from the acetate ester substituents of compound 6.5 to 
form a ligand with two carboxylic acid groups. Compound 6.5 PF6 was dissolved in 
excess HCl (aq) and heated at reflux (110 °C) for 1 hour (Scheme 6.6). The solvent was 
removed in vacuo and the resultant solid was purified by washing with acetone and 
diethyl ether, and was dried in vacuo to isolate compound 6.11 as an off white solid, 
which was analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy and mass 
spectrometry.  
 
Scheme 6.6  Synthesis of compound 6.11 (X = Cl or PF6).  
The 
1
H NMR spectrum of compound 6.11 appeared as expected, with the resonance 
attributed to the tert-butyl groups at δ = 1.54 ppm being absent. The formation of 
compound 6.11 was confirmed by mass spectrometry, with m/z for [6.11-2H-2X+Na]
+ 
at 434.2.           
 In conclusion, although the target DTPA inspired ligands (compounds 6.3 and 
6.8) were not synthesised, three novel DTPA-type NHC ligand precursors have been 
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prepared (compounds 6.5, 6.6 and 6.11), which incorporate different functional groups, 
and offer the potential to form a unique metal-NHC complexes.  
6.2 Formation of metal-NHC complexes using a bis-imidazolium amine ligand 
(compound 6.5) 
Douthwaite et al. were the first group to report the synthesis of an NHC-amine complex 
(Scheme 6.7).
12
 They reacted a bis-imidazolium secondary amine (6.12) with Ag2O to 
form a silver(I)-NHC complex (6.13), which was used as a ligand transfer agent to 
palladium(II). They isolated and crystallographically characterised the palladium(II)-
complex 6.14. The amine was then reduced to form a palladium(II)-NHC amido 
complex 6.15. The same group later reported the synthesis of a palladium(II)-NHC 
complex using a bis-imidazolium tertiary amine NHC precursor (with a benzyl group on 
the amine). In this case the amine nitrogen does not from an interaction with the 
palladium centre (Figure 6.13, A).
13
 Both these palladium-NHC complexes were found 
to be catalytically active in Heck reactions, displaying comparable activity to each 
other.  
 
Scheme 6.7  Reported synthesis of a palladium-NHC amine complex.
12
 
Hazari et al. later reported the synthesis of a related palladium(II)-NHC amine complex, 
which incorporates a further CH2 linker between the amine and NHC groups (Figure 
6.13, B).
14
 The complex was crystallographically characterised and there was found to 
be no interaction between the amine and the palladium centre. The complex was 
catalytically active in both Heck and Suzuki reactions. However, the complex was not 
as active as those prepared by Douthwaite et al. for Heck reactions under the same 
conditions.           
 More recently, a rigid palladium(II)-NHC amido complex was reported by Cross 
et al. (Figure 6.13, C).
15
 They prepared the palladium complex directly through reaction 
of the imidazolium salt with Pd(OAc)2. They also report the preparation of a 
platinum(II) complex from the same ligand precursor.  
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Figure 6.13 Palladium-NHC amine complexes using ligands with a similar architecture to compounds 
6.5, 6.6 and 6.11.
13-15
 
We initially explored the formation of metal-NHC complexes starting from the tertiary 
amine ligand precursor 6.5. The protecting tert-butyl groups and benzyl group will 
prevent the interaction of any other part of the ligand with the metal centre.  
6.2.1 Electrochemical synthesis of a copper(I)-NHC complex starting from 
imidazolium salt 6.5  
Compound 6.5 has a similar architecture to the ligand reported by Douthwaite et al. 
(Figure 6.13, A), with the main difference being the incorporation of the tert-butyl 
acetate functionality on the imidazolium groups. We have found in previous 
investigations that, when using imidazolium precursors that are functionalised with 
acetate ester groups, the most common approaches reported in the literature for metal-
NHC formation were unsuccessful. Under basic reaction conditions, the methylene 
groups of the acetate esters appear to deprotonate and cause undesired side reactions. 
However, the electrochemical method was successful for the synthesis of copper(I)-
NHCs from imidazolium salts that were functionalised with acetate ester groups.
16
 The 
electrochemical method was therefore explored with compound 6.5 PF6 (Scheme 6.8).  
 
Scheme 6.8  Electrochemical synthesis of Cu(I)-NHC complex 6.16.  
Copper plates were used as both the sacrificial anode and cathode (1 × 3 cm), and the 
reaction was performed in anhydrous acetonitrile. Compound 6.5 PF6 was added to the 
flask and degassed. Anhydrous acetonitrile was added (15 ml) and the solution was 
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degassed for 1 hour by bubbling argon through. The electrodes were inserted into the 
solution and a potential applied such to maintain a constant current of 50 mA. The 
reaction was monitored by 
1
H NMR spectroscopy, and ended when the resonance for 
the C2 protons was no longer present in the 
1
H NMR spectrum (25 minutes, 2 Q). The 
mixture was filtered to remove suspended copper particles, and the solvent removed in 
vacuo to yield complex 6.16 as an off white solid, which was characterised by 
1
H NMR 
and 
13
C{
1
H} NMR spectroscopy combined with mass spectrometry. A 
1
H NMR 
spectrum (MeCN-d3) of the product is displayed in Figure 6.14.    
 It is evident that an NHC complex has formed due to the disappearance of the 
resonance attributed to the C2 protons observed at δ = 8.66 ppm (DMSO-d6) in the 
imidazolium precursor 6.5 PF6. Signals are observed in the correct regions to be 
assigned as CH, CH2 and CH3 protons. However, there are five CH2 and two CH3 
regions (integrate as 2.5:1), which is more than would be expected if one symmetrical 
complex was formed.  
 
Figure 6.14  
1
H NMR spectrum (MeCN-d3) of Cu(I)-NHC complex 6.16 at 298 K.  
The 
13
C{
1
H} NMR spectrum of complex 6.16 displays a low field resonance at δ = 
181.0 ppm, attributable to a C2 proton bound to copper. Again, as with the 
1
H NMR 
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spectrum, there are six separate resonances assigned to carbons of CH2 groups, and two 
resonances assigned to carbons of CH3 groups. The mass spectrometry data confirmed 
the presence of the chelating copper complex with m/z observed for [6.16-PF6]
+
 at 
586.25, which displays the correct splitting pattern for the +1 species (Figure 6.15). 
Crystallisations were attempted in a range of solvents / solvent systems, but no crystals 
were obtained that were suitable for analysis by single crystal X-ray diffraction. A 
crystal structure may have assisted in the assignment of the NMR spectra.  
 
Figure 6.15  Mass spectrometry data of complex 6.16 (bottom), calculated for [6.16-PF6]
+
 (top).  
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6.2.2 Transmetallation from copper(I)-NHC complex 6.16 to palladium  
An attractive route for the synthesis of a wide range of transition-metal NHC complexes 
is to use the direct NHC ligand transfer from one metal to another. As discussed 
previously, copper(I)-NHCs have been reported as carbene transfer agents to 
ruthenium(II), palladium(II), nickel(II) and gold(I).
17-19
 The reaction of complex 6.16 
with PdCl2(MeCN)2 was investigated (Scheme 6.9).  
 
Scheme 6.9  Transmetallation reaction from copper(I) (complex 6.16) to palladium(II) (suggested 
structure for the palladium(II)-NHC complex).    
Complex 6.16 and PdCl2(MeCN)2 were stirred in DCM at room temperature for 12 
hours. DCM is an attractive choice of solvent for transmetallation as the copper salts 
formed as by-products precipitate from DCM, which helps to drive the reaction to 
completion, and assists in the purification of the product. The solution was filtered to 
remove the inorganic salts and the solvent of the filtrate was removed in vacuo. The 
product was analysed by 
1
H NMR spectroscopy and mass spectrometry, but the data 
could not be assigned to a desirable product. The reaction was repeated in acetonitrile, 
and the product purified by dissolving in DCM and filtering through celite. The solvent 
of the filtrate was removed and the product was analysed by 
1
H NMR and 
13
C{
1
H} 
NMR spectroscopy combined with mass spectrometry. The 
1
H NMR spectrum is 
displayed in Figure 6.16.         
 The 
1
H NMR spectrum (MeCN-d3) indicates the formation of a metal-NHC 
complex (or complexes) as there is no high field resonance for the C2 proton. The 
signals have shifted compared to the copper(I)-NHC complex, suggesting that transfer 
to palladium has occurred. The spectrum is very broad at low temperatures (243 K), 
becoming sharper on heating (323 K), with the broad resonance at δ = 2.65 ppm (243 K) 
becoming two sharp resonances at 342 K. Although the spectra cannot be fully 
assigned, there are resonances in the correct regions to be assigned as CH, CH2 and CH3 
protons of the desired product. The 
13
C{
1
H} NMR spectrum was also complicated, 
displaying a large number of resonances. However, no resonance was observed for the 
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C2 carbon bound to copper at δ = 181 ppm, and instead two low field resonances were 
observed at δ = 141 ppm and δ = 167 ppm. The resonance at δ = 141 ppm is 
characteristic of a palladium(II)-NHC complex that has a trans-coordinating two 
electron donor ligand such as PdX2(NHC)(py) or PdX2(NHC)(MeCN), whereas, the 
resonance at δ = 167 ppm is characteristic for a bidentate palladium(II)-NHC complex 
of the type Pd(NHC)2X2.
20, 21
  The mass spectrometry data suggests the formation of a 
monodentate palladium-NHC complex bearing two palladium centres, with m/z at 842.0 
for [6.17-2MeCN-Cl]
+ 
and m/z at 983.9 for [6.17+Na]
+
.  
 
Figure 6.16  
1
H NMR spectrum  (MeCN-d3) of complex 6.17 at 243 K and 342 K.  
Single crystals suitable for analysis by single crystal X-ray diffraction were obtained 
from the reaction mixture (MeCN / diethyl ether), but they were found to be copper(I) 
tetrakisacetonitrile hexafluorophosphate. Attempts were made to purify the product and 
remove the copper(I) salts but, to date, no crystals of a palladium complex have been 
obtained that are suitable for analysis by single crystal X-ray diffraction.   
 There are a number of products that could be formed in this transmetallation 
reaction, though only complex 6.17 has been identified in the mass spectrometry data. 
These include monomeric, dimeric, and oligomeric palladium(II) species, which may 
have cis or trans geometry about the palladium centres.
22
 Some of the possible products 
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are displayed in Figure 6.17, where the carbenes in the bis-NHC complexes are 
coordinated in a trans fashion. If a mixture of products is formed in the reaction this 
may account for the broad and complicated 
1
H NMR spectrum. Furthermore, it may 
account for the large number of signals that are seen in the 
13
C{
1
H} NMR spectrum. A 
similar finding was reported by Danopoulos et al. when they investigated the synthesis 
of bis-NHC complexes of palladium through transmetallation from silver. They 
observed mixtures of monomeric, dimeric, and oligomeric palladium(II) species which 
were inseparable.
23
  
 
Figure 6.17  Possible products formed from the transmetallation reaction from copper(I) (complex 6.5) to 
palladium(II).  
6.3 Conclusion  
In conclusion, although the synthesis of the target DTPA-type ligands (compounds 6.3 
and 6.8) was unsuccessful, three novel bis-imidazolium amine ligands were prepared 
(compounds 6.5, 6.6 and 6.11), which incorporate different functional groups and offer 
the potential to form unique metal-NHC complexes.     
 To date, only compound 6.5 has been investigated as a potential NHC-ligand 
precursor. The electrochemical approach was used to synthesise a copper(I)-NHC 
complex (complex 6.16), which was used as a carbene transfer agent for the formation 
of a palladium(II)-NHC complex (6.17). Complex 6.17 appears to have a different 
structure to the palladium-NHC amine complexes that have been previously reported, 
with the monodentate PdCl2(NHC)(MeCN) complex being identified. However, it 
Chapter 6. Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DTPA 
  
158 
 
appears that complex 6.17 was not produced selectively and other products were formed 
during the transmetallation reaction.  
6.4 Future work  
Further work would include the purification and full characterisation of the products 
formed in the transmetallation reaction (Scheme 6.9). If the monodentate palladium-
NHC complex 6.17 can be isolated from the reaction, this would be an interesting 
complex to test as a catalyst in the Heck reaction and compare with the bis-NHC 
complexes reported in the literature (Figure 6.13). Having an acetonitrile group trans to 
the NHC may improve the efficiency of the catalyst, as the acetonitrile molecule will be 
weakly bound owing to the strong trans effect of the NHC group.    
 The use of compounds 6.6 and 6.11 as NHC-ligand precursors should also be 
investigated. Compound 6.6 incorporates acetate ester functionalities, hence the 
electrochemical method would most likely be the best approach for the synthesis of 
metal-NHC complexes using this ligand precursor. Compound 6.11 incorporates acetic 
acid functionalities so the electrochemical route would not be a viable synthetic route 
for this ligand. We have previously observed that during electrochemical reactions, 
acetic acid groups appear to be eliminated from the compound. The use of a base (e.g. 
n
BuLi), followed by coordination of the free NHC to a metal centre should be a suitable 
synthetic route for the formation of metal-NHC complexes using compound 6.11. As 
compounds 6.6 and 6.11 incorporate different functional groups, for example 
carboxylate or an amine donor, it would be interesting to examine the resulting 
complexes in catalysis.   
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7 Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DOTA: Ligand synthesis and metal complexation   
1, 4, 7, 10-Tetraazacylododecane tetraacetic acid (DOTA) is a macrocyclic octadentate 
ligand that incorporates four tertiary nitrogen donors and four carboxylic acid donor 
groups (Figure 7.1, A). The ligand binds to metals and forms complexes with enhanced 
stability over similar complexes with non-chelating ligands. This enhanced stability is a 
consequence of both the chelating and macrocyclic effects, which are attributed to a 
combination of entropic and enthalpic factors that favour the formation of a rigid 
macrocyclic structure.
1
 A major application for the DOTA ligand is in MRI, where 
DOTA is coordinated to gadolinium(III) and the complex is used as a contrast agent 
(Dotarem®).
2
 MRI relies on the different distributions of water molecules in the 
examined tissue, and on the proton relaxational properties of the water molecules‟ 
longitudinal (T1) and transverse (T2) magnetic relaxational times.
3
 Contrast agents alter 
the relaxational properties of the water molecules in the areas where they accumulate, 
enhancing the image produced in MRI. Ligands that bind to gadolinium and form stable 
complexes are vital, as dechelation of the gadolinium has been linked to a disease called 
NSF (nephrogenic systemic fibrosis), which can lead to serious and sometimes fatal 
complications.
4, 5
 Therefore, the design of ligands that bind to gadolinium and form very 
stable complexes is vital. Most research performed so far has focused on varying the 
carboxylic acid functionalities of DOTA, which has often had a favourable increase in 
T1 relaxational times. There are fewer examples in the literature where the nitrogen 
donors of DOTA have been altered.
6
 This is of interest as it could offer the possibility of 
more rigid ligands which will decrease the rotational rate and increase relaxivity. 
Furthermore, it may be possible to design more stable gadolinium chelates.   
 In this work, ligands have been designed that are inspired by the structural motif 
of DOTA. In the first target DOTA-type ligand, two of the tertiary nitrogen atom donors 
were replaced by imidazolium groups, offering the potential to form metal-NHC 
complexes from this ligand (Figure 7.1, B). The proposed macrocyclic hexadenate 
ligand (compound 7.2) incorporates two tertiary nitrogen atom donors, two carboxylic 
acid groups and two imidazolium groups. However, the formation of the macrocyclic 
ligand 7.2 was unsuccessful. Our next approach involved the functionalisation of a pre-
formed macrocyclic ligand with an imidazolium group (Figure 7.1, C). The potentially 
nonadentate ligand incorporates four tertiary nitrogen donors, four carboxylic acid 
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groups and one imidazolium group. A synthetic route for the formation of the DOTA-
type ligand C is described (compound 7.17, n = 3), and a gadolinium complex of the 
ligand was prepared (7.19). The efficiency of the gadolinium complex as a contrast 
agent was probed by measuring the relaxivity (ri).      
 A copper complex of the ligand was prepared electrochemically, which showed 
a mixed-valence complex, with a copper(I)-NHC and a copper(II) ion bound inside the 
macrocycle (7.20). This demonstrates the potential to coordinate this unique ligand to 
metals through two different types of binding sites.  
 
Figure 7.1  The structure of DOTA (A) and the novel DOTA inspired NHC-ligand precursors (B) and 
(C), (n = 1, 3). 
7.1 Synthesis of DOTA inspired NHC ligand precursors  
 
Scheme 7.1  Proposed synthesis of DOTA-inspired NHC ligand precursor (7.2).  
The proposed synthetic route for the preparation of the DOTA-type ligand 7.2 is 
outlined in Scheme 7.1. The tert-butyl acetate ligand precursors (compounds 6.1 and 
6.2) were synthesised to prevent any competing reactions of the acetic acid group upon 
cyclisation. The aim was to remove the tert-butyl groups in the final step to form the 
target ligand (compound 7.2). Preparation of the ligand precursors 
(amino(dichloromethyl) tert-butyl acetate (6.1) and amino(dimethyl-imidazole) tert-
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butyl acetate (6.2)) was carried out as described in Chapter 6. Compounds 6.1 and 6.2 
were added together slowly, under high dilution conditions, with a view to forming the 
cyclic product and minimising the formation of polymeric species. The reaction was 
attempted at different temperatures (30-70 °C), in different solvents (DCM / acetone), 
and the reaction time was varied (24-72 hours). In all cases, analysis by 
1
H NMR 
spectroscopy (DMSO-d6) suggested imidazolium species to have formed due to the shift 
in the C2 imidazole proton from δ = 7.45 ppm to between δ = 9.00 and δ = 9.50 ppm. 
However, a mixture of products was evident with no clear evidence for the formation of 
the target molecule. Analysis of the products by mass spectrometry did not provide any 
indication of the formation of the target macrocyclic molecule, or identifiable polymeric 
species. In addition, the experiments proved to be irreproducible, with repeated 
experiments producing different results each time.      
 As discussed in Chapter 6, compound 6.1 is unstable, requiring careful handling 
and storage at 4 °C. Compound 6.1 has the potential to form an imine, with the lone pair 
on the tertiary nitrogen of the amine attacking the adjacent carbon (Chapter 6, Figure 
6.2). The formation of the imine in the above reactions was indicated by both mass 
spectrometry and infrared spectroscopy. It is likely that the instability of compound 6.1 
was causing the problems in the cyclisation reaction.     
 The stability of compound 6.2 was examined to determine if it could also be 
degrading in a similar manner during the reaction. Compound 6.2 was dissolved in 
acetone-d3 in an NMR tube and heated to 56 °C, with any reaction / degradation being 
followed over time (72 hours). Compound 6.2 was found to be stable to prolonged 
heating, with no significant changes being observed in the 
1
H NMR spectrum. However, 
it is still possible that the lone pair of electrons on the tertiary amine of compound 6.2 is 
causing problems in the cyclisation reaction. Indeed, we have previously observed that 
when reacting compound 6.2 with tert-butyl chloroacetate, in an attempt to functionalise 
the neutral imidazole and form the imidazolium species, a complicated mixture of 
products was formed that appeared to include imidazolium and imidazole species 
(Chapter 6, Figure 6.6). We proposed that the lone pair on the tertiary nitrogen was 
either reacting with the tert-butyl chloroacetate to form the quaternary amine salt, that 
decomposed into further species. Or that the lone pair on the tertiary amine was causing 
the product to decompose once an imidazolium salt had formed. It is possible that a 
similar process was occurring in the cyclisation reaction.    
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 Considering these findings, we decided to protect the amine with a more 
electron withdrawing group, to render it less basic. The benzoyl group was selected as it 
is more electron withdrawing than tert-butyl acetate. Compound 7.3 was synthesised in 
accordance with literature procedure.
7
 Benzoyl chloride and hexamethylenetetramine 
were dissolved in xylene and the mixture was heated at 135 °C for 18 hours. The 
solvent was removed in vacuo to yield a yellow oil that was analysed by 
1
H NMR 
spectroscopy. Compound 7.3 was identified in the 
1
H NMR spectrum (CDCl3), with the 
chemical shifts being consistent with the reported literature values.
7
 However, the 
compound was not produced selectively and multiple products were formed. Attempts 
were made to distil the oil and isolate the pure product (96 °C / 10
-2
 torr), but the boiling 
point of compound 7.3 was too high at the vacuum achieved, and the mixture 
decomposed before the target compound was collected.  
 
Scheme 7.2  Proposed product from the reaction of hexamethylenetetramine and benzoyl chloride.  
The protecting group on the tertiary amine nitrogen was therefore altered to an acetyl 
group, as the boiling point of amino(dichloromethyl) acetyl (compound 7.4) is lower 
(51 °C / 10
-2
 torr). Compound 7.4 was synthesised in accordance with the literature 
procedure.
7
 Acetyl chloride and hexamethylenetetramine were added to a small 
ampoule and the solution was heated in a closed system at 120 °C for 5 hours. The 
solvent was removed in vacuo to yield a yellow oil. Distillation of the resultant oil 
yielded compound 7.4 as a colourless oil, which was analysed by 
1
H NMR and
 13
C{
1
H} 
NMR spectroscopy, and was consistent with the reported literature values. The 
compound was too toxic and volatile for any further analysis to be obtained.
7
 
 
Scheme 7.3  Proposed product from the reaction of hexamethylenetetramine and acetyl chloride.  
Compound 7.4 was reacted with imidazole in the presence of a base, in an attempt to 
prepare the bisimidazolium compound 7.5 (Scheme 7.4). The reaction proved 
unsuccessful, with starting material being identified in the product mixture.  
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Scheme 7.4  Proposed product from the reaction of compound 7.4 with imidazole.  
The formation of compound 6.2 (amino(dimethyl-imidazole) tert-butyl acetate) had also 
proved unsuccessful using the chloromethylated intermediate 6.1. Therefore a direct 
approach was taken to prepare compound 6.2 starting from glycine tert-butyl ester 
hydrochloride (H2NCH2CO2
t
Bu) and reacting this with two equivalents of formaldehyde 
and excess imidazole. The same approach was tried for the formation of compound 7.5 
by reacting acetamide with formaldehyde and excess imidazole (Scheme 7.5). Again, 
the reaction proved to be unsuccessful with mostly starting material being isolated. 
Although the exact mechanism of this reaction is not known, the problem may be due to 
the increased electron withdrawing effect of the acetyl group deactivating the primary 
amine nitrogen lone pair.  
 
Scheme 7.5  Proposed product from the reaction between acetamide, formaldehyde and imidazole.  
As the synthesis and purification of these compounds was proving challenging, we 
moved to a commercially available tertiary amine which is protected with an electron 
withdrawing group, namely N,N-bis(2-chloroethyl)-p-toluene sulfonamide (compound 
7.6). Although this compound contains chloroethyl rather than chloromethyl groups, the 
material is a solid so is easier to work with and can be obtained in 90 % purity. In 
addition, the extra CH2 group should increase the stability as it is less likely that an 
imine will form. In the absence of a base, the reaction of compound 7.6 with excess 
imidazole produced only starting material. Therefore a base (KOH or K2CO3) was used 
to deprotonate the imidazole, followed by dropwise addition of a solution of compound 
7.6 (Scheme 7.6). A small amount of imidazole species was isolated, even when using a 
large excess of base and prolonged heating at reflux. The 
1
H NMR spectrum was 
complicated and suggested that more than one imidazole species was present. The 
desired product was identified in the mass spectrum with m/z 360.1 assigned as 
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[7.7+H]
+
. However, other high mass species were also present, once again suggesting 
that the desired product was not produced selectively. Attempts were made to isolate the 
desired product from the reaction mixture, but these were unsuccessful.  
 
Scheme 7.6  Proposed product from the reaction of compound 7.6 and imidazole.  
Although the data has not yet proved adequate to draw any direct conclusions as to what 
is occurring in these reactions, it is apparent that the nitrogen of the tertiary amine in 
these compounds is causing complications, even when protected by an electron 
withdrawing group. The reaction of imidazole with chloromethylated or 
bromomethylated compounds that do not contain an amine nitrogen usually proceed 
cleanly, often without the need for a base. This is a method used within our research 
group and there are examples contained within Chapters 2-4. The fact that this is 
proving so challenging must therefore be due to the inclusion of the amine functionality.
  We therefore altered the structure of the target ligand to a preformed 
macrocyclic ligand functionalised with an imidazolium group (compound 7.12). The 
starting material (compound 7.8) incorporates three tertiary nitrogen atoms, which are 
functionalised with tert-butyl acetate groups, and a secondary nitrogen atom. The aim 
was to functionalise the secondary nitrogen with an imidazolium group to introduce a 
potential NHC moiety to the macrocycle. A proposed synthetic route is outlined in 
Scheme 7.7.   
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Scheme 7.7  Proposed synthesis of DOTA-inspired NHC ligand precursor (7.12).  
Compound 7.8 was purchased from CheMatch and compound 7.9 was prepared in 
accordance with literature procedure.
8
 Imidazole and paraformaldehyde were heated at 
80 °C, in the presence of a catalytic amount of triethylamine, forming hydroxyl-methyl 
imidazole. This was reacted with thionyl chloride to yield compound 7.9 as the HCl salt, 
which was isolated as a white hygroscopic solid and characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined with mass spectrometry.
8
  
 Compound 7.8 and compound 7.9 were added to a Schlenk flask and dissolved 
in acetonitrile, Cs2CO3 was added and the mixture was heated at reflux (85 °C) for 12 
hours. The mixture was filtered to remove the inorganic salts and the solvent was 
removed in vacuo to yield a yellow oil. The isolated product was analysed by 
1
H NMR 
and 
13
C{
1
H} NMR spectroscopy and mass spectrometry. The 
1
H NMR spectrum 
(CDCl3) of the product is displayed in Figure 7.2, and compared with that of the starting 
macrocyclic ligand compound 7.8. The 
1
H NMR spectrum of the product appears as 
expected, with a characteristic resonance for the C2 imidazole proton downfield at δ = 
7.53 ppm. The imidazole backbone protons appear as one resonance at δ = 6.95 ppm, 
suggesting that the protons are coincidently in the same environment. The remainder of 
the spectrum is very similar to that of the un-functionalised macrocyclic compound 7.8, 
displaying three broad resonances for the three inequivalent methylene protons of the 
macrocycle (5, 6, 7), and a low field resonance for the tert-butyl groups (8). The 
remaining two resonances at δ = 3.23 ppm and δ = 3.22 ppm are assigned as the 
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methylene protons of the acetate groups (3), and the methylene protons linking the 
macrocycle and the imidazole group (4). The formation of compound 7.10 was 
confirmed by mass spectrometry with a signal for [7.10+Na]
+
 at m/z 617.4 (Figure 7.3). 
           
 
Figure 7.2  
1
H NMR spectra (CDCl3) displaying compound 7.8 (bottom) and the product formed from the 
reaction between compound 7.8 and 7.9 (top) at 298 K.  
Although the mass spectrum displays a signal for the expected compound (7.10), the 
starting macrocyclic ligand (7.8) is also observed at m/z 515.3 assigned as [7.8+H]
+
. In 
addition, there is evidence of a macrocylic compound containing two methyl imidazole 
groups at m/z 697.4. The integrations from the 
1
H NMR spectrum also suggest the 
presence of further products, with the imidazole resonances integrating to less than 
expected if compound 7.10 has formed exclusively in the reaction. The reaction time 
was increased from 12 hours to 72 hours, but analysis by 
1
H NMR spectroscopy and 
mass spectrometry suggested that the same product mixture was formed. The 
purification of the product mixture was attempted by column chromatography (Silica 
gel, 10 % MeOH / CHCl3) but the desired product was not isolated.   
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Figure 7.3  Mass spectrometry data displaying the products that were isolated from the reaction of 7.8 
with 7.9.  
Therefore an approach was taken to react compound 7.8 with an imidazolium to prepare 
an imidazolium functionalised macrocyclic ligand directly (Scheme 7.8). The length of 
the alkyl chain on compound 7.14 can be varied depending on the required chain length 
between the macrocycle and imidazolium group. A propyl chain length was selected for 
ease of synthesis.  
 
Scheme 7.8  Proposed synthesis of DOTA-inspired NHC ligand precursor 7.16 (n = 3). 
The synthesis of compound 7.14 (where n = 3) was achieved through the reaction of 
tert-butyl chloroacetate with 1-propanol imidazole to yield compound 7.13, which was 
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reacted with thionyl chloride to give compound 7.14 (Scheme 7.9). The addition of 
triethylamine was found to be necessary to neutralise the HCl formed in the reaction and 
protect the tert-butyl groups. The product was purified by recrystallisation from DCM / 
diethyl ether and was analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy combined 
with mass spectrometry. The 
1
H NMR spectrum appears as expected, with a 
characteristic low field resonance for the C2 imidazolium proton at δ = 9.29 ppm. The 
formation of compound 7.14 was confirmed by mass spectrometry with m/z at 259.1 
assigned as [7.14-Cl]
+
. It should be noted that compound 7.14 was isolated with the 
triethylamine chloride salt, which could not all be separated from the product, though 
this did not prove to be a problem in further reactions.  
 
Scheme 7.9  Synthesis of compound 7.14. 
Compound 7.8 and compound 7.14 were added to a Schlenk flask and dissolved in 
acetonitrile. Cs2CO3 was added, and the mixture was heated at reflux (85 °C) for 12 
hours. The solution was filtered to remove the inorganic salts and the solvent was 
removed in vacuo. Analysis of the isolated material by 
1
H NMR spectroscopy and mass 
spectrometry showed that only starting material was present. The reaction conditions 
were varied (base, reaction vessel, addition of NaBr / NaI, temperature, reaction time). 
It was found that the desired product was formed in the highest yield when the reaction 
was performed in acetonitrile, in a sealed ampoule, with K2CO3 and NaBr added to the 
reaction mixture. The mixture was heated at 50 °C for 96 hours and the reaction was 
monitored by HPLC mass spectrometry. The product was identified in the HPLC mass 
spectrum at m/z 737.5 for [7.15-Br]
+
 and m/z 396.3 for [7.15-Br+H]
2+
. The mixture was 
filtered to remove the inorganic salts, and the solution was removed in vacuo to yield a 
yellow oil. The oil was washed with diethyl ether and dried in vacuo to yield a yellow 
hygroscopic solid. Analysis of the product by 
1
H NMR spectroscopy and mass 
spectrometry indicated that the solid was a mixture of the starting material (7.8), and the 
desired product (7.15). Compound 7.15 was isolated from the reaction mixture using 
HPLC, and analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy and mass 
spectrometry. The 
1
H NMR spectrum of compound 7.15 is displayed in Figure 7.4.
 The 
1
H NMR spectrum of compound 7.15 (CDCl3) appears as expected, with a 
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characteristic resonance for the imidazolium C2 proton downfield at δ = 10.04 ppm. 
The backbone imidazole protons appear as two separate resonances at δ = 8.34 ppm and 
δ = 7.35 ppm. The resonance at δ = 8.23 ppm has not been assigned, but is most likely 
due to formic acid from the HPLC separation. The methylene protons on the acetate 
tether of the imidazolium group appear as a singlet resonance at δ = 5.02 ppm, and a 
broad triplet resonance at δ = 4.64 ppm is assigned to the CH2 group closest to the 
imidazolium group on the propyl chain. The remaining CH2 protons appear as broad 
resonances between δ = 3.77 ppm and δ = 2.63 ppm. There are three resonances 
assigned to the CH3 protons of the tert-butyl groups at δ = 1.47 ppm, δ = 1.45 ppm and δ 
= 1.43 ppm that integrate as 1:1:2. The formation of compound 7.15 was confirmed by 
mass spectrometry with m/z 841.4 assigned as [7.15+Na]
+
, m/z 737.5 assigned as [7.15-
Br]
+
, and  m/z 396.3 assigned as [7.15-Br+H]
2+
. The purity of the compound was 
established by HPLC-MS and elemental analysis.  
 
Figure 7.4  
1
H NMR spectrum (CDCl3) of compound 7.15 at 298 K.  
The tert-butyl protecting groups of compound 7.15 were removed by dissolving the 
compound in TFA and stirring the solution at room temperature for 12 hours. The TFA 
was removed in vacuo and the resultant oil was triturated with diethyl ether to yield a 
yellow solid. Compound 7.16 was analysed by 
1
H NMR and 
13
C{
1
H} NMR 
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spectroscopy combined with mass spectrometry. The 
1
H NMR spectrum appeared as 
expected, with the only difference between this and the 
1
H NMR spectrum of compound 
7.15 being the loss of the resonances assigned to the tert-butyl groups at δ = 1.47 ppm, 
1.45 ppm and 1.43 ppm.  The removal of the tert-butyl groups was further indicated by 
13
C{
1
H} NMR spectroscopy, with no resonance assigned to the tert-butyl groups (seen 
at δ = 27.99 ppm and 28.16 ppm in compound 7.15), and mass spectrometry with m/z 
513.3 assigned as [7.16-Br]
+
.  
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7.2 Formation of a gadolinium complex using DOTA inspired NHC ligand 
precursor (7.17)  
Magnetic resonance imagining (MRI) is a common imaging technique used in medical 
diagnostics. MRI relies on the different distribution and properties of water in the 
examined tissues, and on the proton relaxational properties of the water. As relaxational 
properties of water in different tissues can be very similar, or even identical, standard 
MRI techniques do not always produce images that can be used for diagnostics. 
Contrast agents modify the relaxational properties of water in areas where they 
accumulate, so the intensity of the MRI signal can be selectively enhanced through the 
administration of a contrast agent.       
 Gadolinium based contrast agents are used widely in clinical practice today. 
They consist of a gadolinium(III) metal centre surrounded by a chelating (e.g. 
Magnevist®) or macrocyclic (e.g. Dotarem®) organic ligand. Gadolinium(III) has 
seven unpaired electrons and a magnetic moment 657 times higher than that of a proton, 
making gadolinium(III) complexes highly paramagnetic. The proton nuclear spins of the 
surrounding water molecules interact with the local magnetic field generated by the 
paramagnetic metal ion. The effect is that both T1 (longitudinal), and T2 (transverse), 
magnetic relaxational times of the surrounding water molecules are shortened.
9, 10
 The 
effect of the contrast agent on T1 dominate compared to T2 at the low concentrations 
that are used in diagnostics. Therefore, a T1 weighted image produces a brighter more 
defined picture.          
 The efficacy of a contrast agent at shortening T1 and T2 of the surrounding 
water molecules is dependent upon its relaxivity (ri), where the i refers to what is being 
measured, for T1 i =1 and for T2 i = 2.
1
 The relaxivity of a contrast agent can be 
calculated by measuring Ri(obs) (which equates to 1 / Ti) at different concentrations of 
contrast agent (C). Plotting Ri(obs) against concentration (C) gives a linear graph, the 
gradient of which gives the relaxivity (ri). The relaxivity is also dependent on the 
strength of the magnetic field (Tesla) and the temperature of the solution, hence these 
parameters are reported with ri values. The relaxivity gives a measure of the change in 
the relaxation rate of water molecules in the presence of a contrast agent, and so 
provides a direct measure of the efficacy of a contrast agent. Two widely used 
commercially available contrast agents, Magnevist® and Dotarem®, have r1 = 3.3 mM
-
1
 s
-1
 (1.5 T, 37 °C) and r1 = 2.9 mM-1 s-1 (1.5 T, 37 °C) respectively.11 
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i = 1: effect of the contrast agent on T1 
 i = 2: effect of the contrast agent on T2 
 Ri = global relaxational rate constants 
of water in the system [s
-1
] 
 
 
Ti(diam) = relaxational time of water 
in the absence of contrast agent [s] 
Ti(obs) = relaxational time of water in 
the presence of contrast agent [s] 
 C = concentration of the paramagnetic 
ion in the contrast agent [mmol
-1 
L] 
 ri = relaxivity [mM
-1
 s
-1
] 
Figure 7.5  Equation to calculate the relaxivity of a contrast agent (ri).
1
 
The main contributing factors towards the overall relaxivity are; a) the number of 
exchangeable water molecules that are bound to the metal ion, b) the time constant for 
the exchange of the metal bound water with the bulk water (inner sphere relaxation), c) 
the interaction of the surrounding bulk water molecules with the paramagnetic metal ion 
(outer sphere relaxation), and d) the rotational correlation time, which represents the 
tumbling of the complex.
3, 12
 These properties can be altered by changing the ligand 
design. For example, hexadentate and heptadentate ligands have been designed that 
allow for two coordinated water molecules (most commercially available contrast 
agents are octadentate and incorporate one bound water molecule).
3, 13
 These complexes 
have been shown to have up to twice the relaxivity of commercially available contrast 
agents. However, as they do not incorporate as many donor groups in the ligand, they 
are often not as stable as octadentate ligands.
3, 13
 The rotational correlation time of a 
contrast agent can be altered by increasing the molecular weight or the rigidity of the 
ligand.
14
 Different strategies have been used to increase the molecular weight such as 
attaching a DOTA / DTPA gadolinium complex to a sugar, an antibody, or even to a 
calixarene scaffold.
15-17
         
 To the best of our knowledge there are no examples in the literature of DOTA-
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type ligands with a tethered imidazolium group, such as compound 7.16. Our aim was 
to coordinate compound 7.16 to gadolinium and, after determining the structure of the 
complex, probe the relaxivity. Compound 7.16 is an octadentate ligand that incorporates 
four tertiary nitrogen donors and four carboxylic acid groups. There is also the potential 
to deprotonate the imidazolium in the presence of a base and coordinate through the 
NHC.  Depending on the flexibility of the imidazolium tether, the fourth carboxylate 
donor on the imidazolium group may be too far removed to form an interaction with the 
gadolinium metal ion. Compound 7.16 was dissolved in water and 0.96 equivalents of 
GdCl3.6H2O was added. The pH of the solution was increased to pH 6 by the slow 
addition of NaOH solution (0.1 M) with continuous stirring. The solution was stirred at 
room temperature for 24 hours and the solvent was removed in vacuo to yield a 
colourless oil which was analysed by mass spectrometry. The desired gadolinium 
complex 7.17 was observed in the mass spectrum with m/z 668.2 assigned as [7.17-Br]
+
, 
and m/z 690.1 assigned as [7.17-Br-H+Na]
+
 (Figure 7.7). We propose that the 
carboxylate donor of the imidazolium group does not interact with the gadolinium metal 
ion due to its distance from the metal centre. However, without the aid of a crystal 
structure, this cannot be confirmed.  
 
Figure 7.6  Suggested product from the reaction between compound 7.16 and GdCl3.6H2O. Any bound 
water molecules are omitted.  
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Figure 7.7  Mass spectrometry data of complex 7.17 (top) and calculated for [7.17-Br]
+ 
(bottom).  
We were interested in measuring the relaxation properties of compound 7.17. The 
assumption was made that, as less than one equivalent of GdCl3.6H2O was used in the 
reaction, all the gadolinium in the solution was complexed by the ligand and there was 
no uncoordinated gadolinium. Therefore the amount of gadolinium that had been added 
to the reaction was used to calculate the concentration of gadolinium in the contrast 
agent. Five concentrations of the contrast agent were made up in deionised water in 
standard NMR tubes (50 mM, 25 mM, 16.66 mM, 8.33 mM, 2.5 mM). The T1 
relaxational time of the water molecules was recorded at the different concentrations, 
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using a Maran Benchtop NMR analyser (20 MHz, 0.5 T, 23.8 ± 0.5 °C). Each T1 
measurement was recorded three times and an average of the three results was taken. A 
graph was plotted of 1 / T1 (s
-1
) against concentration (mM), which showed the 
expected linear correlation (Figure 7.8). The gradient of the line was calculated to give a 
relaxivity (r1) = 5.70 mM
-1
 s
-1
 (0.5 T, 23.8 ± 0.5 °C). This result is very promising, as 
the relaxivity of complex 7.17 is larger than the commercially available Gd-DOTA 
contrast agent Dotarem® (r1 = 3.3 mM
-1
 s
-1
 (1.5 T, 37 °C)).11  
 
Figure 7.8  Plot of 1 / T1 (s
-1
) versus concentration (mM) of the gadolinium contrast agent.  
The favourable r1 (r1 = 5.70 mM
-1
 s
-1
 (0.5 T, 23.8 ± 0.5 °C)) of complex 7.17 
demonstrates that it has the potential to be used as a T1 contrast agent. However, these 
results are preliminary and several other factors need to be taken into account. The 
stability of the complex in solution needs to be examined to verify that the ligand 
remains coordinated to the gadolinium metal ion, and that gadolinium is not leached 
into solution. Other properties of the complex should also be examined such as the 
number of exchangeable water molecules. If the fourth carboxylate tether on the 
imidazolium group does not interact with the gadolinium centre then it is likely that the 
complex will have two water molecules coordinating to the gadolinium ion. This may 
account for the relatively high relaxivity that is observed, but may also cause problems 
with the stability of the complex. The number of coordinated water molecules can be 
determined in the solid state by single crystal X-ray crystallography. If single crystals 
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cannot be grown, the number of coordinated water molecules can be determined in 
solution based studies by preparing Eu(III) or Tb(III) analogues of the  complex and 
measuring the luminescence lifetime in H2O and D2O. Comparison of luminescence 
lifetimes can be directly related to the number of coordinated water molecules in the 
inner sphere of a complex.
18
        
 Once these parameters have been measured, the effect of the imidazolium group 
on the ligand can be explored. As discussed previously (Chapter 2 and 3), imidazolium 
units offer the potential to be effective anion receptors due to the strong hydrogen 
bonding interactions they form with anions of the type [(C-H)
+
····X
-
]. At present, 
complex 7.17 incorporates a bromide counter anion, which is a coordinating anion that 
will interact with the C2 imidazolium proton. This [(C-H)
+
····X
-
] interaction may 
influence the geometry of complex 7.17. In the presence of other anions, such as the 
non-coordinating PF6 anion, the geometry of the ligand may be different and this could 
have a direct effect on relaxivity. Therefore, we propose that complex 7.17 could find 
application as an anion sensing contrast agent.    
7.3 Electrochemical synthesis of a copper-NHC complex using the DOTA 
inspired NHC-ligand precursor (7.15)  
Compounds 7.15 and 7.16 may bind metals inside the macrocycle, in addition to having 
the potential to form a metal-NHC complex. The binding of metals inside the 
macrocycle has already been demonstrated through the synthesis of the gadolinium 
complex 7.17. The formation of complex 7.17 requires the use of a base (NaOH), 
however, under aqueous reaction conditions the NHC would not be formed. Therefore, 
under these conditions, the metal is only coordinated to the ligand through the nitrogen 
and oxygen donors of the macrocycle. As an extension of this work, we were keen to 
demonstrate the potential of coordinating these compounds to metals through the 
formation of a metal-NHC bond. Ultimately, this offers the potential to form a 
bimetallic complex which could have some properties associated with the metal inside 
the macrocycle, and other properties due to the metal-NHC moiety.   
 We have found in previous investigations that the formation of metal-NHC 
complexes using imidazolium precursors that are functionalised with acetate ester, or 
acetic acid groups, can be problematic due to other acidic protons associated with these 
functional groups. However, the electrochemical synthetic method has overcome this 
problem when using imidazolium ligands with acetate ester groups. Therefore the 
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electrochemical method was explored using compound 7.15 and copper, and was 
followed as outlined previously (Scheme 7.10). The mixture was electrolysed for 25 
minutes (2 Q), during which time the solution turned bright green. The solvent was 
removed in vacuo to yield a green solid, which was dissolved in DCM and filtered to 
remove the suspended copper particles. The solvent of the filtrate was removed in vacuo 
and compound 7.18 was analysed by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy, mass 
spectroscopy and elemental analysis.  
 
Scheme 7.10  Electrochemical synthesis of complex 7.18.  
Upon examination of the 
1
H NMR spectrum it is evident that an NHC has formed due to 
the disappearance of the resonance attributed to the C2 proton observed at δ = 10.04 
ppm in the imidazolium precursor 7.15 (Figure 7.9). The remainder of the spectrum 
appears as expected, with the backbone imidazolium protons as two separate resonances 
at δ = 7.21 ppm and δ = 7.13 ppm. The singlet resonance at δ = 4.84 ppm is assigned to 
the methylene protons of the acetate tether, and a broad triplet resonance at δ = 4.20 
ppm is attributed to the CH2 group nearest the carbene on the propyl chain. The CH2 
protons on the acetate groups of the macrocycle are at δ = 3.48 ppm. The remaining 
CH2 protons on the macrocycle and on the propyl chain are observed between δ = 2.92 
ppm to δ = 2.14 ppm as broad resonances. Upfield there is one resonance at δ = 1.45 
ppm attributed to the CH3 protons of the tert-butyl groups. The formation of the copper 
carbene was also indicated by 
13
C{
1
H} NMR spectroscopy which displays a low field 
resonance at δ = 177.2 ppm, indicative of a C2 carbon bound to copper.  
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Figure 7.9  
1
H NMR spectrum (MeCN-d3) of complex 7.18 at 298 K.  
The mass spectrometry data is indicative of a mixed valence copper(I) / copper(II) 
complex, with m/z 1024.2 attributed to [7.18-Br]
+
. The formation of a Cu(II) complex is 
also implied by the colour change that was observed during the reaction, with the 
solution turning from colourless to green. In previous work, the electrochemical method 
has produced only copper(I) species, which are stabilised by using acetonitrile as the 
solvent. We suspect that the redox potential of the copper is altered when it is bound 
inside the macrocycle, which may favour further oxidation of copper(I) to copper(II). 
Elemental analysis confirmed the formation of  complex 7.18.   
 The presence of the copper(II) ion was confirmed using EPR spectroscopy. The 
spectrum was recorded as a frozen glass of acetonitrile at 200 K, giving rise to an 
averaged spectrum of all orientations of the molecule. A typical four-line spectrum of 
copper(II) was recorded owing to the selection rule 2nI+1 (s = ½ and I = 3/2), whereby 
the unpaired electron spin interacts with the copper nucleus (Figure 7.10). The hyperfine 
coupling constants of the z-component (Az) is 167 G and is in the range expected for a 
copper(II) nucleus (no hyperfine coupling was observed in the x, y component of this 
spectrum). The Landé splitting energy, the „g factor‟, was calculated using the equation 
displayed in Figure 7.11, giving gz = 2.25 and gxy = 2.08, which are within 
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expectation.
19
 The g values are such that z > x = y, which suggests that the geometry of 
the copper(II) centre is „axial‟, therefore the unpaired electron is in the dx2-y2 or dxy 
orbital.
20
 For copper(II) this is much more likely to be the dx
2
-y
2
 orbital, hence the 
geometry is either square-planar or square-pyramidal.  
 
Figure 7.10  EPR spectrum (MeCN) of compound 7.18 recorded as a frozen glass at 200 K.  
 
 
Figure 7.11  Relationship between Lande g factor and experimental conditions where h equals Planck‟s 
constant, v is the frequency of the instrument, β is the Bohr magneton and B is the experimental position 
of the absorbance peak. 
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7.4 Electrochemical synthesis of a gold complex using the DOTA inspired NHC-
ligand precursor (7.15)  
Gold complexes have been important in therapeutics for a number of years, being used 
to treat conditions such as rheumatoid arthritis. More recently gold complexes, 
including gold-NHCs, have been shown to have potential application as anticancer 
drugs, with some gold(I) and gold(III) complexes displaying good cytotoxicity.
21-23
 As 
discussed in previous chapters, the electrochemical method has the potential to be 
extended for the synthesis of other transition metal-NHC complexes by simply 
substituting the copper anode for the desired transition metal anode. The 
electrochemical method was repeated with compound 7.15, in this instance using a 
copper plate as the cathode, and gold wire as the anode. The mixture was electrolysed 
for 116 minutes, (6 Q). The solution was filtered to remove the suspended gold 
particles, and the solvent was removed in vacuo to yield a dark purple oil. The colour 
was most likely due to the presence of gold nanoparticles that were unable to be 
removed by filtration. The compound was analysed by 
1
H NMR and 
13
C{
1
H} NMR 
spectroscopy, combined with mass spectrometry.  
 
Scheme 7.11  Electrochemical synthesis of complex 7.19 / 7.20.  
Analysis by 
1
H NMR spectroscopy (MeCN-d3, DMSO-d6, CDCl3) was inconclusive, 
with the spectra appearing extremely broad in all cases. A gold mirror formed in the 
NMR tube over time, which may have contributed to the broadness of the spectra. The 
13
C{
1
H} NMR spectrum was complicated, displaying multiple resonances in the 
expected regions, and providing little insight into the complex that had been formed. 
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Mass spectrometry proved to be the most valuable analytical technique, with m/z 
1015.40 with the correct splitting pattern to be assigned as [7.15+Au]
+
. However, there 
are two possibilities as to the structure of the complex: either gold(I) is coordinated to 
the nitrogen atoms inside the macrocycle (complex 7.19) with m/z at 1015.40 being 
assigned as [7.19-Br]
+
, or the gold(I)-NHC complex (complex 7.20) has been 
synthesised, with m/z 1015.40 being assigned as [7.20+H]
+
. Unfortunately, without the 
aid of a crystal structure, the coordination of gold(I) to 7.15 has not yet been 
determined. However, the electrochemical method has proved to be a viable synthetic 
route for the formation of a gold(I) complex using ligand 7.15.    
       
 
Chapter 7. Synthesis of NHC ligand precursors that are inspired by the structural motif 
of DOTA 
  
183 
 
 
 
 
Figure 7.12  Mass spectrum of the product formed in the electrochemical method using compound 7.15 
and gold (top). The expanded spectrum for the dominant peak
 
and calculated for [7.19-Br]
+
 / 
[7.20+H]
+
(bottom).  
Calculated  
Measured  
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7.5 Conclusion  
In conclusion, a synthetic procedure has been successfully developed for the synthesis 
of novel imidazolium-functionalised DOTA-type ligands (compounds 7.15 and 7.16). 
Compound 7.16 was coordinated to gadolinium and the potential of the complex (7.17) 
as a contrast agent was explored by measuring the relaxivity (r1). It was found that 
complex 7.17 has a relaxivity of (r1)  = 5.70 mM
-1
 s
-1
 (0.5 T, 23.8 ± 0.5 °C), which is 
larger than that of the commercially available Gd-DOTA contrast agent Dotarem® (r1 = 
3.3 mM
-1
 s
-1
 (1.5 T, 37 °C)).11       
 The potential for the imidazolium-functionalised DOTA-type ligand to 
coordinate through an NHC in addition to the macrocycle was explored. It was found 
that the electrochemical synthetic approach yielded a mixed valence copper complex 
(7.18), where a copper(II) ion is coordinated inside the macrocycle, in addition to the 
formation of a copper(I)-NHC. The electrochemical method was extended to include 
gold as the sacrificial anode. A gold(I) complex was synthesised using ligand 7.15, 
though the coordination geometry of the gold(I) could not be determined. 
7.6 Future work  
The work described in this Chapter is at an early stage and has the potential to be 
developed further. The use of complex 7.17 as an anion sensing contrast agent should 
be explored, which would involve fully determining the structure and stability of the 
complex, and examining the influence of the imidazolium tether. As imidazolium 
groups offer the potential to be effective anion receptors, the structure of the complex 
may change in the presence of different anions which may have a direct effect on the 
relaxivity (r1). MRI contrast agents have been reported that respond to changes in pH, 
the presence of metal ions, nitric oxide, lactate, glucose, and that detect enzymatic 
activity.
24-29
 As anions are known to play important roles in biological systems, an anion 
sensing contrast agent could prove beneficial.     
 The introduction of the imidazolium functionality into the DOTA scaffold also 
offers the potential to prepare metal-NHC complexes of these ligands.  This has been 
demonstrated in this work through the synthesis of the copper complex 7.18. As an 
extension of this work, a complex could be prepared that has a gadolinium(III) ion 
bound inside the macrocycle (which would include coordination of the carboxylate 
groups) and a transition metal coordinated to the NHC group. This offers the potential 
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to synthesise a therapeutic contrast agent, which could also have anticancer or 
antimicrobial properties associated with the NHC complex.
30-32
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8 Experimental 
8.1 General Considerations  
All manipulations were performed under an atmosphere of dry nitrogen or argon by 
means of standard Schlenk line or glovebox techniques unless otherwise stated. The gas 
was dried by passing through a twin-column drying apparatus containing molecular 
sieves (4Å) and P2O5. Anhydrous solvents were prepared by passing the solvent over 
activated alumina to remove water, copper catalyst to remove oxygen and molecular 
sieves to remove any remaining water, via the Dow-Grubbs solvent system. They were 
then degassed using standard freeze-pump-thaw techniques. Deuterated chloroform, 
acetonitrile and DMSO were dried over CaH2, cannula filtered or distilled, and then 
freeze-pump-thaw degassed before use. Metal precursors, PdCl2(MeCN)2 and 
[RuCl2(cymene)]2 were prepared using literature procedures.
1, 2
 All other reagents and 
solvents were used as supplied by Aldrich or Fisher, or prepared as outlined, without 
need for further purification. DO3AtBu was purchased from CheMatch and used as 
received. Propan-1-ol imidazole was purchased from CHESS and used as received.  
HPLC was performed by Mr Martin Huscroft, School of Chemistry, University of 
Leeds, using Agilent 1260 Prep LC system, with Agilent 1260 prep scale fraction 
collector coupled with agilent 6100 series single quad mass spec and Chemstation 
Software. Solvents used were methanol / water + 0.1 % formic acid, gradient 50-95 % 
methanol + 0.1 % formic acid. The time was 8 minutes at a flow of 20 mL / min. The 
column used was water XBridge Prep C18 5 m OBD 19 × 100 mm.  
8.2 Characterisation 
1
H and 
13
C{
1
H} NMR spectra were recorded either by the author, or by Mr. Simon 
Barrett, School of Chemistry, University of Leeds, using a Bruker DPX300 
spectrometer (operating frequency 300.1 MHz for 
1
H and 75.48 MHz for 
13
C) or on a 
Bruker DRX500 spectrometer (operating frequency 500.13 MHz for 
1
H and 125.03 
MHz for 
13
C{
1
H}). Chemical shift values are quoted in parts per million (ppm, δ) and 
coupling constants J are quoted in Hertz (Hz). Multiplicities are reported as singlet (s), 
doublet (d), triplet (t), quartet (q), quintet (quintet), broad (br) or multiplet (m). 
Attribution of the 
1
H and 
13
C{
1
H} signals was performed using two dimensional 
1
H
1
H 
and 
1
H
13
C correlation techniques.
13
C{
1
H} resonances were also confirmed using 
13
C{
1
H} DEPT experiments.  
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Microanalyses were performed by Mr. Martin Huscroft and Mr. Ian Blakeley, School of 
Chemistry, University of Leeds, using a Carlo Erba Elemental Analyser MOD 1106 
spectrometer.  
Mass spectra were collected by Ms. Tanya Marinko-Covell or Dr. Stuart Warriner, 
School of Chemistry, University of Leeds, either on a Bruker Daltonics (micro T.O.F.) 
instrument operating in the electrospray mode, or a GCT Premier (T.O.F.) instrument 
operating in electron impact mode, using methanol, DMSO, or acetonitrile as the 
solvent. 
X-ray diffraction data were collected by Mr. Colin Kilner or Dr. Marc Little, School of 
Chemistry, University of Leeds, on a Bruker Nonius X8 diffractometer fitted with an 
Apex II detector with Mo-Kα radiation (λ = 0.71073 Å). Crystals were mounted under 
oil on glass fibres. Data sets were corrected for absorption using a multiscan method, 
and the structures were solved by direct methods using SHELXS-97 and refined by full-
matrix least squares on F
2
 using SHELXL-97, interfaced through the program X-Seed.
3, 
4
 Molecular graphics for all structures were generated using POV-RAY in the X-Seed 
program.  
The structure of compound 4.2 and complex 4.6 contained significant void space, and 
residual electron density was too diffuse to adequately model, hence SQUEEZE routine 
of the program PLATON was employed in these cases.
5
  
X-band electron paramagnetic resonance spectra were recorded by Mr. Jonathan 
Loughrey, School of Chemistry, University of Leeds, using a Bruker EMX spectrometer 
(Bruker Biospin GmbH) fitted with a frequency counter. Spectra were recorded and 
viewed using the WINEPR software package (Bruker Analytische Messtechnik GmbH). 
Samples were cooled to 200 K using a continuous-flow cryostat and liquid nitrogen 
coolant.  
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8.3 Experimental for Chapter 2  
8.3.1 4-Hydroxy-tert-butyl calix[4]arene (2.1)6  
4-Tert-butylphenol (25.00 g, 0.166 mmol), formaldehyde 
(18 mL, 0.24 mmol, 37-41 % solution) and sodium 
hydroxide (0.265 g, 0.0066 mmol, 0.040 equiv) were added 
to a round bottomed flask and heated for 7 hours 
maintaining the temperature between 110-120 °C. During 
this time the solution thickened and became a hard yellow 
solid. The solid was broken into pieces and stored in the 
oven at 50 °C (mass of precursor = 27.5 g). The precursor (16.0 g) was suspended in 
diphenyl ether (510 mL) in a three necked round bottom flask that was fitted with a 
mechanical stirrer, a nitrogen inlet and a condenser. During the first phase of the 
reaction the condenser was left off the reaction setup whilst the heat was gradually 
increased and nitrogen was blown rapidly over the mixture to aid the removal of water. 
Once water evolution stopped and the temperature of the solution had reached around 
220 °C, the condenser was put in place and the mixture heated at reflux (257 °C) for 2 
hours under nitrogen. The solution was allowed to cool to room temperature. Ethyl 
acetate (600 mL) was added and the suspension stirred for 30 minutes then left to stand 
for 30 minutes. The precipitate was collected by reduced pressure filtration, washed 
with ethyl acetate (2 × 60 mL) then acetic acid (1 × 80 mL) and collected as a white 
solid (11.80 g) which was a mixture of the 4-tert-butylcalix[4]arene and 4-tert-
butylcalix[8]arene. The white solid was added to toluene (150 mL) and heated at reflux 
(115 °C) for 30 minutes then filtered whilst hot. Upon cooling the 4-tert-
butylcalix[4]arene precipitated from the toluene solution as white crystals and was 
collected by reduced pressure filtration (Yield: 5.60 g, 40 %).  
1
H NMR (500 MHz, CDCl3, 300 K): δ = 10.27 (s, 4H, OH), 6.98 (s, 8H, 1), 4.19 (d, 
3
JH-
H = 13 Hz, 4H, 2), 3.42 (d, 
3
JH-H = 13 Hz, 4H, 2), 1.12 (s, 36H, 3). 
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 147.09 (quaternary, Ar), 144.99 
(quaternary, Ar), 127.87 (CH, Ar), 126.00 (quaternary, Ar), 33.03 (quaternary, 
t
Bu), 
31.81 (CH2), 31.34 (CH3).  
ESI+MS m/z 666.5 [M+NH4]
+ 
EI+HRMS calcd. for C44H60N1O4 [M+NH4]
+
: 666.4517. Found: 666.4538 
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8.3.2  4-Hydroxy calix[4]arene (2.2)7  
4-Hydroxy-tert-butyl calix[4]arene (2.1) (5.00 g, 6.75 mmol) was 
added to a three necked round bottom flask and the reagent and 
apparatus were degassed. Anhydrous toluene (150 mL) was added 
and the mixture heated at 65 °C, with stirring, for 20 minutes. The 
solution was cooled to 55 °C, treated with anhydrous AlCl3 (5.40 g, 
37 mmol) and heated for 2 hours at 55 °C. The mixture was cooled to room temperature 
before being poured into ice (250 g), washed with 1M HCl solution (2 × 250 mL) and 
the organic phase separated. The aqueous phase was washed with dichloromethane (2 × 
150 mL) and the organic layers combined, dried over CaCl2, filtered, and the solvent 
removed in vacuo to yield a yellow oil. This was triturated with diethyl ether (500 mL) 
to yield a white solid (Yield: 1.89 g, 66 %).  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 10.24 (s, 4H, OH), 7.30-6.72 (m, 12H, 1, 3), 
4.32 (br d, 4H, 2), 3.61 (br d, 4H, 2).  
13
C{
1
H} NMR (75 MHz, CDCl3, 300 K): δ = 149.33 (quaternary, Ar), 129.29 
(quaternary, Ar), 128.21 (CH, Ar), 122.86 (CH, Ar), 32.13 (CH2).  
ESI+MS m/z 442.2 [M+NH4]
+
                                                                      
EI+HRMS calcd. for C28H28N1O4 [M+NH4]
+
: 442.2013. Found: 442.2023 
8.3.3  Bromomethylated 4-hydroxy calix[4]arene (2.3)8  
Zn powder (0.115 g, 1.77 mmol) was added to glacial acetic 
acid (62 mL) in a round bottom flask, followed by HBr (33 
% wt in acetic acid, 7.5 mL) and stirred for 30 minutes. 4-
Hydroxy calix[4]arene (2.2) (1.50 g, 3.54 mmol), 
paraformaldehyde (5.6 g, 187 mmol) and HBr solution (37 
mL) were added and the mixture heated at 90 °C for 72 
hours. The solution was allowed to cool before the 
precipitate was collected under reduced pressure filtration, washed with water (2 × 20 
mL) and dried by washing with diethyl ether (2 × 30 mL). The product was collected as 
a white solid (Yield: 2.06 g, 73 %).  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 10.02 (s, 4H, OH), 7.03 (s, 8H, 1), 4.25 (s, 8H, 
3), 4.14 (br d, 4H, 2), 3.16 (br d, 4H, 2).  
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13
C{
1
H} NMR (75 MHz, CDCl3, 300 K): δ = 147.91 (quaternary, Ar), 130.68 
(quaternary, Ar), 128.93 (CH, Ar), 127.26 (quaternary, Ar), 32.25 (CH2), 30.56 (CH2).  
ESI+MS m/z 637.2 [M-2Br+H]
+
                                                                      
8.3.4 Tetrakis(methylimidazole) calix[4]arene (2.4)9, 10 
Bromomethylated-4-hydroxy calix[4]arene (2.3) (2.00 g, 
2.53 mmol) and imidazole (6.88 g, 101.2 mmol) were 
added to a Schlenk flask and the reagents degassed. 
Anhydrous methanol (70 mL) was added and the solution 
heated at 75 °C for 72 hours. The reaction mixture was 
allowed to cool before water (100 mL) was added 
resulting in the formation of a white precipitate. The 
precipitate was collected by reduced pressure filtration, 
washed with water (2 × 50 mL) and dried by washing with diethyl ether (2 × 50 mL). 
The product was collected as an off white solid (Yield: 0.40 g, 21 %).  
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 7.95 (s, 4H, 6), 7.72 (s, 4H, 4 / 5), 7.06 (s, 
4H, 4 / 5), 6.80 (s, 8H, 1), 4.91 (s, 8H, 3), 4.22 (br d, 4H, 2), 3.13 (br d, 4H, 2), OH 
resonance not observed. 
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300K): δ = 154.94 (quaternary, Ar), 137.01 (CH, 
NCN), 130.76 (quaternary, Ar), 127.47 (CH), 126.94 (CH), 126.30 (quaternary, Ar), 
120.38 (CH), 50.28 (CH2), 32.61 (CH2).  
ESI+MS m/z 745.3 [M+H]
+
, 767.3 [M+Na]
+ 
EI+HRMS calcd. for C44H41N8O4 [M+H]
+
: 745.3245. Found: 745.3228 
EI+HRMS calcd. for C44H40N8NaO4 [M+Na]
+
:767.3065. Found: 767.3039 
Anal.calcd. for C44H40N8O4.3H2O: C, 66.15 %; H, 5.80 %; N, 14.03 %. Found: C, 
66.50 %; H, 5.50 %; N, 14.65%.  
Recrystallisation from chloroform resulted in colourless prism crystals suitable for 
single crystal X-ray diffraction analysis.  
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Tetrakis(methylimidazolium) calix[4]arene Br (2.5 Br)
11
  
Bromomethylated-4-hydroxy calix[4]arene (2.3) (1.00 g, 
1.26 mmol) was added to a Schlenk flask and the reagent 
degassed. Anhydrous DCM (50 mL) was added, 
followed by 1-methyl imidazole (0.46 mL, 5.60 mmol). 
The solution was stirred at room temperature for 12 
hours. The product precipitated from solution as a white 
solid that was collected by filtration, washed with DCM 
(3 × 20 mL), and dried in vacuo (Yield: 1.20 g, 84 %).  
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 9.31 (s, 4H, 6), 7.80 (s, 4H, 4 / 5), 7.70 (s, 
4H, 4 / 5), 7.17 (s, 8H, 1), 5.12 (s, 8H, 3), 3.86 (s, 12H, 7), bridging CH2 resonances are 
not observed due to ring inversion at room temperature rendering them broad, OH 
resonance not observed.  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300K): δ = 152.97 (quaternary, Ar), 136.21 (CH, 
NCN), 129.65 (quaternary, Ar), 128.78 (CH), 123.53 (CH), 121.91 (CH), 51.73 (CH2), 
35.64 (CH3).  
ESI+MS m/z 1147.1 [M+Na]
+
, 936.2 [M-2Br-H]
+
, 881.3 [M-3Br-2H]
+ 
Colourless crystals suitable for single crystal X-ray diffraction analysis were grown by 
the vapour diffusion of diethyl ether into a methanol solution of 2.5 Br.  
8.3.5 Tetrakis(methylimidazolium) calix[4]arene PF6 (2.5 PF6)
11
  
Tetrakis(methylimidazolium) calix[4]arene Br (2.5 Br) 
(0.58 g, 5.15 mmol) was dissolved in H2O (10 mL) and a 
H2O solution (10 mL) of NH4PF6 (0.24 g, 1.4 mmol) was 
added dropwise with stirring. The mixture was stirred for 
30 minutes, filtered, and the solid washed with water (3 × 
5 mL) followed by diethyl ether (3 × 5 mL), and dried in 
air. The product was collected as a white solid (Yield: 
0.55 g, 87 %).  
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 9.03 (s, 4H, 6), 7.70 (s, 4H, 4 / 5), 7.67 (s, 
4H, 4 / 5), 7.11 (s, 8H, 1), 5.09 (s, 8H, 3), 3.86 (s, 12H, 7), bridging CH2 resonances are 
not observed due to ring inversion at room temperature rendering them broad, OH 
resonance not observed.  
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1
H NMR (500 MHz, MeCN-d3, 248 K): δ = 8.47 (s, 4H, 6), 7.32 (s, 4H, 4 / 5), 7.26 (s, 
4H, 4 / 5), 7.15 (s, 8H, 1), 5.03 (s, 8H, 3), 4.17 (d, 4H, 
2
JHH = 13.8 Hz, 2), 3.78 (s, 12H, 
7), 3.50 (d, 4H, 
2
JHH = 13.8 Hz, 2). 
 
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300K): δ = 152.14 (quaternary, Ar), 136.14 (CH, 
NCN), 129.36 (quaternary, Ar), 128.83 (CH), 123.84 (CH), 122.11 (CH), 51.77 (CH2), 
38.96 (CH3).  
ESI+MS m/z 1239.3 [M-PF]
+ 
EI+HRMS calcd. for C48H52F18N8O4P3 [M-PF6]
+
: 1239.3031. Found: 1239.3047 
Anal.calcd. for C48H52F24N8O4P4.2H2O: C, 40.57 %; H, 3.88 %; N, 7.99 %. Found: C, 
40.95 %; H, 3.85 %; N, 7.80 %.  
8.3.6 1H NMR spectroscopic titration experiments  
1
H NMR spectroscopic titration experiments were carried out by the author using a 
Bruker DPX300 spectrometer running at 300.1 MHz at room temperature. All chemical 
shifts are reported in ppm. A specific concentration of host, typically 15-23 mM, was 
made up in a single NMR tube in DMSO-d6 (0.8 mL). The anions as their 
tetrabutylammonium salts, were made up to 1 mL, 10 times the concentration of the 
host, with DMSO-d6. 20 µL aliquots of the guest were added to the NMR tube and the 
spectra recorded after each addition. 
8.4 Experimental for Chapter 3  
8.4.1 Mesityl calix[4]arene (3.1)12  
α-Chloroisodurene (5.00 g, 29.6 mmol) was dissolved in anhydrous 
dichloromethane (60 mL) in a round bottom flask. Tin chloride (1M 
in DCM, 6 mL, 6 mmol) was added resulting in a red solution and the 
slow formation of a precipitate. The mixture was heated at reflux (40 
°C) for two hours then allowed to cool to room temperature before 
water (60 mL) was added and the mixture stirred for 30 minutes. The dichloromethane 
layer containing a precipitate was extracted. The water layer was washed with 
dichloromethane (3 x 15 mL) and the dichloromethane layers combined. The solvent 
was removed in vacuo to yield a cream solid (4.85 g, 40 %).  
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 6.72 (s, 4H, 1), 3.81 (s, 8H, 2), 2.26 (s, 
24H, 3), 1.12 (s, 12H, 4). 
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13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 137.64 (quaternary, Ar), 135.91 
(quaternary, Ar), 133.25 (quaternary, Ar), 130.34 (CH, Ar), 31.92 (CH2), 21.45 (CH3), 
17.98 (CH3). 
ESI+MS m/z 551.4 [M+Na]
+ 
EI+HRMS calcd. for C40H48Na [M+Na]
+
: 551.3648. Found: 551.3663  
8.4.2 Bromomethylated mesityl calix[4]arene (3.2)8 
Zinc powder (0.18 g, 2.85 mmol) was added to glacial acetic 
acid (100 mL) in a round bottom flask, followed by HBr (33 
% wt in acetic acid, 12 mL) and stirred for 30 minutes. 
Mesityl calix[4]arene (3.1) (3.00 g, 5.67 mmol), 
paraformaldehyde (9.00 g, 3 mmol) and HBr solution (60 mL) 
were added and the mixture heated at 90 °C for 72 hours. The 
solvent was removed in vacuo to yield a white solid that was washed with water (3 x 10 
mL) followed by diethyl ether (3 x 10mL) and dried in vacuo (Yield: 5.0 g, 97 %). 
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 4.56 (s, 8H, 5), 3.90 (s, 8H, 2), 2.36 (s, 
24H, 3), 1.01 (s, 12H, 4).  
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 138.47 (quaternary, Ar), 137.03 
(quaternary, Ar), 133.67 (quaternary, Ar), 132.32 (quaternary, Ar), 33.44 (CH2), 33.29 
(CH2), 19.08 (CH3), 17.07 (CH3). 
8.4.3 Methyl-imidazole mesityl calix[4]arene (3.3)9, 13  
Bromomethylated-mesityl calix[4]arene (3.2) (1.50 g, 1.67 
mmol) and imidazole (4.60 g,  66.9 mmol) were added to a 
Schlenk flask and the reagents degassed. Anhydrous 
methanol was added (50 mL) and the reaction heated at 
reflux (75 °C) for 72 hours. The solution was allowed to 
cool and the solvent was removed in vacuo. The product 
was extracted into chloroform (3 × 30 mL) from water (50 mL) and the chloroform 
layer washed with water (50 mL). The solvent was removed in vacuo to yield a cream 
solid (0.43 g, 30 %). 
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 7.47 (s, 4H, 8), 6.96 (s, 4H, 6 / 7), 6.81 (s, 
4H, 6 / 7), 5.32 (s, 8H, 5), 4.06 (s, 8H, 2), 2.38 (s, 24H, 3), 1.19 (s, 12H, 4).  
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13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ = 137.89 (quaternary, Ar), 136.43 (CH, 
Im), 135.41 (quaternary, Ar), 133.13 (quaternary, Ar), 129.66 (quaternary, Ar), 128.30 
(CH, Im), 118.39 (CH, Im), 45.80 (CH2), 32.66 (CH2), 17.88 (CH3) 16.86 (CH3). 
ESI+MS m/z 425.3 [M+2H]
2+
, 849.5 [M+H]
+  
EI+HRMS calcd. for C56H66N8 [M+2H]
2+
: 425.2700. Found: 425.2699  
8.4.4 Propanol-tethered methyl-imidazolium mesityl calix[4]arene Br (3.4 Br)  
Bromomethylated mesityl calix[4]arene (3.2) (0.20 g, 
0.22 mmol) was added to a Schlenk flask and the 
reagent degassed. Anhydrous DCM (10 mL) was 
added followed by a DCM solution (2 mL) of 1-(3-
hydroxypropyl)-1H-imidazole (0.12 g, 0.94 mmol). 
The resultant solution was stirred at room 
temperature for 48 hours, during which time the 
product precipitated from solution as a white solid. 
The solution was filtered and the solid was washed with DCM (3 × 5 mL) and dried in 
vacuo (Yield: 0.25 g, 81 %).  
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.93 (s, 4H, 8), 7.83 (s, 4H, 6 / 7), 7.46 (s, 
4H, 6 / 7), 5.53 (s, 8H, 5), 4.70 (t, 4H, 
3
JHH = 6.5 Hz, OH), 4.24 (t, 8H, 
3
JHH  = 6.5 Hz, 
9), 4.02 (s, 8H, 2), 3.38 (q, 8H,
 3
JHH = 6.5 Hz, 11), 2.34 (s, 24H, 3), 1.92 (quintet, 8H, 
3
JHH = 6.5 Hz, 10), 1.12 (s, 12H, 4).  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ = 138.62 (quaternary, Ar), 136.88 ( 
quaternary, Ar), 136.04 (CH, Im), 134.42, (quaternary, Ar) 129.97 (quaternary, Ar), 
123.24 (CH, Im), 122.35 (CH, Im), 57.64 (CH2), 55.41 (CH2), 49.20 (CH2), 46.98 
(CH2), 32.74 (CH2), 18.86 (CH3), 17.61 (CH3).  
ESI+MS m/z 1325.5 [M-Br]
+
 
EI+HRMS calcd. for C68H92N8O4Br3 [M-Br]
+
: 1325.4766. Found: 1325.4764 
Anal.cald. for C68H92Br4N8O4.CH2Cl2: C, 55.62 %, H, 6.39 %, N, 7.52 %. Found: C, 
55.20 %, H, 6.70 %, N, 7.20 %. 
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8.4.5 Propanol-tethered methyl-imidazolium mesityl calix[4]arene PF6 (3.4 PF6)  
Propanol-tethered methyl-imidazolium mesityl 
calix[4]arene Br (3.4 Br) (0.20 g, 0.14 mmol) was 
dissolved in methanol (10 mL) and a methanol 
solution (10 mL) of NH4PF6 (0.24 g, 1.4 mmol) was 
added to the solution dropwise with stirring. The 
mixture was stirred for 30 minutes then filtered to 
isolate the solid. The solid was washed with 
methanol (3 × 5 mL) and dried in air. The product 
was collected as a white solid (Yield: 0.15 g, 63 %).  
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.83 (s, 4H, 8), 7.78 (s, 4H, 6 / 7), 7.45 (s, 
4H, 6 / 7), 5.49 (s, 8H, 5), 4.69 (br, 4H, OH), 4.24 (t, 8H, 
3
JHH = 6.3 Hz, 9), 4.02 (s, 8H, 
2), 3.34 (br, 8H, 11), 2.34 (s, 24H, 3), 1.90 (quintet, 8H, 
3
JHH = 6.3 Hz, 10), 1.13 (s, 
12H, 4).  
13
C{
1
H} NMR (125 MHz DMSO-d6, 300 K): δ = 138.48 (quaternary, Ar), 136.77 
(quaternary, Ar), 135.87 (CH, Im), 134.25 (quaternary, Ar), 127.75 (quaternary, Ar), 
123.12 (CH, Im), 122.22 (CH, Im), 57.54 (CH2), 48.99 (CH2), 46.87 (CH2), 33.31 
(CH2), 32.70 (CH2), 18.71 (CH3), 17.61 (CH3).  
ESI+MS m/z 1519.62 [M-PF6]
+
; 687.3 [M-2PF6]
2+ 
EI+HRMS calcd. for C68H92N8O4F18P3 [M-PF6]
+
: 1519.6161. Found: 1519.6136 
Anal.cald. for C68H92F24N8O4P4: C, 49.04 %; H, 5.57 %; N, 6.73 %. Found: C, 49.35 
%, H, 5.65 %, N, 6.55 %. 
Colourless crystals of 3.4 3Cl.PF6 and 3.4 4Br suitable for single crystal X-ray 
diffraction were grown by slow evaporation of saturated acetonitrile solutions of 
compound 3.4 PF6 with four equivalents NBu4
+
 X
- 
(where X = Cl or Br).  
8.4.6 1H NMR spectroscopic titration experiment  
The 
1
H NMR spectroscopic titration experiments were carried out by the author using a 
Bruker DPX300 spectrometer running at 300.1 MHz, at room temperature. The 
chemical shifts are reported in ppm. Compound 3.4 PF6 (0.01 g, 6.02 × 10
-6
 moles) was 
made up in a single NMR tube in MeCN-d3 (0.5 mL). Tetrabutylammonium bromide 
(0.00234 g, 7.25 × 10
-5
 moles) was dissolved in MeCN-d3 (1 mL), approximately 10 
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times the concentration of the host. 10 µL aliquots of the guest were added to the NMR 
tube and the spectra recorded after each addition. 
8.4.7 Reaction of compound 3.4 Br with Ag2O in methanol  
Propanol-tethered methyl-imidazolium mesityl calix[4]arene Br (3.4 Br) (0.45 g, 0.32 
mmol) was added to a Schlenk flask containing 3Å molecular sieves and the reagent 
was degassed. Anhydrous methanol was added (25 mL) followed by Ag2O (0.09 g, 0.38 
mmol). The resultant suspension was stirred at room temperature, in the dark, for 2 
hours. The mixture was filtered through celite and the solvent removed in vacuo to yield 
an off white solid (0.15 g).  
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 7.80 (s, 4H, CH), 7.44 (s, 4H, CH), 5.50 (s, 
8H, CH2), 4.21 (m, 8H, CH2), 4.01 (s, 8H, CH2), 3.38 (m, 8H, CH2), 2.34 (s, 24H, 
CH3), 1.91 (m, 8H, CH2), 1.12 (s, 12H, CH3).  
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 138.47 (quaternary), 136.88 
(quaternary), 134.27 (quaternary), 123.08 (CH), 122.16 (CH), 57.46 (CH2), 48.93 
(CH2), 46.82 (CH2), 33.30 (CH2), 32.76 (CH2), 18.68 (CH3), 17.52 (CH3).  
8.4.8 Reaction of compound 3.4 Br with Ag2O in THF / methanol (1:1) 
Propanol-tethered methyl-imidazolium mesityl calix[4]arene Br (3.4 Br) (0.45 g, 0.32 
mmol) was added to a Schlenk flask that contained 3Å molecular sieves and the reagent 
was degassed. Anhydrous THF was added (15 mL) followed by anhydrous methanol 
dropwise (approximately 5 mL) until the compound was dissolved in solution. Ag2O 
(0.09 g, 0.38 mmol) was added and the resultant suspension was stirred at room 
temperature, in the dark, for 12 hours. The mixture was filtered through celite and the 
solvent removed in vacuo to yield a yellow film (0.20 g).  
1
H NMR (500 MHz, MeOD-d4, 300 K): δ = 7.61 (s, 4H, CH), 7.27 (s, 4H, CH), 5.50 (s, 
8H, CH2), 4.24 (t, 8H, 
2
JHH= 7 Hz, CH2), 4.04 (s, 8H, CH2), 3.46 (m, 8H, CH2), 2.32 (s, 
24H, CH3), 1.96 (m, 8H, CH2), 1.51 (s, 12H, CH3).  
13
C{
1
H} NMR (125 MHz, MeOD-d4, 300 K): δ = 182.39 (quaternary), 138.47 
(quaternary), 136.88 (quaternary), 134.27 (quaternary), 129.04 (quaternary), 123.08 
(CH), 122.16 (CH), 57.46 (CH2), 48.93 (CH2), 46.82 (CH2), 33.30 (CH2), 32.76 (CH2), 
18.68 (CH3), 17.52 (CH3).  
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8.4.9 Reaction of 3.4 Br with Cu2O  
Propanol-tethered methyl-imidazolium mesityl calix[4]arene Br (3.4 Br) (0.69 g, 0.5 
mmol) and Cu2O (0.42, 3 mmol) were added a Schlenk flask containing 3Å molecular 
sieves, and the reagents were degassed. Anhydrous acetonitrile (20 mL) was added and 
the suspension heated at 90 °C for 120 hours, under an atmosphere of argon. The 
solvent was removed in vacuo to yield a red solid. The product was dissolved in 
anhydrous acetone, filtered, and the solvent removed in vacuo to yield a pale yellow 
solid (Yield: 0.01 g), which was found to be a mixture of copper-NHC complexes.  
1
H NMR (300 MHz, acetone-d6, 300 K): δ = 8.79 (s, CH), 7.83 (s, CH), 7.55 (s, CH), 
7.35 (s, CH), 7.04 (s, CH), 7.02 (s, CH), 6.13 (s, CH2), 5.77 (s, CH2), 5.47 (s, CH2), 
4.45 (t, CH2), 4.26 (br, CH2), 4.14 (br, CH2), 3.6 (br, CH2), 2.49 (br, CH3), 2.47 (br, 
CH3), 2.42 (s, CH3), 1.85 (m, CH2), 1.24-1.29 (br, CH3).  
ESI+MS m/z 1678.1 [3.4-4H+4Cu+Na]
+
; 1593.2 [3.4-3H+3Cu-Br+2MeCN]
+
; 1449.3 
[3.4-2H+2Cu-Br]
+
; 1385.4 [3.4-H+Cu-Br]
+
 
8.5 Experimental for Chapter 4 
8.5.1 1-Tert-butylacetate imidazole (4.1)14 
To a solution of imidazole (1.00 g, 14.7 mmol) in ethyl acetate (16 
mL) in a round bottom flask was added powered potassium 
carbonate (2.80 g, 20.5 mmol) and the mixture was heated to reflux 
(76 °C). Tert-butyl chloroacetate (2.1 mL, 14.7 mmol) dissolved in ethyl acetate (5 mL) 
was added dropwise to the refluxing solution. The reaction was heated at reflux (76 °C) 
for 12 hours. The reaction was allowed to cool and then quenched with cold water (10 
mL). The ethyl acetate layer was separated and the aqueous layer washed with ethyl 
acetate (2 × 10 mL). The ethyl acetate layers were combined, washed with brine (20 
mL), and dried over sodium sulphate. The solution was filtered, and the filtrate was 
removed in vacuo to yield a yellow solid. The solid was stirred with hexane (5 mL) at 
room temperature for one hour, filtered, and the solid washed further with hexane (2 × 2 
mL) to afford the target compound (Yield: 1.02 g, 55 %). The product was purified by 
column chromatography (10 % MeOH / chloroform, I2 active by TLC). 
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 7.40 (s, 1H, 1), 6.98 (s, 1H, 2 / 3), 6.87 (s, 
1H, 2 / 3), 4.52 (s, 2H, 4) 1.39 (s, 9H, 5).  
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13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 166.3 (quaternary, COO
t
Bu,), 138.7 
(CH), 129.8 (CH), 120.3 (CH), 83.4 (quaternary, 
t
Bu,), 49.5 (CH2), 28.3 (CH3).  
ESI+MS m/z 183.1 [M+H]
+ 
EI+HRMS calcd. for C9H15N2O2 [M+H]
+
: 183.1128. Found: 183.1136. 
Anal.cald. for C9H15N2O2: C, 59.32 %; H, 7.74 %; N, 15.37 %. Found: C, 59.25 %, H, 
7.80 %, N, 15.45 %. 
8.5.2 Acetate-tethered methyl-imidazolium-mesityl calix[4]arene Br (4.2 Br)   
Bromomethylated mesityl calix[4]arene (3.3) (0.30 g, 
0.33 mmol) was added to Schlenk flask and the 
reagent was degassed. Anhydrous THF was added (10 
mL) followed by a THF solution (10 mL) of 3-(tert-
butyl)-acetic acid imidazole (4.1) (0.26 g, 1.4 mmol). 
The resultant solution was stirred at room temperature 
for 48 hours. The product precipitated from solution 
as a white solid that was collected by filtration, 
washed with anhydrous THF (2 × 5 mL), and dried in 
vacuo (Yield: 0.25 g, 46 %). 
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.92 (s, 4H, 8), 7.81 (s, 4H, 6 / 7), 7.57 (s, 
4H, 6 / 7), 5.62 (s, 8H, 5), 5.13 (s, 8H, 9), 4.01 (s, 8H, 2), 2.34 (s, 24H, 3), 1.43 (s, 36H, 
10), 1.14 (s, 12H, 4).  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ = 166.08 (quaternary, COO
t
Bu), 138.49 
(quaternary, Ar), 136.91 (CH, Im), 136.83 (quaternary, Ar), 134.83 (quaternary, Ar), 
127.83 (quaternary, Ar), 124.42 (CH, Im), 121.97 (CH, Im), 93.34 (quaternary, 
t
Bu), 
50.13 (CH2), 48.90 (CH2), 32.91 (CH2), 28.01 (CH3), 18.73 (CH3), 17.53 (CH3).  
ESI+MS m/z 734.4 [M-2Br]
2+ 
EI+HRMS calcd. for C80H110N8O8Br2 [M-2Br]
+
: 734.3401. Found: 734.3382. 
Colourless crystals suitable for single crystal X-ray diffraction analysis were grown by 
slow diffusion of ethyl acetate into a DMSO solution of compound 4.2 Br.  
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8.5.3 Acetate-tethered methyl-imidazolium-mesityl calix[4]arene PF6 (4.2 PF6)  
Acetate-tethered methyl-imidazolium-mesityl 
calix[4]arene bromide (4.2 Br) (0.2 g, 0.14 mmol) 
was dissolved in methanol (10 mL) and a methanol 
solution (10 mL) of NH4PF6 (0.24 g, 1.4 mmol) was 
added to the solution dropwise with stirring. The 
mixture was stirred for 30 minutes then filtered to 
isolate the solid. The solid was washed with methanol 
(3 × 5 mL) and dried in air. The product was 
collected as a white solid (Yield: 0.15 g, 63 %). 
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.80 (s, 4H, 8), 7.73 (s, 4H, 6 / 7), 7.49 (s, 
4H, 6 / 7), 5.55 (s, 8H, 5), 5.07 (s, 8H, 9), 4.02 (s, 8H, 2), 2.34 (s, 24H, 3), 1.45 (s, 36H, 
10), 1.12 (s, 12H, 4).  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ = 165.76 (quaternary, COO
t
Bu), 138.09 
(quaternary, Ar), 136.56 (CH, Im), 136.44 (quaternary, Ar), 133.91 (quaternary, Ar), 
127.37 (quaternary, Ar), 124.07 (CH, Im), 121.64 (CH, Im), 82.98 (quaternary,
 t
Bu), 
50.07 (CH2), 48.87 (CH2), 32.87 (CH2), 27.72 (CH3), 18.73 (CH3), 17.53 (CH3).  
 ESI+MS m/z 1744.7 [M-PF6]
+
; 799.4 [M-2PF6]
2+ 
EI+HRMS calcd. for C80H108N8O8P3F18 [M-PF6]
+
: 1744.6543. Found: 1744.7286. 
Anal.cald. for C80H108F24N8O8P4: C, 50.85 %; H, 5.76 %; N, 5.93 %. Found: C, 49.90 
%; H, 5.60 %; N, 5.65 %.  
8.5.4 Acetic acid- tethered methyl-imidazolium-mesityl calix[4]arene Br (4.3 Br)  
A HCl solution (37 %, 4 mL, 50 mmol) of acetate 
tethered mesityl calix[4]arene Br (4.2 Br) (1.00 g, 
0.62 mmol) was heated at reflux (110 °C) for one 
hour. The solution was cooled to room temperature 
and the solvent removed in vacuo. The resultant solid 
was washed with acetone (2 × 10 mL), followed by 
diethyl ether (2 × 10 mL) and dried in vacuo to yield 
a crystalline yellow solid (0.71 g, 71 %).  
Chapter 8. Experimental 
  
201 
 
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.87 (s, 4H, 8), 7.79 (s, 4H, 6 / 7), 7.57 (s, 
4H, 6 / 7), 5.80 (s, 8H, 5), 5.13 (s, 8H, 9), 4.01 (s, 8H, 2), 2.35 (s, 24H, 3), 1.12 (s, 12H, 
4).  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ= 166.08 (quaternary, COOH), 138.30 
(quaternary, Ar), 136.52 (CH, Im), 136.44 (quaternary, Ar), 133.93 (quaternary, Ar), 
127.46 (quaternary, Ar), 124.07 (CH, Im), 121.56 (CH, Im), 49.80 (CH2), 48.88 (CH2), 
32.87 (CH2), 18.33 (CH3), 17.14 (CH3).  
ESI+MS m/z 1081.5 [M-4Br-3H]
+ 
EI+HRMS calcd. for C64H73N8O8 [M-4Br-3H]
+
: 1081.5551. Found: 1081.5513 
Anal.cald. for C64H76N8O8Br4.H2O: C, 54.02 %; H, 5.53 %; N, 7.87 %. Found: C, 54.50 
%, H, 5.80 %, N, 7.25 %.  
8.5.5 Acetic acid-tethered methyl-imidazolium-mesityl calix[4]arene PF6 (4.3 PF6) 
Acetic acid-tethered methyl-imidazolium-mesityl 
calix[4]arene Br (4.3 Br) (0.20 g, 0.14 mmol) was 
dissolved in methanol (10 mL) and a methanol 
solution (10 mL) of NH4PF6 (0.24 g, 1.4 mmol) was 
added to the solution dropwise with stirring. The 
mixture was stirred for 30 minutes then filtered to 
isolate the solid. The solid was washed with methanol 
(3 × 5 mL) and dried in air. The product was 
collected as a white solid (Yield: 0.16 g, 68 %).  
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.71 (s, 4H, 8), 7.69 (s, 4H, 6 / 7), 7.45 (s, 
4H, 6 / 7), 5.54 (s, 8H, 5), 4.87 (s, 8H, 9), 4.02 (s, 8H, 2), 2.35 (s, 24H, 3), 1.13 (s, 12H, 
4).  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ = 167.46 (quaternary, COOH), 138.11 
(quaternary, Ar), 136.45 (CH, Im), 136.24 (quaternary, Ar), 133.90 (quaternary, Ar), 
127.43 (quaternary, Ar), 124.04 (CH, Im), 121.21 (CH, Im), 50.75 (CH2), 48.69 (CH2), 
32.89 (CH2), 18.30 (CH3), 17.05 (CH3).  
ESI+MS m/z 1227.53 [M-2PF6-2H]
+
; 1373.51 [M-2PF6-H]
+ 
EI+HRMS calcd. for C64H75N8O8P2F12 [M-2PF6-H]
+
: 1373.4991. Found: 1373.5125 
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8.5.6 1-Methyl-3-tert-butylacetate imidazolium chloride (4.4) 
1-Methylimidazole (1.60 mL, 20 mmol) and tert-butyl 2-
chloroacetate (2.90 mL, 20 mmol) were added to a Schlenk 
flask. The mixture was stirred at room temperature for 18 hours 
during which time the mixture solidified. The target compound was recrystallised from 
DCM / hexane as a white solid, which was washed with diethyl ether (2 × 10 mL) and 
dried in vacuo (Yield: 3.59 g, 77 %). 
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 9.31 (s, 1H, 1), 7.78 (s, 2H, 2, 3), 5.22 (s, 
2H, 4), 3.91 (s, 3H, 6), 1.44 (s, 9H, 5).  
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 165.80 (quaternary, COO
t
Bu,), 137.70 
(CH), 123.60 (CH), 123.10 (CH), 82.90 (quaternary, 
t
Bu), 49.50 (CH2), 35.70 (CH3), 
27.60 (CH3).  
ESI+MS m/z 197.1 [M-Cl]
+ 
EI+HRMS calcd. for C10H17N2O2 [M–Cl]
+
: 197.1285. Found: 197.1307. 
8.5.7 Copper(I)-(1-methyl-3-tert-butlyacetate)-N-heterocyclic carbene Cl (4.5)15 
1-Methyl-3-tert-butylacetate imidazolium chloride (4.4) (0.23 g, 1 
mmol) was added to a three-necked round-bottomed flask. 
Anhydrous MeCN (15 mL) was added and the copper electrodes 
(1 x 3 cm
2
) were inserted in to the reaction mixture. The mixture 
was electrolysed at 50 mA for 50 minutes (2Q), under an atmosphere of argon. The 
mixture was filtered, and the solvent was removed in vacuo, to yield an off white solid 
(Yield: 0.14 g, 48 %).  
1
H NMR (500 MHz, CDCl3, 300 K): δ = 6.98 (s, 1H, 2 / 3), 6.93 (s, 1H, 2 / 3), 4.78 (s, 
2H, 4), 3.81 (s, 3H, 6), 1.45 (s, 9H, 5).  
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 178.00 (quaternary, Cu-C), 166.47 
(quaternary, COO
t
Bu), 122.02 (CH), 83.72 (quaternary, 
t
Bu), 52.60 (CH2), 38.29 (CH3), 
28.00 (CH3). 
ESI+MS m/z 300.1 [M-Cl+MeCN]
+ 
EI+HRMS calcd. for C12H19CuN3O2 [M–Cl+MeCN]
+
: 300.0768. Found: 300.0761. 
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Anal.cald. for C10H19CuN3O2.1/3DCM: C, 38.36 %; H, 5.19 %; N, 8.66 %. Found: C, 
38.40 %, H, 5.15 %; N, 8.70 %.  
8.5.8 Tetrakis-(p-copper(I)-N-heterocyclic carbene) mesityl calix[4]arene (4.6) 
Acetate-tethered methyl-imidazolium-mesityl 
calix[4]arene Br (4.2) (0.81 g, 0.5 mmol) was 
added to a three-necked round-bottomed flask. 
Anhydrous MeCN (15 mL) was added and the 
copper electrodes (1 × 3 mL) were inserted into 
the reaction mixture. The potential was adjusted 
so that a current of 10 mA was maintained. The 
mixture was electrolysed for 1920 minutes (6 Q) 
under an atmosphere of argon, filtered, and the 
solvent removed in vacuo to yield a pale yellow 
solid (Yield: 0.2 g, 21 %).  
1
H NMR (300 MHz, MeCN-d3, 300 K): δ = 7.08 (s, 4H, 1 / 2), 6.69 (s, 4H, 1 / 2), 5.37 
(s, 8H, 3), 4.79 (s, 8H, 4), 4.03 (s, 8H, 5), 2.34 (s, 24H, 6), 1.44 (s, 36H, 7), 1.18 (s, 
12H, 8).  
13
C{
1
H} NMR (75 MHz, CDCl3, 300K): δ = 178.65 (quaternary, Cu-C), 166.57 
(quaternary, COO
t
Bu), 138.84 (quaternary, Ar), 137.21 (quaternary, Ar), 133.80 
(quaternary, Ar), 128.13 (quaternary, Ar), 121.58 (CH), 119.72 (CH), 83.74 
(quaternary, 
t
Bu), 67.98 (CH2),  65.85 (CH2), 53.08 (CH2), 50.88 (CH2), 33.42 (CH2), 
28.09 (CH3), 25.62 (CH2), 18.68 (CH3), 17.69 (CH3).  
ESI+MS m/z 1879.2 [M+H]
+
  
EI+HRMS calcd. for C80H104Cu4N8O8Br4 [M+H]
+
: 1879.1929. Found: 1879.0310. 
Anal. Calcd. for C80H105Br4Cu4N8O8.2CH2Cl2: C, 48.56; H, 5.43; N, 5.39. Found: C, 
48.30; H, 5.40; N, 5.25.  
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8.5.9 Tetrakis-p-(palladium(II)-N-heterocyclic carbene) mesityl calix[4]arene (4.7) 
Tetrakis-(p-copper(I)-N-heterocyclic 
carbene) mesityl calix[4]arene (4.6) (1.00 g, 
0.5 mmol) was added to a Schlenk flask. 
KBr (1.20 g, 20 mmol) was added followed 
by anhydrous DCM (5 mL). PdCl2(MeCN)2 
(0.55 g, 2.15 mmol) was added to the 
reaction and the mixture was stirred at room 
temperature for 12 hours. The solvent was 
removed in vacuo before acetonitrile (20 
mL) was added to dissolve the product. The 
mixture was filtered through a celite plug and the solvent reduced in vacuo (5 mL). 
Diethyl ether (5 mL) was added to precipitate the product as a yellow solid that was 
collected by gravity filtration and dried by washing with diethyl ether (2 × 10 mL). The 
product was purified by the filtration of an acetonitrile solution of 4.7 through a silica 
plug. The solvent was removed in vacuo to yield a red solid (0.59 g, 47 %).  
1
H NMR (300 MHz, CD3CN, 300 K): δ = 7.11 (s, 4H, 1 / 2), 6.14 (s, 4H, 1 / 2), 5.60 (s, 
8H, 3), 5.20 (s, 8H, 4), 4.05 (s, 8H, 5), 2.30 (s, 24H, 6), 1.46 (s, 36H, 7), 1.24 (s, 12H, 
8).  
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 167.26 (quaternary, COO
t
Bu), 147.31 
(quaternary, Pd-C), 139.86 (quaternary, Ar), 138.10 (quaternary, Ar), 135.74 ( 
quaternary, Ar), 129.32 (quaternary, Ar), 124.60 (CH), 120.76 (CH), 83.73 (quaternary, 
t
Bu), 53.74 (CH2), 52.65 (CH2), 34.02 (CH2), 28.51 (CH3), 19.25 (CH3), 18.28 (CH3). 
ESI+MS m/z 992.8 [M-4
t
Bu-2Br]
2+ 
EI+HRMS calcd. for C64H72Br6N8O8Pd4 [M-4
t
Bu-2Br]
2+
: 992.8344; Found: 992.8370. 
Anal. Calcd. for: C80H104Br8N8O8Pd4: C, 40.53; H, 4.42; N; 4.73. Found: C, 38.25, H, 
4.30, N, 4.75.  
Yellow plate crystals suitable for single crystal X-ray diffraction analysis were grown 
by slow diffusion of pentane into an acetonitrile solution of compound 4.7. 
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8.5.10 Tetrakis-p-(rhodium(I)-N-heterocyclic carbene) mesityl calix[4]arene (4.8) 
Tetrakis-(p-copper(I)-N-heterocyclic carbene) mesityl calix[4]arene (4.6) (0.08 g, 0.042 
mmol) was added to a small ampoule followed by KBr (0.04 g, 0.42 mmol) and 
anhydrous chloroform (1 mL). [Rh(COD)Cl]2 (0.042 g, 0.084 mmol) was added and the 
mixture stirred at room temperature for 12 hours. The solution was filtered and the 
solvent removed in vacuo to yield the target complex as a yellow solid (Yield: 0.06 g, 
61 %). The 
1
H NMR and 
13
C{
1
H} NMR spectra were too complicated to be fully 
assigned.  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 6.79 (CH), 6.14 (CH), 5.87 (CH2), 5.63 
(CH2), 5.42 (CH2), 5.05 (CH2), 4.64 (CH2), 4.58 (CH2), 4.22 (CH2), 3.98 (CH2), 2.30 
(CH3), 1.93 (CH3), 1.15 (CH3).  
13
C{
1
H} NMR (75 MHz, CDCl3, 300 K): δ = 182.15 (quaternary, Rh-C, d, 2J
13
C-Rh = 
50.1 Hz), 167.30 (quaternary, COO
t
Bu,), 137.41 (quaternary, Ar), 135.57 (quaternary, 
Ar), 133.02 (quaternary, Ar), 127.89 (quaternary, Ar), 120.22 (CH), 118.55 (CH), 98.01 
(quaternary, 
t
Bu), 97.64 (quaternary, 
t
Bu), 81.96 (CH2), 77.84 (CH2), 68.14 (CH2), 
66.95 (CH2), 64.82 (CH2), 52.43 (CH2), 52.02 (CH2), 49.56 (CH2), 31.95 (CH2), 29.88 
(CH2), 27.95 (CH2), 17.75 (CH3), 16.70 (CH3).  
ESI+MS m/z 1154.8 [M-2Br]
2+
; 2389.4 [M-Br]
+ 
EI+HRMS Calcd. for C112H152Br3N8O8Rh4 [M-Br]
+
: 2389.5464; Found: 2389.4319.  
EI+HRMS Calcd. for C112H152Br2N8O8Rh4 [M-2Br]
2+
: 1154.8166; Found: 1154.8408.  
8.5.11 1-Methyl-3-acetic acid imidazolium chloride (4.9) 
A HCl solution (37 %, 2 mL, 22 mmol) of 1-methyl-2-tert-
butylacetate imidazolium chloride (4.4) (3.90 g, 20 mmol) was 
heated at reflux (110 °C) for one hour. The solution was allowed 
to cool to room temperature and the solvent was removed in vacuo. The resultant solid 
was washed with acetone (2 × 10 mL), followed by diethyl ether (2 × 10 mL), and dried 
in vacuo to yield an off white solid (2.30 g, 82 %).  
1
H NMR (500 MHz, DMSO-d6, 300 K): δ = 9.33 (s, 1H, 1), 7.80 (s, 1H, 2 / 3), 7.78 (s, 
1H, 2 / 3), 5.24 (s, 2H, 4), 3.93 (s, 3H, 5).  
13
C{
1
H} NMR (125 MHz, DMSO-d6, 300 K): δ = 167.96 (quaternary, COOH), 137.65 
(CH), 123.67 (CH), 123.12 (CH), 49.69 (CH2), 35.65 (CH3).  
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ESI+MS m/z 141.1 [M-Cl]
+ 
EI+HRMS calcd. for C6H9N2O2 [M–Cl]
+
: 141.0659. Found: 141.0693. 
8.5.12 Reaction of compound 4.9 with Ag2O in DCM / methanol  
1-Methyl-3-acetic acid imidazolium chloride (4.9) (1.70 g, 10 mmol) was added to a 
Schlenk flask containing 4Å molecular sieves and the reagent was degassed. Anhydrous 
DCM was added (40 mL) followed by anhydrous methanol (20 mL). Ag2O (3.50 g, 15 
mmol) was added to the solution and the resultant suspension was stirred at room 
temperature in the dark, for 12 hours. The mixture was filtered through celite and the 
celite was washed with DCM / methanol (1:1) solution (3 × 10 mL). The solvent was 
removed in vacuo to yield an off white solid (Yield: 0.5 g).  
1
H NMR (500 MHz, MeOD-d4, 300 K): δ = 7.52 (s, 1H, CH), 7.50 (s, 1H, CH), 4.74 
(s, 2H, CH2), 3.92 (s, 3H, CH3).  
13
C{
1
H} NMR (125 MHz, MeOD-d4, 300 K): δ = 171.02 (quaternary, COOH), 124.88 
(CH), 123.97 (CH), 36.28 (CH3).  
ESI+MS m/z 141.1 [4.9-Cl]
+
 
8.5.13 Reaction of compound 4.9 with Ag2O in methanol  
1-Methyl-3-acetic acid imidazolium chloride (4.9) (1.70 g, 10 mmol) was added to a 
Schlenk flask that contained 4Å molecular sieves and the reagent degassed. Anhydrous 
methanol was added (50 mL) followed by Ag2O (3.50 g, 15 mmol). The resultant 
suspension was stirred at room temperature, in the dark, for 12 hours. The mixture was 
filtered through celite and the celite was washed with methanol (3 × 10 mL). The 
solvent was removed in vacuo, to yield a white solid (Yield: 1.00 g). At least two 
carbene products were observed in the NMR spectrum.  
Compound 1; 
1
H NMR (300 MHz, MeOD-d4, 300 K): δ = 7.56 (s, 1H, CH), 7.53 (s, 
1H, CH), 4.77 (s, 2H, CH2), 3.95 (s, 3H, CH3). Compound 2; δ = 7.53 (s, 1H, CH), 
7.24 (s, 1H, CH), 4.73 (s, 2H, CH2), 3.90 (s, 3H, CH3).  
ESI+MS m/z 141.1 [4.9-Cl]
+
; 433.9; 492.0; 566.9. 
Colourless crystals suitable for single crystal X-ray diffraction analysis were grown in 
the dark by vapour diffusion of diethyl ether into a methanol solution of the product 
formed in the reaction. The X-ray crystal structure revealed a zwitterion (compound 
4.10).   
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8.6 Experimental for Chapter 5  
General protocol used for the Suzuki-Miyaura reactions. Phenyl boronic acid was 
reacted with either 4-chlorotoluene or 4-bromotoluene, and the conditions applied were 
the same as those reported by Brenner et al and Dinares et al.
16, 17 
The yields were 
determined by 
1
H NMR spectroscopy using 1,4-dimethoxybenzene as a standard. 
Phenyl boronic acid (0.183 g, 1.5 mmol), Cs2CO3 (0.625 g, 2 mmol) and an acetonitrile 
solution of compound 5 (or palladium source and ligand 3) were added to a carousel 
reactor and the solvent was removed in vacuo. Reaction solvent was added (3 mL) 
followed by the aryl halide (1 mmol). The mixture was stirred vigorously at 80 °C, for 2 
hours, under an atmosphere of nitrogen. The hot mixture was filtered through a pad of 
celite, and the celite washed with the reaction solvent (2 mL). 1,4-Dimethoxybenzene 
(0.069 g, 0.5 mmol) was added to the filtrate and the solvent removed in vacuo. The 
mixture was analysed by 
1
H NMR spectroscopy and the product yields were determined 
by comparing the intensity of the methyl signal of the product (δ = 2.41 ppm) with that 
of the 1,4-dimethoxybenzene (δ = 3.78 ppm).  
8.7 Experimental for Chapter 6  
8.7.1 (Dichloromethyl) amino-tert-butylacetate (6.1) 
Glycine tert-butyl ester hydrochloride (0.419 g, 2.5 mmol) and 
paraformaldehyde (0.195 g, 6.5 mmol) were added to a Schlenk flask 
and the reagents degassed. Anhydrous dichloromethane (7 mL) was 
added and the solution stirred for 1 hour at room temperature. The solution was cooled 
to 0 °C in an ice bath and SOCl2 (0.73 mL, 10 mmol), was added dropwise, purified by 
distillation (59-64 °C).18 The solvent was removed in vacuo to yield a yellow oil that 
solidifies in the fridge. The sample was purified by extraction into anhydrous diethyl 
ether (Yield: 0.21 g, 50 %).  
1
H NMR (500 MHz, CDCl3, 300 K): δ = 5.18 (s, 4H, 1), 3.59 (s, 2H, 2), 1.41 (s, 9H, 3). 
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 168.44 (quaternary, COO
t
Bu), 82.94 
(quaternary, 
t
Bu), 71.60 (CH2), 50.90 (CH2), 28.04 (CH3).  
ESI+MS m/z 192.2 [M-Cl]
+
 
EI+HRMS calcd. for C8H15NO2Cl [M-Cl]
+
: 192.0787. Found: 192.0786. 
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8.7.2 (Dimethylimidazole) amino-tert-butylacetate (6.2)  
Glycine tert-butyl ester hydrochloride (0.67 g, 4 mmol) and 
imidazole (1.02 g, 15 mmol) were added to a Schlenk flask 
containing 4Å molecular sieves and the reagents were degassed. 
Formaldehyde (37-41 wt %, 0.7 mL, 10 mmol) in anhydrous ethanol 
(2 mL) was added followed by anhydrous dichloromethane (15 mL). The mixture was 
stirred at room temperature for 72 hours. The product was extracted into chloroform (3 
x 30 mL) from water (30 mL). The chloroform layer was washed with water (50 mL), 
dried over CaCl2, and filtered. The chloroform was removed in vacuo to yield a yellow 
oil. Diethyl ether (30 mL) was added to the oil and the solution stored in the fridge (4 
°C) for 24 hours. The product precipitated from solution as a crystalline white solid that 
was collected by reduced pressure filtration, washed with diethyl ether (5 x 10 mL) and 
dried in air (Yield: 0.40 g, 35 %).  
1
H NMR (500 MHz, CDCl3, 300 K): δ = 7.63 (s, 2H, 1), 7.12 (s, 2H, 2 / 3), 6.97 (s, 2H, 
2 / 3), 4.93 (s, 4H, 4), 3.35 (s, 2H, 5), 1.44 (s, 9H, 6).  
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 169.13 (quaternary, COO
t
Bu), 137.43 
(CH), 130.14 (CH), 118.80 (CH), 82.64 (quaternary, 
t
Bu), 63.01 (CH2), 51.35 (CH2), 
28.12 (CH3). 
ESI+MS m/z 292.2 [M+H]
+ 
EI+HRMS calcd. for C14H22N5O2 [M+H]
+
: 292.1768. Found:
 
292.1761
 
Anal.calcd. for C14H21N5O2: C, 57.71%; H, 7.27%; N, 24.04%. Found: C, 57.15%; H, 
7.20%; N, 23.75%.  
Colourless crystals suitable for single crystal X-ray diffraction analysis were grown by 
slow evaporation of a saturated chloroform solution of compound 6.2.  
8.7.3 1-methyl-3-acetic acid imidazolium tetrafluroborate and related imidazolium 
species
19
  
1-Methylimidazole (0.8 mL, 10 mmol) and chloroacetic acid (0.945 g, 10 mmol) were 
added to a Schlenk flask and heated at 70 °C for 12 hours. The mixture was allowed to 
cool to room temperature and the resultant oil was washed with anhydrous diethyl ether 
(3 × 2 mL). Sodium tetrafluoroborate (1.098 g, 10 mmol) was added followed by 
anhydrous acetonitrile (20 mL) and the suspension was heated at reflux (84 °C) for 24 
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hours. Once cooled, the solution was filtered to remove the white precipitate, and the 
solvent was removed from the filtrate in vacuo, to yield a yellow oil that was assigned 
by 
1
H NMR spectroscopy and mass spectrometry to be a mixture of products (Figure 
8.1).  
 
Figure 8.1  Products formed in the reaction between 1-methyl imidazole and chloroacetic acid (n = 2-6). 
1
H NMR (500 MHz, d6-DMSO, 300 K): δ = 9.10 (s, 1H, C10), 9.03 (s, 1.6H, B5), 8.91 
(s, 1.8H, A1), 7.71 (d, 
3
JH-H= 1.45 Hz, 1H, C12), 7.70 (d, 
3
JH-H= 1.45 Hz, 1H, C11), 
7.68 (m, 1.6H, B7), 7.66 (m, 1.6H, B6), 7.62 (br, 1.8H, A3), 7.59 (br, 1.8H, A2), 5.38 
(s, 2H, C13), 5.08 (s, 3.2H, B8), 4.74 (s, 2H, C14), 3.92 (s, 3H, C15), 3.09 (s, 4.8H, 
B9), 3.86 (s, 5.4H, A4). 
ESI+MS m/z 141.1 [B]
+
; 199.1 [C]
+
; 257.1 [D (n=2)]
+
; 315.1 [D (n=3)]
+
; 373.1 [D 
(n=4)]
+
; 4.31.1 [D (n=5)]
+
; 489.1 [D (n=6)]
+ 
EI+HRMS calcd. for C6H9N2O2 [B]
+
: 141.0659 Found: 141.0695  
8.7.4 Bis(2-dichloroethyl) amino benzyl (6.4)20 
An aqueous solution (12.5 mL) of bis(2-dichloroethyl)amine 
hydrochloride (5.00 g, 0.028 mol) was poured into an aqueous 
solution of sodium hydroxide (12.5 mL, 0.031 mol) and the mixture 
was stirred for 5 minutes. The organic phase was separated, dissolved in acetonitrile 
(12.5 mL), and dried over MgSO4 for 1 hour. The resulting filtrate was poured into a 
mixture of potassium carbonate (13.0 g, 0.13 mol) in acetonitrile (12.5 mL), and an 
acetonitrile solution (7.5 mL) of benzyl bromide (2.41 mL, 0.02 mol) was added. The 
mixture was stirred at room temperature for 12 hours, filtered to remove the undissolved 
inorganic solids, and the solvent was removed in vacuo to yield a yellow oil. A mixture 
of triethylamine (2.26 mL) in 40-60 petroleum ether (12.5 mL) was added to the oil, 
generating a white precipitate. The mixture was stirred at room temperature for 1 hour, 
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filtered to remove the triethylamine salt, and the solvent was removed in vacuo to yield 
a yellow oil. DCM (5 mL) was added to dissolve the oil followed by petroleum ether 
dropwise (approximately 4 mL), until the solution became cloudy. The mixture was 
cooled in the fridge for 12 hours, filtered to remove the precipitate, and concentrated in 
vacuo to yield compound 6.4 as a colourless oil (3.2 g, 49 %).  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 7.25-7.38 (m, 5H, 1), 3.74 (s, 2H, 2), 3.50 (t, 
3
JHH= 7 Hz, 4H, 3), 2.93 (t, 
3
JHH= 7 Hz, 4H, 4).  
13
C{
1
H} NMR (75 MHz, CDCl3, 300 K): δ = 138.93 (ipso-C6H5), 129.14 (CH), 128.88 
(CH), 128.67 (CH), 128.52 (CH), 127.47 (CH), 58.90 (CH2), 56.48 (CH2), 42.09 (CH2).  
ESI+MS m/z 232.0 [M+H]
+ 
EI+HRMS calcd. for C11H16NCl2 [M+H]
+
: 232.0654. Found:
 
232.0662.
 
8.7.5 Bis[2-imidazolium(3-tert-butylacetate)ethyl]amino benzyl Cl (6.5 Cl) 
Bis(2-dichloroethyl) amino benzyl (6.4) (1 mL, 
2.80 g, 12.1 mmol) and 1-tert-butylacetate 
imidazole (4.1) (4.43 g, 24.2 mmol) were added 
to a Schlenk flask. Anhydrous 1,4-dioxane (14 
mL) was added and the mixture was heated at reflux (105 °C) for 12 hours. The solution 
was cooled to room temperature and the solvent was removed in vacuo to yield a yellow 
oil. The product was extracted into H2O (10 mL), and the H2O layer was washed with 
DCM (4 × 5 mL), followed by petroleum ether (2 × 5 mL). The H2O was removed in 
vacuo to yield a pale yellow oil that, when washed with diethyl ether (2 × 5 mL) and 
dried in vacuo, solidified as an off-white hygroscopic solid (Yield: 1.12 g, 16 %).  
1
H NMR (500 MHz, MeOD-d4, 300 K): δ = 9.10 (s, 2H, 1), 7.61 (s, 2H, 2 / 3), 7.59 (s, 
2H, 2 / 3), 7.29-7.15 (m, 5H, 4), 5.16 (s, 4H, 5), 4.40 (t, 4H, 
3
JHH = 6 Hz, 6), 3.74 (s, 2H, 
7), 3.07 (t, 4H, 
3
JHH = 6 Hz, 8), 1.54 (s, 18H, 9).  
13
C{
1
H} NMR (75 MHz, D2O, 300 K): δ =167.19 (quaternary, COO
t
Bu), 139.34 (ipso-
C6H5), 138.79 (CH), 130.52 (CH), 129.74 (CH), 129.65 (CH), 128.65 (CH), 128.03 
(CH), 125.10 (CH), 123.57 (CH), 85.26 (quaternary, 
t
Bu), 59.48 (CH2), 54.61 (CH2), 
51.60 (CH2), 49.16 (CH2), 28.35 (CH3).  
ESI+MS m/z 560.3 [M-Cl]
+
 
EI+HRMS calcd. for C29H43Cl1N5O4 [M-Cl]
+
: 560.2998. Found: 560.3022. 
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8.7.6  Bis[2-imidazolium(3-tert-butylacetate)ethyl]amino benzyl PF6 (6.5 PF6) 
Bis[2-imidazolium(3-tert-butylacetate)ethyl] 
amino benzyl Cl (6.5 Cl) (0.80 g, 1.43 mmol) 
was dissolved the minimum amount of H2O 
and a H2O solution (5 mL) of NH4PF6 (2.19 g, 13.4 mmol) was added dropwise with 
stirring. A white precipitate formed immediately. The mixture was stirred at room 
temperature for 30 minutes, and filtered to isolate the solid. The solid was washed with 
H2O (3 × 10 mL) followed by diethyl ether (3 × 10 mL) and dried in vacuo. Compound 
6.5 PF6 was collected as a colourless crystalline solid (Yield: 0.9 g, 82 %).  
1
H NMR (500 MHz, MeOD-d4, 300 K): δ = 8.68 (s, 2H, 1), 7.48 (s, 2H, 2), 7.41 (s, 2H, 
3), 7.26-7.17 (m, 5H, 4), 5.01(s, 4H, 5), 4.25 (br, 4H, 6), 3.72 (s, 2H, 7), 3.02 (br, 4H, 
8), 1.52 (s, 18H, 9).  
13
C{
1
H} NMR (125 MHz, MeOD-d4, 300 K): δ = 165.77 (quaternary, COO
t
Bu), 138.43 
(ipso-C6H5), 137.09 (CH), 129.05 (CH), 128.85 (CH), 128.65 (CH), 128.22 (CH), 
127.11 (CH), 123.53 (CH), 122.08 (CH), 83.11 (quaternary, 
t
Bu), 57.04 (CH2), 52.30 
(CH2), 49.94 (CH2), 46.93 (CH2), 27.37 (CH3).  
ESI+MS m/z 670.3 [M-PF6]
+ 
EI+HRMS calcd. for C29H43F6N5O4P1 [M-PF6]
+
: 670.2951. Found: 670.2952. 
Anal.calcd. for C29H43F12N5O4P2: C, 42.71 %; H, 5.31 %; N, 8.59 %. Found: C, 42.50 
%; H, 5.25 %; N, 8.45 %.  
8.7.7  Bis[2-imidazolium(3-tert-butylacetate)ethyl]amine Cl (6.6 Cl) 
Bis[2-imidazolium(3-tert-butylacetate)ethyl] 
amino benzyl Cl (6.5 Cl) (0.2 g, 0.33 mmol) 
was added to a small ampoule and the reagent 
degassed. A small spatula of Pd / C was added followed by anhydrous ethanol (3 mL). 
The ampoule was freeze-pump-thaw degassed and back-filled with H2 (gas). The 
mixture was heated with stirring at 70 °C for 24 hours in a closed ampoule. The solution 
was cooled to room temperature and filtered through a plug of celite. The celite was 
washed with ethanol (3 × 10 mL) and the volatiles were removed from the filtrate in 
vacuo to yield a white hygroscopic solid (0.33 g, 50 %).  
Chapter 8. Experimental 
  
212 
 
1
H NMR (300 MHz, D2O, 300 K): δ = 8.98 (s, 2H, 1), 7.68 (s, 2H, 2 / 3), 7.63 (s, 2H, 2 
/ 3), 5.19 (s, 4H, 5), 4.46 (t, 4H,
 3
JHH= 6 Hz, 6), 3.24 (t, 4H, 
3
JHH= 6 Hz, 8), 1.61 (s, 18 
H, 9).  
13
C{
1
H} NMR (75 MHz, D2O, 300 K): δ = 166.94 (quaternary, COO
t
Bu), 136.00 (CH), 
123.81 (CH), 122.42 (CH), 85.78 (
t
Bu), 57.44 (CH2), 50.61 (CH2), 47.34 (CH2), 27.10 
(CH3).  
ESI+MS m/z 470.3 [M-Cl]
+ 
EI+HRMS calcd. for C22H37N5O4Cl [M-Cl]
+
: 470.2529. Found: 470.2540 
8.7.8 Bis[2-imidazolium(3-tert-butylacetate)ethyl]amine PF6  (6.6 PF6) 
Bis[2-imidazolium(3-tert-butylacetate)ethyl] 
amino benzyl PF6 (6.5 PF6) (0.20 g, 0.33 mmol) 
was added to a small ampoule and the reagent 
degassed. A small spatula of Pd / C was added followed by anhydrous ethanol (3 mL). 
The ampoule was freeze-pump-thaw degassed and back-filled with H2 (g). The mixture 
was heated with stirring at 70 °C for 24 hours in a sealed ampoule. The solution was 
cooled to room temperature and filtered through a plug of celite. The celite was washed 
with ethanol (3 × 10 mL) and the volatiles were removed from the filtrate in vacuo to 
yield a white hygroscopic solid (0.33 g, 50 %). It appeared that some of the tert-butyl 
groups were also removed during the reaction, with only small resonances observed for 
the CH3 groups in the 
1
H NMR and 
13
C{
1
H} NMR spectra.  
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 9.10 (s, 2H, NCHN), 7.76 (s, 2H, NCHC), 
7.75 (s, 2H, NCHC), 5.17 (s, 4H, CH2), 4.36 (t, 
3
JHH = 5.4 Hz, 4H, CH2), 3.11 (t, 
3
JHH = 
5.4 Hz, 4H, CH2), 1.52 (s, 0.55H, CH3).  
13
C{
1
H} NMR (75 MHz, D2O, 300 K): δ = 168.26 (quaternary), 137.33 (CH), 123.61 
(CH), 122.25 (CH), 49.70 (CH2), 48.00 (CH2), 46.97 (CH2), 27.59 (CH3).  
ESI+MS m/z 580.2 [6.6-PF6]
+
; 161.6 [6.6+2
t
Bu-2PF6]
2+ 
8.7.9 Bis[2-imidazolium(3-tert-butyl-acetic-acid)ethyl]amine PF6 (6.11) 
A HCl solution (37 %, 0.5 mL, 1.3 mmol) of bis[2-
imidazolium(3-tert-butylacetate)ethyl]amine PF6 
(6.5 PF6) (0.40 g, 0.49 mmol) was heated at reflux 
(110 °C) for one hour. The solution was allowed to cool to room temperature and the 
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solvent was removed in vacuo. The resultant solid was washed with acetone (2 × 10 
mL), followed by diethyl ether (2 × 10 mL) and dried in vacuo to yield an off white 
solid (0.25 g, 72 %).  
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 9.31 (s, 2H, 1), 7.77 (s, 2H, 2 / 3), 7.71 (s, 
2H, 2 / 3), 7.51-7.20 (m, 5H, 4), 5.19 (s, 4H, 5), 4.49 (br, 4H, 6), 3.87 (br, 2H, 7), 3.10 
(br, 4H, 8).  
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 168.08 (quaternary, COOH), 137.34 
(ipso-C6H5), 137.29 (CH), 129.31 (CH), 128.27 (CH), 123.64 (CH), 122.11 (CH), 57.01 
(CH2), 52.20 (CH2), 51.99 (CH2), 49.74 (CH2).  
ESI+MS m/z 434.2 [M-2X-2H
+
+Na]
+ 
EI+HRMS calcd. for C21H25N5O4Na [M-2X-2H
+
+Na]
+
: 434.1799. Found: 434.1796.
 
8.7.10 Copper(I)-N-heterocyclic carbene complex using ligand 6.5 PF (6.16)  
Bis[2-imidazolium(3-tert-butylacetate)ethyl]amine PF6 (6.5 
PF6) (0.20 g, 0.24 mmol) was added to a three-necked round-
bottomed flask. Anhydrous MeCN (15 mL) was added and 
the copper electrodes (1 × 3 mL) were inserted into the 
reaction mixture. The potential was adjusted so that a current of 50 mA was maintained. 
The mixture was electrolysed for 25 minutes (2 Q) under an argon atmosphere, filtered, 
and the solvent removed in vacuo. The product was purified by precipitation from DCM 
/ diethyl ether to yield a pale yellow solid (0.17 g, 96 %).  
1
H NMR (300 MHz, MeCN-d3, 300 K): δ = 7.35-7.04 (m, 5H, C5H5), 7.02 (br, 1H, 
NCHN), 6.67 (br, 1H, NCHN), 5.32 (s, 1H, CH2), 4.78 (s, 2H, CH2), 4.72 (s, 1H, 
CH2), 4.19 (m, 4H, NCH2CH2N), 3.69 (s, 2H, CH2), 2.99 (m, 4H, NCH2CH2N), 1.45 
(s, 10H, CH3), 1.40 (s, 8H, CH3).  
13
C{
1
H} NMR (125 MHz, MeCN-d3, 125 K): δ = 181.05 (quaternary, Cu-C), 168.48 
(quaternary, COO
t
Bu), 138.40 (quaternary), 137.46 (quaternary), 130.88 (CH), 129.96 
(CH), 129.34 (CH), 128.78 (CH), 128.64 (CH), 123.46 (CH), 122.77 (CH), 121.98 
(CH), 121.98 (CH), 83.55 (
t
Bu), 58.21 (CH2), 56.04 (CH2), 55.90 (CH2), 53.43 (CH2), 
53.40 (CH2), 47.79 (CH2), 28.72 (CH3), 28.17 (CH3).  
ESI+MS m/z 586.2 [M-PF6]
+ 
EI+HRMS calcd. for C29H41CuN5O4 [M-PF6]
+
: 586.2449. Found: 586.2449. 
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8.7.11  Palladium-N-heterocyclic carbene complex(es) using ligand 6.5 (6.17) 
Compound 6.5 PF6 (0.20 g, 0.24 mmol) was added to 
a three-necked round-bottomed flask. Anhydrous 
MeCN (15 mL) was added and the copper electrodes 
(1 × 3 mL) were inserted into the reaction mixture. 
The potential was adjusted so that a current of 50 mA was maintained. The mixture was 
electrolysed for 25 minutes (2 Q) under an argon atmosphere and then the electrodes 
were removed from the reaction mixture. PdCl2(MeCN)2 (0.125 g, 0.48 mmol) was 
added to the reaction flask and the mixture was stirred at room temperature for 48 hours. 
The solution was filtered and the solvent was removed in vacuo to yield a yellow solid. 
The product was purified by dissolving in DCM and filtering through celite (Yield: 0.12 
g).  
1
H NMR and 
13
C{
1
H} NMR were too broad and complicated to be assigned (see results 
and discussion section for more details).  
ESI+MS m/z 842.0 [M-2MeCN-Cl]
+
; 983.9 [M+Na]
+ 
EI+HRMS calcd. for C29H41Cl3N5O4Pd2 [M-2MeCN-Cl]
+
: 840.0289. Found: 842.0306.  
8.8 Experimental for Chapter 7  
8.8.1 Bis(chloromethyl)amino benzoyl (7.3)21  
Benzoylchloride (7.05 g, 50 mmol) and hexamethylenetetramine (1.15 
g, 8.3 mmol) were dissolved in xylol (50 mL) and the mixture was 
heated at reflux (135 C) for 18 hours. The mixture was concentrated in 
vacuo to yield a yellow oil. Distillation of the oil (96 C / 10-2 torr) was attempted to 
isolate the pure product, however the boiling point of the product was too high and the 
mixture decomposed before it could be collected.
1
H NMR data confirmed the product 
was present in the sample mixture and was consistent with that of the literature.
21
  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 7.53 (m, 5H, 2), 5.40 (s, 4H, 1). 
8.8.2 Bis(chloromethyl)amino acetyl (7.4)21 
Acetyl chloride (3 mL, 3.90 g, 50 mmol) and hexamethylenetetramine 
(1.15 g, 8 mmol) were added to a Schlenk flask. The reaction vessel was 
sealed and the mixture was heated at 120 C for 5 hours. Distillation of the resultant oil 
(80 C / 10-1) yielded bis(chloromethyl)amino acetyl as a colourless oil.  
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1
H NMR (500 MHz, CDCl3, 300 K): δ = 5.46 (s, 4H, 1), 2.32 (s, 3H, 2).  
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 168.97 (quaternary, COMe), 58.4 (CH2), 
54.3 (CH2), 20.67 (CH3).  
8.8.3 1-Methanol imidazole22 
Imidazole (3.00 g, 44 mmol) and paraformaldehyde (1.46 g, 49 mmol) 
were added to a Schlenk flask followed by three drops of triethylamine. 
The flask was sealed and the solids were heated at 80 °C for 1 hour with 
gentle stirring, during which time the solids melted.  The mixture was cooled to room 
temperature to yield a white solid. The product was purified by recrystallisation from 
DCM / hexane (Yield: 2.45 g, 57 %).  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 7.37 (s, 1H, 1), 7.01 (s, 1H, 2 / 3), 6.89 (s, 1H, 
2 / 3), 5.34 (s, 2H, 4), OH resonances not observed.  
13
C{
1
H} NMR (75 MHz, CDCl3, 300 K): δ = 136.18 (CH), 128.40 (CH), 118.64 (CH), 
70.07 (CH2), OH resonance not observed.  
ESI+MS m/z 91.02 [M+H]
+
; 121.03 [M+Na]
+
 
EI+HRMS calcd. for C4H6N2NaO [M+Na]
+
: 121.0372. Found: 121.0386. 
8.8.4 1-Chloromethylimidazole (7.9)22 
1-Methanolimidazole (1.00 g, 0.01 mol) was dissolved in anhydrous 
chloroform (25 mL) in a Schlenk flask. Thionyl chloride (1.4 mL, 0.19 
mol) was added and the mixture was stirred at room temperature for 12 
hours. The solvent was removed in vacuo and the solid was dried in vacuo for two 
hours. The product was purified by recrystallisation from ethanol / diethyl ether (Yield: 
0.625 g, 53 %).  
1
H NMR (300 MHz, D2O, 300 K): δ = 9.08 (s, 1H, 1), 7.75 (s, 1H, 2 / 3), 7.65 (s, 1H, 2 
/ 3), 6.07 (s, 2H, 4).  
13
C{
1
H} NMR (75 MHz, D2O, 300 K): δ = 135.98 (CH), 121.82 (CH), 120.56 (CH), 
54.18 (CH2).  
ESI+MS m/z 117.02 [M]
+ 
EI+HRMS calcd. for C4H6N2Cl [M]
+
: 117.0220. Found: 117.0230. 
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8.8.5 Synthesis of compound 7.10 
DO3AtBu (0.16 g, 0.31 mmol) was added to a Schlenk flask and the reagent degassed. 
1-Chloromethylimidazole (7.9) (0.036 g, 0.31 mmol) and Cs2CO3 (0.33 g, 3.22 mmol) 
were added, followed by anhydrous acetonitrile (10 mL). The mixture was heated at 85 
°C for 12 hours. The solution was cooled to room temperature and filtered to remove 
the inorganic salts. The filtrate was concentrated in vacuo to yield a yellow oil, which 
was assigned by 
1
H NMR spectroscopy and mass spectrometry to be a mixture of 
compounds (Figure 8.2). 
 
Figure 8.2  Compounds identified in the reaction between DO3AtBu and compound 7.10.  
1
H NMR (500 MHz, CDCl3, 300 K): δ = 7.53 (s, 1H, NCHN), 6.95 (s, 2H, NCHCHN), 
3.23 (s, 4H, CH2), 3.22 (s, 8H, CH2), 2.71 (m, 9H, CH2), 2.64 (m, 20H, CH2), 2.46 (m, 
9H, CH2), 1.35 (s, 80H, CH3).  
13
C{
1
H} NMR (125 MHz, CDCl3, 300 K): δ = 169.50 (quaternary, COO
t
Bu), 169.40 
(quaternary, COO
t
Bu), 134.91 (CH), 133.52 (CH), 129.03 (CH), 116.42 (CH), 78.96 
(quaternary, 
t
Bu), 78.92 (quaternary, 
t
Bu), 55.37 (CH2), 50.62 (CH2), 48.80 (CH2), 45.6 
(CH2), 26.41 (CH3), 26.29 (CH3).  
ESI+MS m/z 515.37 [A+H]
+
, 617.39 [B+Na]
+
, 697.42 [C-H-Cl+Na]
+ 
8.8.6 1-Propanol-3-tert-butylaceate imidazolium chloride (7.13)  
1-(3-Hydroxypropyl)-1H-imidazole (1.00 g, 7.9 mmol) 
and tert-butyl chloroacetate (1.25 mL, 8.7 mmol) were 
added to a Schlenk flask. The reagents were stirred for 12 
hours at room temperature. The resultant oil was washed with diethyl ether (2 × 5 mL) 
and dried in vacuo. The product was isolated as a white solid (Yield: 1.94 g, 88 %).  
Chapter 8. Experimental 
  
217 
 
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 9.21 (s, 1H, 1), 7.82 (s, 1H, 2 / 3), 7.74 (s, 
1H, 2 / 3), 5.14 (s, 2H, 4), 4.79 (br, 1H, OH), 4.30 (t, 2H, 
3
JHH  = 6.5 Hz, 5), 3.40 (q, 2H, 
3
JHH = 6.5 Hz, 7), 1.94 (quintet, 2H, 
3
JHH = 6.5 Hz, 6), 1.45 (s, 9H, 8).  
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 165.73 (quaternary, COO
t
Bu), 137.42 
(CH), 123.19 (CH), 122.17 (CH), 83.00 (quaternary, 
t
Bu) , 56.86 (CH2),  49.98 (CH2), 
46.38 (CH2), 32.33 (CH2), 27.63 (CH3). 
ESI+MS m/z 241.2 [M-Cl]
+
 
EI+HRMS calcd. for C12H21N2O3 [M-Cl]
+
: 241.1547. Found: 241.1590. 
8.8.7 1-Chloropropyl-3-tert-butylacetate imidazolium chloride (7.14) 
Compound 7.13 (0.6 g, 2.16 mmol) was added to a 
Schlenk flask and the reagent was degassed. The solid was 
dissolved in anhydrous chloroform (20 mL) and 
triethylamine (0.3 mL, 2.15 mmol) was added. SOCl2 (0.19 mL, 2.15 mmol) was added 
dropwise and the resultant solution was stirred at room temperature for 12 hours. The 
solvent was removed in vacuo and the product was dried in vacuo for two hours. The 
product was purified by recrystallisation from DCM / diethyl ether, and was isolated 
with the triethylammonium chloride salt (Yield: 0.8 g).  
1
H NMR (300 MHz, DMSO-d6, 300 K): δ = 9.29 (s, 1H, 1), 7.86 (s, 1H, 2 / 3), 7.78 (s, 
1H, 2 / 3), 5.16 (s, 2H, 4), 4.38 (t, 2H, 
3
JHH = 6.5 Hz, 5), 3.65 (t, 2H, 
3
JHH = 6.5 Hz, 7), 
2.29 (quintet, 2H, 
3
JHH = 6.5 Hz, 6), 1.45 (s, 9H, 8).  
13
C{
1
H} NMR (75 MHz, DMSO-d6, 300 K): δ = 165.69 (quaternary, COO
t
Bu), 137.58 
(CH), 122.93 (CH), 122.06 (CH), 82.96 (quaternary, 
t
Bu),  50.0 (CH2), 46.58 (CH2), 
45.18 (CH2), 31.99 (CH2), 27.60 (CH3).  
ESI+MS m/z 259.1 [M-Cl]
+ 
EI+HRMS calcd. for C12H20ClN2O2 [M-Cl]
+
: 259.1218. Found: 259.1218 
 
. 
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8.8.8 Synthesis of compound 7.15  
DO3AtBu (1.00 g, 1.9 mmol), NaBr (0.40 g, 3.8 
mmol) and K2CO3 (1.22 g, 9.5 mmol) were added to 
a small ampoule and the reagents degassed. 
Anhydrous acetonitrile (20 mL) was added, followed 
by 1-chloropropyl-3-tert-butylacetate imidazolium 
chloride (7.14) (0.83 g, 2.85 mmol). The ampoule was sealed and the mixture was 
heated at 50 °C for 96 hours, with stirring. The mixture was cooled to room temperature 
and filtered to remove the inorganic salts. The filtrate was concentrated in vacuo to 
yield a yellow oil, which solidified on washing with diethyl ether (20 mL). The product 
was purified by HPLC (methanol / water + 0.1 % formic acid), and was isolated as a 
pale yellow solid (Yield: 0.55 g, 48 %).  
1
H NMR (300 MHz, CDCl3, 300 K): δ = 10.04 (s, 1H, 1), 8.34 (s, 1H, 2 / 3), 7.35 (s, 
1H, 2 / 3), 5.02 (s, 2H, 4), 4.64 (br t, 2H, 5), 3.70 (br, 2H, 6), 3.64-2.76 (m, 22H, 7), 
2.68 (br, 2H, 8), 1.47 (s, 9H, 9 / 11), 1.45 (s, 9H, 9 / 11), 1.43 (s, 18H, 10).  
13
C{
1
H} NMR (75 MHz, CDCl3, 300 K): δ = 170.47 (quaternary, COO
t
Bu), 164.52 
(quaternary, COO
t
Bu), 163.27 (quaternary, COO
t
Bu), 137.77 (CH), 123.75 (CH), 
122.86 (CH), 84.85 (quaternary, 
t
Bu), 82.13 (quaternary, 
t
Bu), 56.06 (CH2), 55.5 (CH2), 
53.0 (CH2), 51.8 (CH2), 50.72 (CH2), 49.87 (CH2), 48.71 (CH2), 47.00 (CH2), 28.15 
(CH3), 27.98 (CH3).  
ESI+MS m/z 841.4 [M+Na]
+
, 737.5 [M-Br]
+
, 369.3 [M-Br+H]
2+ 
EI+HRMS calcd. for C38H69N6O8 [M-Br]
+
: 737.5171. Found: 737.5178. 
Anal.calcd. for C38H69BrN6O8.4H2O: C, 51.28 %; H, 8.72 %, N, 9.44 %. Found: C, 
51.40 %; H, 8.20 %; N, 9.35 %.  
8.8.9 Synthesis of compound 7.16 
Compound 7.15 (0.208 g, 0.25 mmol) was dissolved in 
TFA (2 mL) and the mixture was stirred at room 
temperature for 12 hours. The TFA was removed in 
vacuo to yield a yellow oil, which when triturated with 
diethyl ether became a yellow solid. The product was not purified at this stage and was 
used as isolated, with the yield assumed as 100 %.  
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1
H NMR (300 MHz, D2O, 300 K): δ = 8.90 (s, 1H, 1), 7.56 (s, 1H, 2 / 3), 7.51 (s, 1H, 2 
/ 3), 5.10 (s, 2H, 4), 4.33 (br t, 2H, 5), 3.63-2.84 (m, 24H, 6, 7), 2.37 (br, 2H, 8). 
13
C{
1
H} NMR (75 MHz, D2O, 300 K): δ = 174.30 (quaternary, COOH), 169.70 
(quaternary, COOH), 168.39 (quaternary, COOH), 136.95 (CH), 124.05 (CH), 122.25 
(CH), 54.38 (CH2), 52.95 (CH2), 51.9 (CH2), 51.53 (CH2), 50.1 (CH2), 49.14 (CH2), 
47.57 (CH2), 46.56 (CH2), 42.17 (CH2).  
ESI+MS m/z 513.3 [M-Br]
+ 
8.8.10 Synthesis of gadolinium complex 7.17 
Compound 7.16 (0.13 g, 0.25 mmol) was dissolved in 
water (5 mL). GdCl3.6H2O (0.09 g, 0.24 mmol) was 
added and the pH of the solution was adjusted to pH 6 
by addition of NaOH solution (0.1 M, 1.8 mL). The solution was stirred at room 
temperature for 24 hours. The product was purified by HPLC (methanol / water) and 
isolated as a colourless oil.  
ESI+MS m/z 668.2 [7.19-Br]
+
, 690.1 [7.19-Br+Na]
+
 
EI+HRMS calcd. for C22H33N6GdO8Na [7.19-Br+Na]
+
: 690.1496. Found: 690.1513. 
8.8.11 Relaxivity measurements using complex 7.17  
T1 measurements were recorded with the assistance of Dr. Julie Fisher, School of 
Chemistry, University of Leeds, using a Maran Benchtop NMR analyser operating at 20 
MHz, field strength of 0.5 T, at a temperature of 23.8 ± 0.5 °C. Five known 
concentrations of contrast agent were made up from a neat solution (50 mM) in 
deionised water, in standard NMR tubes (50 mM, 25 mM, 16.66 mM, 8.33 mM and 2.5 
mM). Each T1 measurement was recorded three times and an average of the three 
results was taken.  
8.8.12 Synthesis of copper complex 7.18 
Compound 7.15 (0.20 g, 0.24 mmol) was added to a 
three-necked round-bottomed flask. Anhydrous 
MeCN (15 mL) was added and the copper electrodes 
(1 × 3 mL) were inserted into the reaction mixture. 
The potential was adjusted so that a current of 30 mA 
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was maintained. The mixture was electrolysed for 25 minutes (2 Q) under an argon 
atmosphere, and then the solvent was removed in vacuo. The solid was dissolved in 
DCM, filtered, and the solvent removed in vacuo to yield a green solid (Yield: 0.055 g, 
59 %).  
 
1
H NMR (300 MHz, MeCN-d3, 300 K): δ = 7.21 (s, 1H, 1 / 2), 7.13 (s, 1H, 1 / 2), 4.84 
(s, 2H, 3), 4.20 (br t, 2H, 4), 3.48 (s, 6H, 5), 2.92-2.14 (br, 20H, 6, 7, 8), 1.45 (br s, 36 
H, 9).  
13
C{
1
H} NMR (75 MHz, MeCN-d3, 300 K): δ = 177.21 (quaternary, Cu-C), 168.86 
(quaternary, COO
t
Bu), 168.80 (quaternary, COO
t
Bu), 166.94 (quaternary, COO
t
Bu), 
122.11 (CH), 120.66 (CH), 82.05 (quaternary, 
t
Bu), 80.77 (quaternary, 
t
Bu), 55.30 
(CH2), 55.18 (CH2), 51.97 (CH2), 51.63 (CH2), 49.90 (CH2), 49.06 (CH2), 48.81 (CH2), 
27.06 (CH3), 27.03 (CH3), 26.88 (CH3).  
ESI+MS m/z 1024.2 [M-Br]
+ 
EI+HRMS calcd. for C38H68N6Br2O8Cu2 [M-Br]
+
: 1020.2052. Found: 1022.2044. 
Anal.calcd. for C38H68Br3Cu2N6O8: C, 41.35 %; H, 6.21 %, N, 7.61 %. Found: C, 41.10 
%; H, 6.50 %; N, 7.75 %.  
8.8.13 Synthesis of gold complex (7.19 / 7.20)  
 
Compound 7.15 (0.20 g, 0.24 mmol) was added to a three-necked round-bottomed flask. 
Anhydrous MeCN (15 mL) was added and the copper cathode (1 × 3 mL) and gold 
anode (gold wire, 0.5 mm) were inserted into the reaction mixture. The potential was 
adjusted so that a current of 30 mA was maintained. The mixture was electrolysed for 
116 minutes (6 Q) under an argon atmosphere. The mixture was filtered, and the solvent 
was removed in vacuo to yield a dark purple oil.   
1
H NMR and 
13
C{
1
H} NMR were too broad and complicated to be assigned (see results 
and discussion section for more details).  
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ESI+MS m/z 1015.4 [7.16+Au]
+ 
EI+HRMS calcd. for C38H69Au1Br1N6O8 [7.16+Au]
+
: 1015.4003. Found: 1015.4027.  
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9.1 NMR data for the compounds reported in Chapter 2  
 
Figure 1  
1
H NMR spectrum (CDCl3) of compound 2.1 at 298 K.  
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Figure 2  
1
H NMR spectrum (CDCl3) of compound 2.2 at 298 K.  
 
Figure 3  
1
H NMR spectrum (CDCl3) of compound 2.3 at 298 K.  
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Figure 4  
1
H NMR spectrum (DMSO-d6) of compound 2.5 Br at 298 K. 
 
Figure 5  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 2.5 Br at 298 K.  
Appendix 
  
 
 
 
Figure 6  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 2.5 PF6 at 298 K.  
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9.2 NMR data for the compounds reported in Chapter 3  
 
Figure 7  
1
H NMR spectrum (DMSO-d6) of compound 3.1 at 298 K.  
 
Figure 8  
1
H NMR spectrum (CDCl3) of compound 3.2 at 298 K.  
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Figure 9  
1
H NMR spectrum (DMSO-d6) of compound 3.3 at 298 K.  
 
Figure 10  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 3.4 Br at 298 K.  
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Figure 11  
1
H NMR spectrum (DMSO-d6) of compound 3.4 PF6 at 298 K.  
 
Figure 12  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 3.4 PF6 at 298 K. 
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9.3 NMR data for the compounds / complexes reported in Chapter 4 
 
Figure 13  
1
H NMR spectrum (DMSO-d6) of compound 4.1 at 298 K.  
 
Figure 14  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 4.2 Br at 298 K.  
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Figure 15  
1
H NMR spectrum (DMSO-d6) of compound 4.2 PF6 at 298 K.  
 
Figure 16  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 4.2 PF6 at 298 K.  
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Figure 17  
1
H NMR spectrum (DMSO-d6) of compound 4.3 Br at 298 K.  
 
Figure 18  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 4.3 Br at 298 K.  
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Figure 19  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 4.3 PF6 at 298 K.  
 
Figure 20  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 4.4 at 298 K.  
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Figure 21  
13
C{
1
H} NMR spectrum (CDCl3) of complex 4.5 at 298 K.  
 
Figure 22  
13
C{
1
H} NMR spectrum (CDCl3) of complex 4.6 at 298 K.  
Appendix 
  
 
 
 
Figure 23  
13
C{
1
H} NMR spectrum (CDCl3) of complex 4.7 at 298 K.  
 
Figure 24  
13
C{
1
H} NMR spectrum (CDCl3) of complex 4.8 at 298 K.  
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Figure 25  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 4.9 at 298 K.  
 
Figure 26  
13
C{
1
H} NMR spectrum (MeOD-d4) of the product formed in the reaction of compound 4.9 
with Ag2O in DCM / methanol.  
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Figure 27  
13
C{
1
H} NMR spectrum (MeCN-d3) of the product formed in the electrochemical reaction of 
compound 4.9 at 298 K.  
 
Figure 28  
13
C{
1
H} NMR spectrum (DMSO-d6) of the product formed in the electrochemical reaction of 
4.3 PF6 at 298 K.  
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9.4 NMR data for the compounds / complexes reported in Chapter 6  
 
Figure 29  
1
H NMR spectrum (CDCl3) of compound 6.1 at 298 K.  
 
Figure 30  
13
C{
1
H} NMR spectrum (CDCl3) of compound 6.1 at 298 K.  
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Figure 31  
13
C{
1
H} NMR spectrum (CDCl3) of compound 6.2 at 298 K.  
 
Figure 32  
1
H NMR spectrum (CDCl3) of compound 6.4 at 298 K.  
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Figure 33  
13
C{
1
H} NMR spectrum (MeOD-d4) of compound 6.5 Cl at 298 K.  
 
Figure 34  
1
H NMR spectrum (DMSO-d6) of compound 6.5 PF6 at 298 K.  
Appendix 
  
 
 
 
Figure 35  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 6.5 PF6 at 298 K.  
 
Figure 36  
13
C{
1
H} NMR spectrum (D2O) of compound 6.6 Cl at 298 K. 
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Figure 37  
13
C{
1
H} NMR spectrum (D2O) of compound 6.6 PF6 at 298 K. 
 
Figure 38  
1
H NMR spectrum (DMSO-d6) of compound 6.11 at 298 K.  
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Figure 39  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 6.11 at 298 K. 
 
 
Figure 40  
13
C{
1
H} NMR spectrum (MeCN-d3) of complex 6.16 at 298 K. 
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Figure 41  
13
C{
1
H} NMR spectrum (MeCN-d3) of complex 6.17 at 298 K. 
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9.5 NMR data for the compounds / complexes reported in Chapter 7 
 
Figure 42  
1
H NMR spectrum (CDCl3) of compound 7.3 at 298 K.  
 
Figure 43  
1
H NMR spectrum (CDCl3) of compound 7.4 at 298 K. 
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Figure 44  
1
H NMR spectrum (D2O) of compound 7.9 at 298 K.  
 
Figure 45  
13
C{
1
H} NMR spectrum (CDCl3) of compound 7.9 at 298 K.  
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Figure 46  
1
H NMR spectrum (DMSO-d6) of compound 7.13 at 298 K.  
 
Figure 47  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 7.13 at 298 K.  
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Figure 48  
1
H NMR spectrum (DMSO-d6) of compound 7.14 at 298 K.  
 
Figure 49  
13
C{
1
H} NMR spectrum (DMSO-d6) of compound 7.14 at 298 K.  
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Figure 50   
13
C{
1
H} NMR spectrum (CDCl3) of compound 7.15 at 298 K.  
 
Figure 51  
1
H NMR spectrum (D2O) of compound 7.16 at 298 K.  
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Figure 52  
13
C{
1
H} NMR spectrum (D2O) of compound 7.16 at 298 K.  
 
Figure 53  
13
C{
1
H} NMR spectrum (MeCN-d3) of complex 7.18 at 298 K.  
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Figure 54  
1
H NMR spectrum (MeCN-d3) of complex 7.19 / 7.20 at 298 K.  
 
Figure 55 
13
C{
1
H} NMR spectrum (MeCN-d3) of complex 7.19 / 7.20 at 298 K. 
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9.6 Example spreadsheet for NMR titration experiments  
NMR Titrations 
  Spectrum 
Number 
Volume of 
Guest added 
(ml) 
Total 
volume 
(ml) 
Concentrations 
Equivalents 
of Guest 
Observed Chemical Shift 
(ppm) 
    
Host Guest 
[Proton 
1] 
[Proton 
2] 
[Proton 
3] 
RMM of Host 1384.83 
 
1 0.000 0.800 0.018143 0.000000 0.000000 9.04 7.67 7.02 
Mass of Host 0.0201 g 2 0.010 0.810 0.017919 0.002439 0.136140 9.06 7.68 7.03 
No. of moles of 
Host 1.45E-05 moles 3 0.020 0.820 0.017701 0.004819 0.272280 9.08 7.68 7.03 
Host solution 
volume 0.8 ml 4 0.030 0.830 0.017487 0.007142 0.408420 9.09 7.68 7.04 
    
5 0.040 0.840 0.017279 0.009409 0.544559 9.11 7.69 7.04 
    
6 0.050 0.850 0.017076 0.011623 0.680699       
RMM of Guest 322.37 
 
7 0.060 0.860 0.016877 0.013786 0.816839 9.13 7.71 7.05 
Mass of Guest 0.0637 g 8 0.070 0.870 0.016683 0.015899 0.952979       
No. of moles of 
Guest 1.98E-04 moles 9 0.080 0.880 0.016494 0.017964 1.089119 9.15 7.72 7.05 
Guest solution 
volume 1.0 ml 10 0.090 0.890 0.016308 0.019982 1.225259       
    
11 0.100 0.900 0.016127 0.021955 1.361398 9.17 7.72 7.07 
    
12 0.110 0.910 0.015950 0.023886 1.497538       
    
13 0.120 0.920 0.015777 0.025774 1.633678 9.18 7.73 7.08 
    
14 0.130 0.930 0.015607 0.027621 1.769818       
    
15 0.140 0.940 0.015441 0.029430 1.905958 9.2 7.74 7.08 
    
16 0.150 0.950 0.015278 0.031200 2.042098 9.21 7.74 7.08 
    
17 0.160 0.960 0.015119 0.032933 2.178237       
    
18 0.170 0.970 0.014963 0.034631 2.314377 9.22 7.75 7.09 
    
19 0.180 0.980 0.014811 0.036294 2.450517       
    
20 0.190 0.990 0.014661 0.037923 2.586657 9.23 7.75 7.09 
    
21 0.200 1.000 0.014514 0.039520 2.722797       
    
22 0.210 1.010 0.014371 0.041085 2.858937 9.24 7.76 7.1 
    
23 0.220 1.020 0.014230 0.042619 2.995076       
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9.7 Hyp NMR data 
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Figure 56  HypNMR fitting data for Cl
- 
binding by compound 2.5 PF6. 
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Figure 57  HypNMR fitting data for Br
-
 binding by compound 2.5 PF6. 
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Figure 58  HypNMR fitting data for NO3
-
 binding by compound 2.5 PF6. 
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9.8 Crystallography Data tables  
Details of data collections and structural refinements of compound 2.4, 2.5 Br, 3.4 4Br, 
3.4 3Cl.PF6, 4.2 Br, 4.10, 6.2 and complex 4.7.  
Identification code  Compound 2.4  
Empirical formula  C45H44Cl3N8O5.5  
Formula weight  891.23  
Temperature/K  150(2)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  10.0579(8)  
b/Å  40.788(3)  
c/Å  10.7646(9)  
α/°  90.00  
β/°  101.688(4)  
γ/°  90.00  
Volume/Å
3
  4324.5(6)  
Z  4  
ρcalcmg/mm
3
  1.369  
M/mm
-1
  0.270  
F(000)  1860.0  
Crystal size/mm
3
  0.18 × 0.11 × 0.09  
2Θ range for data collection  4 to 54.38°  
Index ranges  -11 ≤ h ≤ 12, -52 ≤ k ≤ 50, -13 ≤ l ≤ 13  
Reflections collected  61030  
Independent reflections  9587[R(int) = 0.0443]  
Data/restraints/parameters  9587/197/662  
Goodness-of-fit on F
2
  1.031  
Final R indexes [I>=2σ (I)]  R1 = 0.0492, wR2 = 0.1009  
Final R indexes [all data]  R1 = 0.0799, wR2 = 0.1133  
Largest diff. peak/hole / e Å
-3
  0.57/-0.60  
 
Identification code  Compound 2.5 Br  
Empirical formula  C27H37.14Br2N4O4.5  
Formula weight  649.57  
Temperature/K  150(2)  
Crystal system  monoclinic  
Space group  C2/m  
a/Å  17.580(2)  
b/Å  39.483(5)  
c/Å  11.7189(15)  
α/°  90.00  
β/°  130.147(4)  
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γ/°  90.00  
Volume/Å
3
  6217.9(14)  
Z  8  
ρcalcmg/mm
3
  1.388  
M/mm
-1
  2.645  
F(000)  2665.0  
Crystal size/mm
3
  0.46 × 0.37 × 0.15  
2Θ range for data collection  4.12 to 52.22°  
Index ranges  -21 ≤ h ≤ 15, -47 ≤ k ≤ 48, -11 ≤ l ≤ 14  
Reflections collected  36408  
Independent reflections  6241[R(int) = 0.0669]  
Data/restraints/parameters  6241/0/346  
Goodness-of-fit on F
2
  1.039  
Final R indexes [I>=2σ (I)]  R1 = 0.0651, wR2 = 0.1935  
Final R indexes [all data]  R1 = 0.1132, wR2 = 0.2229  
Largest diff. peak/hole / e Å
-3
  1.84/-0.95  
 
Identification code  Compound 3.4 4Br 
Empirical formula  C69.2H94.8Br4N8.6O4.5  
Formula weight  1438.78  
Temperature/K  150(2)  
Crystal system  triclinic  
Space group  P-1  
a/Å  14.5208(7)  
b/Å  16.3118(8)  
c/Å  16.8001(7)  
α/°  89.050(2)  
β/°  74.817(2)  
γ/°  65.845(2)  
Volume/Å
3
  3485.5(3)  
Z  2  
ρcalcmg/mm
3
  1.371  
M/mm
-1
  2.362  
F(000)  1492.0  
Crystal size/mm
3
  0.32 × 0.25 × 0.24  
2Θ range for data collection  3.48 to 56.36°  
Index ranges  -19 ≤ h ≤ 19, -21 ≤ k ≤ 21, -22 ≤ l ≤ 21  
Reflections collected  119266  
Independent reflections  17035[R(int) = 0.0503]  
Data/restraints/parameters  17035/66/834  
Goodness-of-fit on F
2
  1.027  
Final R indexes [I>=2σ (I)]  R1 = 0.0435, wR2 = 0.1105  
Final R indexes [all data]  R1 = 0.0805, wR2 = 0.1272  
Largest diff. peak/hole / e Å
-3
  1.38/-1.22  
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Identification code  Compound 3.4 3Cl.PF6 
Empirical formula  C72H100Cl3F6N10O5P  
Formula weight  1436.94  
Temperature/K  150(2)  
Crystal system  triclinic  
Space group  P-1  
a/Å  15.3602(7)  
b/Å  16.4401(6)  
c/Å  17.6345(12)  
α/°  115.124(3)  
β/°  105.512(3)  
γ/°  101.167(2)  
Volume/Å
3
  3636.1(3)  
Z  2  
ρcalcmg/mm
3
  1.312  
M/mm
-1
  0.220  
F(000)  1524.0  
Crystal size/mm
3
  0.24 × 0.18 × 0.14  
2Θ range for data collection  2.94 to 56.46°  
Index ranges  -20 ≤ h ≤ 20, -21 ≤ k ≤ 21, -23 ≤ l ≤ 23  
Reflections collected  136919  
Independent reflections  17815[R(int) = 0.0347]  
Data/restraints/parameters  17815/40/888  
Goodness-of-fit on F
2
  1.039  
Final R indexes [I>=2σ (I)]  R1 = 0.0901, wR2 = 0.2587  
Final R indexes [all data]  R1 = 0.1196, wR2 = 0.2871  
Largest diff. peak/hole / e Å
-3
  3.70/-1.96  
 
Identification code  Compound 4.2 Br 
Empirical formula  C342H502Br16N32O44S11  
Formula weight  7392.92  
Temperature/K  150(2)  
Crystal system  triclinic  
Space group  P-1  
a/Å  18.4774(16)  
b/Å  22.3850(19)  
c/Å  27.557(2)  
α/°  99.003(4)  
β/°  98.530(4)  
γ/°  96.578(4)  
Volume/Å
3
  11021.8(16)  
Z  1  
ρcalcmg/mm
3
  1.114  
M/mm
-1
  1.562  
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F(000)  3862.0  
Crystal size/mm
3
  0.15 × 0.12 × 0.08  
2Θ range for data collection  2.6 to 45°  
Index ranges  -18 ≤ h ≤ 19, -24 ≤ k ≤ 24, -29 ≤ l ≤ 28  
Reflections collected  108088  
Independent reflections  28814[R(int) = 0.0630]  
Data/restraints/parameters  28814/153/1959  
Goodness-of-fit on F
2
  1.147  
Final R indexes [I>=2σ (I)]  R1 = 0.0949, wR2 = 0.2802  
Final R indexes [all data]  R1 = 0.1237, wR2 = 0.3059  
Largest diff. peak/hole / e Å
-3
  2.78/-1.46  
 
Identification code  Complex 4.7  
Empirical formula  C206H277Br16N39O16Pd8  
Formula weight  5685.43  
Temperature/K  150(2)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  42.542(6)  
b/Å  24.032(4)  
c/Å  14.441(2)  
α/°  90.00  
β/°  95.272(7)  
γ/°  90.00  
Volume/Å
3
  14701(4)  
Z  2  
ρcalcmg/mm
3
  1.284  
M/mm
-1
  2.703  
F(000)  5684.0  
Crystal size/mm
3
  0.32 × 0.27 × 0.05  
2Θ range for data collection  3.34 to 48.88°  
Index ranges  -49 ≤ h ≤ 49, -27 ≤ k ≤ 24, -16 ≤ l ≤ 16  
Reflections collected  88980  
Independent reflections  12096[R(int) = 0.0612]  
Data/restraints/parameters  12096/126/701  
Goodness-of-fit on F
2
  1.110  
Final R indexes [I>=2σ (I)]  R1 = 0.0907, wR2 = 0.2486  
Final R indexes [all data]  R1 = 0.1069, wR2 = 0.2566  
Largest diff. peak/hole / e Å
-3
  1.47/-1.36 
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Identification code  Compound 4.10  
Empirical formula  C6H8N2O2  
Formula weight  140.14  
Temperature/K  150(2)  
Crystal system  orthorhombic  
Space group  Pca21  
a/Å  15.887(2)  
b/Å  4.9335(7)  
c/Å  8.7022(12)  
α/°  90.00  
β/°  90.00  
γ/°  90.00  
Volume/Å
3
  682.07(16)  
Z  4  
ρcalcmg/mm
3
  1.365  
M/mm
-1
  0.105  
F(000)  296.0  
Crystal size/mm
3
  0.3 × 0.3 × 0.07  
2Θ range for data collection  6.94 to 53.02°  
Index ranges  -19 ≤ h ≤ 15, -6 ≤ k ≤ 5, -10 ≤ l ≤ 10  
Reflections collected  4732  
Independent reflections  1382[R(int) = 0.0377]  
Data/restraints/parameters  1382/1/92  
Goodness-of-fit on F
2
  1.028  
Final R indexes [I>=2σ (I)]  R1 = 0.0458, wR2 = 0.1030  
Final R indexes [all data]  R1 = 0.0688, wR2 = 0.1122  
Largest diff. peak/hole / e Å
-3
  0.51/-0.14  
Flack parameter 0(2) 
 
Identification code  Compound 6.2 
Empirical formula  C14H21N5O2 
Formula weight  291.36 
Temperature/K  150(2)  
Crystal system  Monoclinic 
Space group  P21/c  
a/Å  5.5038(4) 
b/Å  27.370(2) 
c/Å  10.4978(8) 
α/°  90 
β/°  101.568(3) 
γ/°  90 
Volume/Å
3
  1549.3(2) 
Z  14 
ρcalcmg/mm
3
  1.249 
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M/mm
-1
  0.087 
F(000)  624 
Crystal size/mm
3
  0.41 × 0.09 × 0.05 
2Θ range for data collection  2.48 to 27.36°  
Index ranges  -6 ≤ h ≤ 7, -34 ≤ k ≤ 35, -13 ≤ l ≤ 13  
Reflections collected  13342 
Independent reflections  3479[R(int) = 0.0617]  
Data/restraints/parameters  3479/0/193 
Goodness-of-fit on F
2
  1.018 
Final R indexes [I>=2σ (I)]  R1 = 0.0428, wR2 = 0.1018 
Final R indexes [all data]  R1 = 0.0650, wR2 = 0.1134  
Largest diff. peak/hole / e Å
-3
  0.305/-0.229 
 
 
 
 
 
 
 
 
 
 
 
 
 
